McCloskey, Eugene, Professor

Professor Eugene McCloskey

MD, FRCPI

School of Medicine and Population Health

Professor in Adult Bone Disease

Honorary Consultant

E.V.McCloskey@sheffield.ac.uk
+44 114 215 9695

+44 114 215 9236

+44 114 261 8775 (fax)

Metabolic Bone Centre, Sorby Wing, Northern General Hospital

Office EU14 at the Medical School

Full contact details

Professor Eugene McCloskey
School of Medicine and Population Health
Metabolic Bone Centre, Sorby Wing
Northern General Hospital
Herries Road
΢��Ȧ
S5 7AU

Profile

For enquiries please contact - SMPH-West-Operational@sheffield.ac.uk

Born in Loughgiel, Northern Ireland, I studied medicine at Trinity College Dublin before arriving in ΢��Ȧ in 1985 via house officer posts in Ayrshire.

Research interests

I developed my longstanding interest in metabolic bone diseases via an MRC Training Fellowship. My initial interests were in the field of malignant bone disease, but subsequently focussed on osteoporosis. I have been the principal investigator in a number of MRC and pharmaceutical industry-funded studies.

I am an acknowledged expert in the fields of vertebral fracture definition, osteoporosis epidemiology as well as non-invasive assessments of bone strength and fracture risk. I have published over 150 peer-reviewed articles, book chapters, guidelines, and reviews.

Current Projects

FRAX and fracture risk assessment
Interaction between physical and pharmaceutical interventions

Publications

Show: Featured publications All publications

Featured publications

Journal articles

Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, Gittoes N, Harvey I, Harvey N, Heawood A , Holland R et al (2018) . The Lancet, 391(10122), 741-747.
Kanis JA, Odén A, McCloskey EV, Johansson H, Wahl DA, Cooper C & IOF Working Group on Epidemiology and Quality of Life (2012) . Osteoporos Int, 23(9), 2239-2256.
Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Dawson-Hughes B, El-Hajj Fuleihan G , Johansson H et al (2011) . Osteoporos Int, 22(9), 2395-2411.
McCloskey EV, Johansson H, Oden A, Vasireddy S, Kayan K, Pande K, Jalava T & Kanis JA (2009) . Osteoporos Int, 20(5), 811-817.
Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A & National Osteoporosis Guideline Group (2008) . Osteoporos Int, 19(10), 1395-1408.
Kanis JA, Johnell O, Oden A, Johansson H & McCloskey E (2008) . Osteoporosis International, 19(4), 385-397.
Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ & Khaltaev N (2008) . Bone, 42(3), 467-475.
McCloskey EV, Beneton M, Charlesworth D, Kayan K, deTakats D, Dey A, Orgee J, Ashford R, Forster M, Cliffe J , Kersh L et al (2007) . J Bone Miner Res, 22(1), 135-141.
Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H , McCloskey EV et al (2004) . Bone, 35(2), 375-382.
Powles T, Paterson S, Kanis JA, McCloskey E, Ashley S, Tidy A, Rosenqvist K, Smith I, Ottestad L, Legault S , Pajunen M et al (2002) . Journal of Clinical Oncology, 20(15), 3219-3224.
McCloskey EV, Dunn JA, Kanis JA, MacLennan IC & Drayson MT (2001) . Br J Haematol, 113(4), 1035-1043.
McCloskey EV, MacLennan ICM, Drayson MT, Chapman C, Dunn J, Kanis JA & MRC Working Party Leukaemia Adults (1998) A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. BRIT J HAEMATOL, 100(2), 317-325.
McCloskey EV, Spector TD, Eyres KS, Fern ED, O'Rourke N, Vasikaran S & Kanis JA (1993) . Osteoporos Int, 3(3), 138-147.

All publications

Journal articles

Veronese N, Harvey NC, Rizzoli R, Fuggle NR, Reginster J-Y, Fuggle NR, Laslop A, Al-Daghri N, Alokail M, Balkowiec-Iskra E , Beaudart C et al (2025) . Drugs & Aging, 42(3), 179-181.
Jaalkhorol M, Johansson H, Avirmed S, Dashtseren A, Bruyère O, Lorentzon M, Harvey NC, McCloskey EV & Kanis JA (2025) . Archives of Osteoporosis, 20(1), 27.
Tan ATH, Johansson H, Harvey NC, Lorentzon M, Kanis JA, McCloskey E & Schini M (2025) . Gaceta Médica de México, 160(4).
Tan ATH, Johansson H, Harvey NC, Lorentzon M, Kanis JA, McCloskey E & Schini M (2024) . Gaceta Médica de México, 160(4).
Gandham A, Gregori G, Johansson L, Larsson BAM, Johansson H, Harvey NC, Vandenput L, McCloskey E, Kanis JA, Litsne H , Axelsson K et al (2024) . Osteoporosis International, 1-10.
Kistler-Fischbacher M, Armbrecht G, Gängler S, Theiler R, Rizzoli R, Dawson-Hughes B, Kanis JA, Hofbauer LC, Schimmer RC, Vellas B , Da Silva JAP et al (2024) . Journal of Bone and Mineral Research, 39(6), 661-671.
Tai T-W, Chen H-Y, Shih C-A, Huang C-F, McCloskey E, Lee J-K, Yeap SS, Cheung C-L, Charatcharoenwitthaya N, Jaisamrarn U , Kuptniratsaikul V et al (2024) . Osteoporosis and Sarcopenia.
Jones C, Gray S, Brown M, Brown J, McCloskey E, Rai BP, Clarke N & Sachdeva A (2024) . European Urology Oncology.
Goel H, Binkley N, Boggild M, Chan WP, Leslie WD, McCloskey E, Morgan SL, Silva BC & Cheung AM (2024) . Journal of Clinical Densitometry, 27(1), 101452-101452.
Johansson H, Pandey D, Lorentzon M, Harvey NC, McCloskey EV & Kanis JA (2023) . Archives of Osteoporosis, 19(1), S269-S269.
Albergaria BH, Zerbini CAF, Lazaretti-Castro M, Eis SR, Vilaca T, Johansson H, Harvey NC, Liu E, Vandenput L, Lorentzon M , Schini M et al (2023) . Archives of Osteoporosis, 18(1).
Leslie WD, Binkley N, Goel H, Hans D & McCloskey EV (2023) . Journal of Clinical Densitometry, 101429-101429.
Leslie WD, Binkley N, Goel H, McCloskey EV & Hans D (2023) . Journal of Clinical Densitometry, 26(4), 101430-101430.
López Gavilánez E, Johansson H, Harvey N, Lorentzon M, McCloskey E, Valdivieso Jara J & Kanis JA (2023) . Revista Colombiana de Reumatología (English Edition), 30(3), 199-206.
Leslie WD, Binkley N, Goel H, Hans D & McCloskey EV (2023) . Journal of Clinical Densitometry, 101415-101415.
Yeh EJ, Gitlin M, Sorio F & McCloskey E (2023) . Archives of Osteoporosis, 18.
Ye C, Morin SN, Lix LM, McCloskey EV, Johansson H, Harvey NC, Kanis JA & Leslie WD (2023) . Journal of Bone and Mineral Research.
Leslie WD, Binkley N, Hans D & McCloskey EV (2023) . Journal of Clinical Densitometry.
Leslie WD, Goel H, Binkley N, McCloskey EV & Hans D (2023) . Journal of Bone and Mineral Research.
Westbury LD, Beaudart C, Bruyère O, Cauley JA, Cawthon P, Cruz‐Jentoft AJ, Curtis EM, Ensrud K, Fielding RA, Johansson H , Kanis JA et al (2023) . Journal of Cachexia, Sarcopenia and Muscle.
Payer J, Vyskočil V & McCloskey E (2023) Award of top experts and collaborators of the Society for Metabolic Diseases of the Skeleton ČLS JEP. Clinical Osteology(3), 49.
Leslie WD, Binkley N, McCloskey EV, Johansson H, Harvey NC, Lorentzon M, Kanis JA & Hans D (2023) . Journal of Clinical Densitometry, 101378-101378.
Haarhaus M, Aaltonen L, Cejka D, Cozzolino M, de Jong RT, D'Haese P, Evenepoel P, Lafage-Proust M-H, Mazzaferro S, McCloskey E , Salam S et al (2023) . Clinical Kidney Journal, 16(3), 456-472.
Schini M, Bhatia P, Shreef H, Johansson H, Harvey NC, Lorentzon M, Kanis JA, Bandman O & McCloskey EV (2022) . Bone, 116651-116651.
Harvey NC, Clegg PD, Dennison EM, Greenhaff P, Griffin SJ, Gregson CL, Jackson MJ, Lord JM, McCloskey EV, Stevenson E , Tobias JH et al (2022) . Archives of Osteoporosis, 17(1).
Dimai HP, Johansson H, Harvey NC, Lorentzon M, Liu E, Vandenput L, Fahrleitner-Pammer A, Pietschmann P, Muschitz C, McCloskey EV & Kanis JA (2022) . Archives of Osteoporosis, 17(1).
Harvey NC, Orwoll E, Cauley JA, Kwok T, Karlsson MK, Rosengren BE, Ribom E, Cawthon PM, Ensrud K, Liu E , Laskou F et al (2022) . JBMR Plus.
Kanis JA, McCloskey EV, Harvey NC, Cooper C, Rizzoli R, Dawson-Hughes B, Maggi S & Reginster J-Y (2022) . Aging Clinical and Experimental Research, 34(12), 3155-3157.
Albergaria B-H, Zerbini CAF, Szejnfeld VL, Eis SR, Silva DMW, de Fatima Lobato da Cunha M, McClung MR, Kanis JA, McCloskey EV, Vilaca T & Lazaretti-Castro M (2022) . Archives of Osteoporosis, 17(1).
Chotiyarnwong P, McCloskey EV, Harvey NC, Lorentzon M, Prieto-Alhambra D, Abrahamsen B, Adachi JD, Borgström F, Bruyere O, Carey JJ , Clark P et al (2022) . Archives of Osteoporosis, 17(1).
McCloskey E, Harvey NC, Lorentzon M, Johansson H, Hans D & Kanis JA (2022) . Calcif Tissue Int.
Gregson CL, Armstrong DJ, Bowden J, Cooper C, Edwards J, Gittoes NJL, Harvey N, Kanis J, Leyland S, Low R , McCloskey E et al (2022) . Archives of Osteoporosis, 17(1).
Zheng Z, Johansson H, Harvey NC, Lorentzon M, Vandenput L, Liu E, Kanis JA & McCloskey EV (2022) . J Bone Miner Res.
Gregson CL, Armstrong DJ, Bowden J, Cooper C, Edwards J, Gittoes NJL, Harvey N, Kanis J, Leyland S, Low R , McCloskey E et al (2022) . Archives of Osteoporosis, 17(1).
Saleh YAL, Sulimani RA, Alomary S, Alnajjar YI, Vandenput L, Liu E, Lorentzon M, Harvey NC, McCloskey EV, Johansson H , Kanis JA et al (2022) . Archives of Osteoporosis, 17(1).
Gupta A, Maslen C, Vindlacheruvu M, Abel RL, Bhattacharya P, Bromiley PA, Clark EM, Compston JE, Crabtree N, Gregory JS , Kariki EP et al (2022) . Therapeutic Advances in Musculoskeletal Disease, 14.
Abdulla N, Alsaed OS, Lutf A, Alam F, Abdulmomen I, Al Emadi S, Harvey NC, Liu E, Vandenput L, Lorentzon M , McCloskey E et al (2022) . Archives of Osteoporosis, 17(1).
Willers C, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M, McCloskey EV, Borgström F & Kanis JA (2022) . Archives of Osteoporosis, 17(1).
McCloskey E, Rathi J, Heijmans S, Blagden M, Cortet B, Czerwinski E, Hadji P, Payer J, Palmer K, Stad R , O’Kelly J et al (2022) . Archives of Osteoporosis, 17(1).
Harvey NC, Poole KE, Ralston SH, McCloskey EV, Sangan CB, Wiggins L, Jones C, Gittoes N, Compston J, Abrahamsen B , Gregson C et al (2022) . Archives of Osteoporosis, 17(1).
Johansson L, Johansson H, Axelsson KF, Litsne H, Harvey NC, Liu E, Leslie WD, Vandenput L, McCloskey E, Kanis JA & Lorentzon M (2022) . Osteoporosis International.
Vandenput L, Johansson H, McCloskey EV, Liu E, Åkesson KE, Anderson FA, Azagra R, Bager CL, Beaudart C, Bischoff-Ferrari HA , Biver E et al (2022) . Osteoporosis International.
Al-Daghri NM, Sabico S, Al-Saleh Y, Sulimani R, Aljohani NJ, Sheshah E, Alodhayani A, Harvey NC, Liu E, Lorentzon M , McCloskey EV et al (2021) . Archives of Osteoporosis, 16(1).
Möller S, Skjødt MK, Yan L, Abrahamsen B, Lix LM, McCloskey EV, Johansson H, Harvey NC, Kanis JA, Rubin KH & Leslie WD (2021) . Osteoporos Int.
Soriano-Arroquia A, Gostage J, Xia Q, Bardell D, McCormick R, McCloskey E, Bellantuono I, Clegg P, McDonagh B & Goljanek-Whysall K (2021) . Aging Cell.
Johansson H, Naureen G, Iqbal R, Jafri L, Khan AH, Umer M, Liu E, Vandenput L, Lorentzon M, McCloskey EV , Kanis JA et al (2021) . Osteoporosis International.
Lorentzon M, Johansson H, Harvey NC, Liu E, Vandenput L, McCloskey EV & Kanis JA (2021) . Climacteric, 1-7.
Povoroznyuk V, Grygorieva N, Johansson H, Lorentzon M, Harvey NC, McCloskey EV, Musienko A, Liu E, Kanis JA, Zaverukha N & Ivanyk O (2021) . Journal of Osteoporosis, 2021, 1-7.
Kebaetse M, Nkhwa S, Mogodi M, Masunge J, Gureja YP, Ramabu M, Mmopelwa T, Sharif I, Orford A, Harvey NC , McCloskey EV et al (2021) . Archives of Osteoporosis, 16(1).
Lesnyak O, Zakroyeva A, Babalyan V, Cazac V, Gabdulina G, Ismailov S, Lobanchenko O, Rudenka E, Tsagareli M, Johansson H , Harvey NC et al (2021) . Archives of Osteoporosis, 16(1).
Kanis JA, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M, McCloskey EV, Willers C & Borgström F (2021) . Arch Osteoporos, 16(1), 82.
McCloskey EV, Borgstrom F, Cooper C, Harvey NC, Javaid MK, Lorentzon M & Kanis JA (2021) . Osteoporosis International.
Papaioannou A, McCloskey E, Bell A, Ngui D, Mehan U, Tan M, Goldin L & Langer A (2021) . Archives of Osteoporosis, 16.
Harvey NC, Orwoll E, Kwok T, Karlsson MK, Rosengren BE, Ribom E, Cauley JA, Cawthon PM, Ensrud K, Liu E , Cruz-Jentoft AJ et al (2021) . Journal of Bone and Mineral Research.
Kanis JA, Johansson H, Harvey NC, Lorentzon M, Liu E, Vandenput L & McCloskey EV (2021) . Osteoporosis International.
(2021) . The Journal of Clinical Endocrinology & Metabolism, 106(4), e1931-e1931.
Harvey NC, Kanis JA, Liu E, Vandenput L, Lorentzon M, Cooper C, McCloskey E & Johansson H (2021) . Osteoporosis International, 32(10), 1973-1979.
Johansson H, Dela SS, Cassim B, Paruk F, Brown SL, Conradie M, Harvey NC, Jordaan JD, Kalla AA, Liu E , Lorentzon M et al (2021) . Archives of Osteoporosis, 16(1).
Naureen G, Johansson H, Iqbal R, Jafri L, Khan AH, Umer M, Liu E, Vandenput L, Lorentzon M, Harvey NC , McCloskey EV et al (2021) . Archives of Osteoporosis, 16.
Kebaetse M, Nkhwa S, Mogodi M, Masunge J, Gureja YP, Ramabu M, Mmopelwa T, Sharif I, Orford A, Johansson H , Harvey NC et al (2021) . Archives of Osteoporosis, 16.
Lu T, Forgetta V, Keller-Baruch J, Nethander M, Bennett D, Forest M, Bhatnagar S, Walters RG, Lin K, Chen Z , Li L et al (2021) . Genome Medicine, 13(1).
McCloskey EV, Johansson H, Harvey NC, Lorentzon M, Shi Y & Kanis JA (2021) . Osteoporosis International.
Altai Z, Montefiori E, van Veen B, A. Paggiosi M, McCloskey EV, Viceconti M, Mazzà C & Li X (2021) . PLoS ONE, 16(2).
Harvey NC, Kanis JA, Liu E, Cooper C, Lorentzon M, Bea JW, Carbone L, Cespedes Feliciano EM, Laddu DR, Schnatz PF , Shadyab AH et al (2021) . Journal of Bone and Mineral Research.
Hartley A, Hardcastle SA, Frysz M, Parkinson J, Paternoster L, McCloskey E, Poole KES, Javaid MK, Aye M, Moss K , Williams M et al (2021) . Arthritis Research & Therapy, 23(1).
Larsson BAM, Johansson L, Johansson H, Axelsson KF, Harvey N, Vandenput L, Magnusson P, McCloskey E, Liu E, Kanis JA , Sundh D et al (2021) . Osteoporosis International, 32(1), 75-84.
Leslie WD, Morin SN, Lix LM, McCloskey EV, Johansson H, Harvey NC & Kanis JA (2021) . Osteoporosis International, 32(1), 113-122.
Duerksen DR, Lix LM, Johansson H, McCloskey EV, Harvey NC, Kanis JA & Leslie WD (2021) . Osteoporosis International, 32(1), 93-99.
López Gavilánez E, Johansson H, Harvey N, Lorentzon M, McCloskey E, Valdivieso Jara J & Kanis JA (2021) . Revista Colombiana de Reumatologia.
Burden AM, Tanaka Y, Xu L, Ha YC, McCloskey E, Cummings SR & Glüer CC (2021) . Osteoporosis International, 32(5), 817-829.
Kanis JA, Harvey NC, Lorentzon M, Liu E, Vandenput L, McCloskey EV & Johansson H (2021) . Osteoporosis International, 32(1), 165-171.
Tsourdi E, Zillikens MC, Meier C, Body J-J, Gonzalez Rodriguez E, Anastasilakis AD, Abrahamsen B, McCloskey E, Hofbauer LC, Guañabens N , Obermayer-Pietsch B et al (2021) . The Journal of Clinical Endocrinology & Metabolism, 106(1), 264-281.
Kanis JA, Johansson H, Harvey NC, Gudnason V, Sigurdsson G, Siggeirsdottir K, Lorentzon M, Liu E, Vandenput L, Leslie WD & McCloskey EV (2021) . Osteoporosis International, 32(1), 47-54.
McCloskey E, Paterson AH, Powles T & Kanis JA (2021) . Bone, 143, 115715-115715.
Spain L, Yang L, Wilkinson JM & McCloskey E (2020) . Bone, 144.
Montefiori E, Kalkman B, Henson W, Paggiosi M, McCloskey E & Mazza C (2020) . PLoS ONE, 15(12).
Wu C-H, Hung W-C, Chang I-L, Tsai T-T, Chang Y-F, McCloskey EV, Watts NB, McClung MR, Huang C-F, Chen C-H , Wu K-L et al (2020) . Bone Reports, 13.
Brown JE, Handforth C, Compston JE, Cross W, Parr N, Selby P, Wood S, Drudge-Coates L, Walsh JS, Mitchell C , Collinson FJ et al (2020) . Journal of Bone Oncology, 25.
Lesnyak O, Ismailov S, Shakirova M, Alikhanova N, Zakroyeva A, Abboskhujaeva L, Johansson H, Harvey NC, McCloskey E & Kanis JA (2020) . Archives of Osteoporosis, 15(1).
Leslie WD, Schousboe JT, Morin SN, Martineau P, Lix LM, Johansson H, McCloskey EV, Harvey NC & Kanis JA (2020) . Archives of Osteoporosis, 15(1).
Borgström F, Karlsson L, Ortsäter G, Norton N, Halbout P, Cooper C, Lorentzon M, McCloskey EV, Harvey NC, Javaid MK & Kanis JA (2020) . Archives of Osteoporosis, 15(1).
Kirilova E, Johansson H, Kirilov N, Vladeva S, Petranova T, Kolarov Z, Liu E, Lorentzon M, Vandenput L, Harvey NC , McCloskey E et al (2020) . Archives of Osteoporosis, 15(1).
Issayeva S, Lesnyak O, Zakroyeva A, Issayeva B, Dilmanova D, Johansson H, Liu E, Lorentzon M, Harvey NC, McCloskey E & Kanis JA (2020) . Archives of Osteoporosis, 15(1).
Zakroyeva A, Lesnyak O, Cazac V, Groppa L, Russu E, Chislari L, Rotaru L, Johansson H, Harvey NC, McCloskey E , Lorentzon M et al (2020) . Archives of Osteoporosis, 15(1).
Bischoff-Ferrari HA, Vellas B, Rizzoli R, Kressig RW, da Silva JAP, Blauth M, Felson DT, McCloskey EV, Watzl B, Hofbauer LC , Felsenberg D et al (2020) . JAMA, 324(18), 1855-1855.
Trela-Larsen L, Kroken G, Bartz-Johannessen C, Sayers A, Aram P, McCloskey E, Kadirkamanathan V, Blom AW, Lie SA, Furnes ON & Wilkinson JM (2020) . Bone & Joint Research, 9(11), 808-820.
Almog YA, Rai A, Zhang P, Moulaison A, Powell R, Mishra A, Weinberg K, Hamilton C, Oates M, McCloskey E & Cummings SR (2020) . Journal of Medical Internet Research, 22(10).
McCloskey EV, Harvey NC, Johansson H, Lorentzon M, Vandenput L, Liu E & Kanis JA (2020) . Osteoporosis International.
Miller PD, Bilezikian JP, Fitzpatrick LA, Mitlak B, McCloskey EV, Cosman F & Bone HG (2020) . Current Medical Research and Opinion.
Paggiosi MA, Peel N, McCloskey E, Walsh JS & Eastell R (2020) . Bone Reports, 13, 100677-100677.
Zotov E, Hills AF, de Mello FL, Aram P, Sayers A, Blom AW, McCloskey EV, Wilkinson JM & Kadirkamanathan V (2020) . International Journal of Medical Informatics, 142.
Kanis JA, Cooper C, Dawson-Hughes B, Harvey NC, Johansson H, Lorentzon M, McCloskey EV, Reginster J-Y & Rizzoli R (2020) . Osteoporosis International, 31(11), 2063-2067.
McCloskey E, Rathi J, Heijmans S, Blagden M, Cortet B, Czerwinski E, Hadji P, Payer J, Palmer K, Stad R , O’Kelly J et al (2020) . Osteoporosis International.
Kanis JA, Chandran M, Chionh SB, Ganeson G, Harvey NC, Koh W-P, Kwok T, Lau TC, Liu E, Lorentzon M , McCloskey EV et al (2020) . Archives of Osteoporosis, 15(1).
Forgetta V, Keller-Baruch J, Forest M, Durand A, Bhatnagar S, Kemp JP, Nethander M, Evans D, Morris JA, Kiel DP , Rivadeneira F et al (2020) . PLoS Medicine, 17(7).
Kanis JA, Johansson H, Harvey NC, Gudnason V, Sigurdsson G, Siggeirsdottir K, Lorentzon M, Liu E, Vandenput L & McCloskey EV (2020) . Osteoporosis International, 31(10), 1817-1828.
Pepe J, Body J-J, Hadji P, McCloskey E, Meier C, Obermayer-Pietsch B, Palermo A, Tsourdi E, Zillikens MC, Langdahl B & Ferrari S (2020) . The Journal of Clinical Endocrinology & Metabolism.
Almog Y, Rai A, Mishra A, Moulaison A, Powell R, Weinberg K, Hamilton C, Oates M, McCloskey E & Cummings SR (2020) . Journal of the Endocrine Society, 4(Supplement_1).
Lesnyak O, Zakroyeva A, Lobanchenko O, Johansson H, Liu E, Lorentzon M, Harvey NC, McCloskey E & Kanis JA (2020) . Archives of Osteoporosis, 15(1).
Hartley A, Hardcastle SA, Paternoster L, McCloskey E, Poole KES, Javaid MK, Aye M, Moss K, Granell R, Gregory J , Williams M et al (2020) . Osteoarthritis and Cartilage, 28(9), 1180-1190.
Chotiyarnwong P & McCloskey EV (2020) . Nature Reviews Endocrinology, 16(8), 437-447.
Leslie WD, Schousboe JT, Morin SN, Martineau P, Lix LM, Johansson H, McCloskey EV, Harvey NC & Kanis JA (2020) . Osteoporosis International, 31(6), 1059-1067.
Condurache CI, Chiu S, Chotiyarnwong P, Johansson H, Shepstone L, Lenaghan E, Cooper C, Clarke S, Khioe RFS, Fordham R , Gittoes N et al (2020) . Osteoporosis International, 31(3), 457-464.
Kanis JA, Harvey NC, McCloskey E, Bruyère O, Veronese N, Lorentzon M, Cooper C, Rizzoli R, Adib G, Al-Daghri N , Campusano C et al (2020) . Osteoporosis International, 31(4), 797-798.
Kanis JA, Harvey NC, Johansson H, Liu E, Vandenput L, Lorentzon M, Leslie WD & McCloskey EV (2020) . Aging Clinical and Experimental Research, 32(2), 187-196.
Leslie WD, Schousboe JT, Morin SN, Martineau P, Lix LM, Johansson H, McCloskey EV, Harvey NC & Kanis JA (2020) . Osteoporosis International, 31(6), 1079-1087.
Chotiyarnwong P, McCloskey E, Eastell R, McClung MR, Gielen E, Gostage J, McDermott M, Chines A, Huang S & Cummings SR (2020) . Journal of Bone and Mineral Research.
Rozenberg S, Al-Daghri N, Aubertin-Leheudre M, Brandi M-L, Cano A, Collins P, Cooper C, Genazzani AR, Hillard T, Kanis JA , Kaufman J-M et al (2020) . Osteoporosis International, 31(12), 2271-2286.
McCloskey E, Harvey N, Johansson H, Lorentzon M, Vandenput L & Kanis JA (2020) . Osteoporosis International, 31(6), 1179-1180.
Koromani F, Oei L, Shevroja E, Trajanoska K, Schoufour J, Muka T, Franco OH, Ikram MA, Zillikens MC, Uitterlinden AG , Krestin GP et al (2020) . Diabetes Care, 43(1), 137-144.
Leslie WD, Morin SN, Lix LM, Martineau P, Bryanton M, McCloskey EV, Johansson H, Harvey NC & Kanis JA (2020) . JAMA Network Open, 3(1).
Kanis JA, Harvey NC, McCloskey E, Bruyère O, Veronese N, Lorentzon M, Cooper C, Rizzoli R, Adib G, Al-Daghri N , Campusano C et al (2020) . Osteoporosis International, 31(1), 1-12.
Harvey NC, Lorentzon M, Kanis JA, McCloskey E & Johansson H (2020) . Journal of Public Health, 42(4), e440-e448.
Gossiel F, Paggiosi MA, Naylor KE, McCloskey EV, Walsh J, Peel N & Eastell R (2020) . Bone, 131.
Chotiyarnwong P, Harvey NC, Johansson H, Liu E, Lorentzen M, Kanis JA & McCloskey EV (2019) . Archives of Osteoporosis, 14(1).
McCloskey EV, Fitzpatrick LA, Hu M-Y, Williams G & Kanis JA (2019) . Archives of Osteoporosis, 14(1).
Lopez Gavilanez E, Johansson H, McCloskey E, Harvey NC, Segale Bajana A, Marriott Blum D, Navarro Grijalva M, Diaz Curiel M & Kanis JA (2019) . Archives of Osteoporosis, 14(1).
Fathi Kazerooni A, Pozo JM, McCloskey EV, Saligheh Rad H & Frangi AF (2019) . Journal of Magnetic Resonance Imaging.
Svedbom A, Borgstrom F, Hernlund E, Alekna V, Bianchi ML, Clark P, Diaz Curiel M, Dimai HP, Jurisson M, Olga L , McCloskey E et al (2019) . Value in Health, 22, S705-S706.
Anastasilakis AD, Tsourdi E, Makras P, Polyzos SA, Meier C, McCloskey EV, Pepe J & Zillikens MC (2019) . Bone, 127, 401-418.
Farzi M, Pozo JM, McCloskey E, Eastell R, Harvey N, Wilkinson JM & Frangi AF (2019) . IEEE Transactions on Medical Imaging.
Lorentzon M, Branco J, Brandi ML, Bruyère O, Chapurlat R, Cooper C, Cortet B, Diez-Perez A, Ferrari S, Gasparik A , Herrmann M et al (2019) . Advances in Therapy, 36(10), 2811-2824.
Bauer JM, Cruz-Jentoft AJ, Fielding RA, Kanis JA, Reginster J-Y, Bruyère O, Cesari M, Chapurlat R, Al-Daghri N, Dennison E , Kaufman J-M et al (2019) . Calcified Tissue International, 105(2), 125-126.
Leslie WD, Morin SN, Lix LM, Martineau P, Bryanton M, McCloskey EV, Johansson H, Harvey NC & Kanis JA (2019) . Osteoporosis International, 30(11), 2195-2203.
Beaudart C, Rolland Y, Cruz-Jentoft AJ, Bauer JM, Sieber C, Cooper C, Al-Daghri N, Araujo de Carvalho I, Bautmans I, Bernabei R , Bruyère O et al (2019) . Calcified Tissue International, 105(1), 1-14.
Leslie WD, Morin SN, Lix LM, Niraula S, McCloskey EV, Johansson H, Harvey NC & Kanis JA (2019) . The Oncologist, 24(11), 1432-1438.
Dennison EM, Cooper C, Kanis JA, Bruyère O, Silverman S, McCloskey E, Abrahamsen B, Prieto-Alhambra D & Ferrari S (2019) . Osteoporosis International, 30(9), 1733-1743.
Leslie WD, Morin SN, Lix LM, Niraula S, McCloskey EV, Johansson H, Harvey NC & Kanis JA (2019) . Journal of Bone and Mineral Research, 34(8), 1428-1435.
Wilkinson JM, Trela-Larsen L, Bartz-Johannessen C, Sayers A, Aram P, McCloskey E, Kadirkamanathan V, Blom A, Lie S & Furnes O (2019) . Osteoarthritis and Cartilage, 27, S229-S229.
Harvey NC, Kanis JA, Liu E, Johansson H, Lorentzon M & McCloskey E (2019) . Osteoporosis International, 30(3), 537-539.
Naylor KE, McCloskey EV, Jacques RM, Peel NFA, Paggiosi MA, Gossiel F, Walsh JS & Eastell R (2019) . Osteoporosis International.
Bauer JM, Cruz-Jentoft AJ, Fielding RA, Kanis JA, Reginster J-Y, Bruyère O, Cesari M, Chapurlat R, Al-Daghri N, Dennison E , Kaufman J-M et al (2019) . Calcified Tissue International, 105(2), 109-124.
Kanis JA, Johansson H, Harvey NC, Lorentzon M, Liu E, Borgström F & McCloskey EV (2019) . Osteoporosis International, 30(2), 525-526.
Khashayar P, Keshtkar A, Ostovar A, Larijani B, Johansson H, Harvey NC, Lorentzon M, McCloskey E & Kanis JA (2019) . Osteoporosis International, 30(11), 2225-2230.
Svedbom A, Hadji P, Hernlund E, Thoren R, McCloskey E, Stad R & Stollenwerk B (2019) . Osteoporosis International, 30(9), 1745-1754.
Harvey NC, Odén A, Orwoll E, Lapidus J, Kwok T, Karlsson MK, Rosengren BE, Ribom E, Cooper C, Cawthon PM , Kanis JA et al (2018) . Journal of Bone and Mineral Research, 33(12), 2150-2157.
Buckinx F, Landi F, Cesari M, Fieding RA, Visser M, Engelke K, Maggi S, Dennison E, Al-Daghri NM, Allepaerts S , Bauer J et al (2018) . Journal of Cachexia, Sarcopenia and Muscle, 9(7), 1272-1274.
Alsayednoor J, Metcalf L, Rochester J, Dall’Ara E, McCloskey E & Lacroix D (2018) . Biomechanics and Modeling in Mechanobiology, 17(6), 1715-1730.
Ramanau H, Chernyanin I, Rudenka E, Lesnyak O, Zakroyeva A, Bilezikian JP, Johansson H, Harvey NC, McCloskey EV & Kanis JA (2018) . Archives of Osteoporosis, 13(1).
Chandran M, McCloskey EV, Thu WPP, Logan S, Hao Y, Tay D, Ang WC, Aung TKK, Choo KS, Ali A , Yan SX et al (2018) . Archives of Osteoporosis, 13(1).
Kanis JA, Johansson H, Harvey NC & McCloskey EV (2018) . Archives of Osteoporosis, 13(1).
Povoroznyuk VV, Grygorieva NV, Korzh MO, Strafun SS, Vaida VM, Klymovytsky FV, Vlasenko RO, Kanis JA, Johansson H & McCloskey EV (2018) . Journal of Clinical Densitometry, 21(4), 603-603.
Aram P, Trela-Larsen L, Sayers A, Hills AF, Blom AW, McCloskey EV, Kadirkamanathan V & Wilkinson JM (2018) . American Journal of Epidemiology, 187(10), 2252-2262.
Kemp GJ, Jackson MJ, McCloskey EV, Mathers JC & CIMA Toolkit Working Group (2018) . Age and Ageing, 47(6), 774-777.
Kemp GJ, Birrell F, Clegg PD, Cuthbertson DJ, De Vito G, Van Dieën JH, Del Din S, Eastell R, Garnero P, Goljanek-Whysall K , Hackl M et al (2018) . Age and Ageing, 47, iv1-iv19.
Buckinx F, Landi F, Cesari M, Fieding RA, Visser M, Engelke K, Maggi S, Dennison E, Al-Daghri NM, Allepaerts S , Bauer J et al (2018) . Journal of Cachexia, Sarcopenia and Muscle, 9(4), 788-790.
Shepstone L & McCloskey E (2018) . The Lancet, 392(10147), 552-553.
Martineau P, Leslie WD, Johansson H, Harvey NC, McCloskey EV, Hans D & Kanis JA (2018) . Bone, 113, 161-168.
Leslie WD, Johansson H, McCloskey EV, Harvey NC, Kanis JA & Hans D (2018) . Journal of Bone and Mineral Research, 33(11), 1923-1930.
McCloskey E, Johansson H, Harvey NC, Shepstone L, Lenaghan E, Fordham R, Harvey I, Howe A, Cooper C, Clarke S , Gittoes N et al (2018) . Journal of Bone and Mineral Research, 33(6), 1020-1026.
Kanis JA, Johansson H, Odén A, Harvey NC, Gudnason V, Sanders KM, Sigurdsson G, Siggeirsdottir K, Fitzpatrick LA, Borgström F & McCloskey EV (2018) . Osteoporosis International, 29(8), 1747-1757.
Harvey NC, McCloskey E, Kanis JA, Compston J & Cooper C (2018) . Osteoporosis International, 29(7), 1511-1513.
Povoroznyuk VV, Grygorieva NV, Kanis JA, McCloskey EV, Johansson H, Strafun SS, Korzh MO, Vaida VM, Klymovytsky FV, Forosenko VS & Vlasenko RO (2018) . Journal of Osteoporosis, 2018.
Paggiosi MA, Yang L, Blackwell D, Walsh JS, McCloskey E, Peel N & Eastell R (2018) . Osteoporosis International, 29(6), 1367-1378.
Naylor KE, Bradburn M, Paggiosi MA, Gossiel F, Peel NFA, McCloskey EV, Walsh JS & Eastell R (2018) . Osteoporosis International, 29(6), 1407-1417.
Turner DA, Khioe RFS, Shepstone L, Lenaghan E, Cooper C, Gittoes N, Harvey NC, Holland R, Howe A, McCloskey E , O'Neill TW et al (2018) . Journal of Bone and Mineral Research, 33(5), 845-851.
Buckinx F, Landi F, Cesari M, Fielding RA, Visser M, Engelke K, Maggi S, Dennison E, Al-Daghri NM, Allepaerts S , Bauer J et al (2018) . Journal of Cachexia, Sarcopenia and Muscle, 9(2), 269-278.
Gossiel F, Scott JR, Paggiosi MA, Naylor KE, McCloskey EV, Peel NFA, Walsh JS & Eastell R (2018) . Journal of Clinical Endocrinology and Metabolism, 103(4), 1302-1309.
Yang S, Luo Y, Yang L, Dall'Ara E, Eastell R, Goertzen AL, McCloskey EV, Leslie WD & Lix LM (2018) . Bone, 110, 386-391.
Harvey NC, Odén A, Orwoll E, Lapidus J, Kwok T, Karlsson MK, Rosengren BE, Ljunggren Ö, Cooper C, McCloskey E , Kanis JA et al (2018) . Journal of Bone and Mineral Research, 33(3), 510-516.
Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, Gittoes N, Harvey I, Harvey N, Heawood A , Holland R et al (2018) . The Lancet, 391(10122), 741-747.
Leslie WD, Majumdar SR, Morin SN, Lix LM, Schousboe JT, Ensrud KE, Johansson H, McCloskey EV & Kanis JA (2018) . Osteoporosis International, 29(3), 759-767.
Leslie WD, Shevroja E, Johansson H, McCloskey EV, Harvey NC, Kanis JA & Hans D (2018) . Osteoporosis International, 29(3), 751-758.
Johansson H, Hongslo Vala C, Odén A, Lorentzon M, McCloskey E, Kanis JA, Harvey NC, Ohlsson C, Stefan Lohmander L, Kärrholm J & Mellström D (2018) . Osteoporosis International, 29(3), 741-749.
Metcalf LM, Dall'Ara E, Paggiosi MA, Rochester JR, Vilayphiou N, Kemp GJ & McCloskey EV (2018) . Bone, 106, 69-77.
Svedbom A, Borgström F, Hernlund E, Ström O, Alekna V, Bianchi ML, Clark P, Curiel MD, Dimai HP, Jürisson M , Uusküla A et al (2018) . Quality of Life Research, 27(3), 707-716.
Svedbom A, Borgstöm F, Hernlund E, Ström O, Alekna V, Bianchi ML, Clark P, Curiel MD, Dimai HP, Jürisson M , Kallikorm R et al (2018) . Osteoporosis International, 29(3), 557-566.
Robinson SM, Reginster JY, Rizzoli R, Shaw SC, Kanis JA, Bautmans I, Bischoff-Ferrari H, Bruyère O, Cesari M, Dawson-Hughes B , Fielding RA et al (2018) . Clinical Nutrition, 37(4), 1121-1132.
Povoroznyu VV, Grygorieva NV, McCloskey EV, Johansson H & Kanis JA (2017) . International Journal of Osteoporosis and Metabolic Disorders, 11(1), 7-13.
Lesnyak O, Sahakyan S, Zakroyeva A, Bilezikian JP, Hutchings N, Babalyan V, Galstyan R, Lebedev A, Johansson H, Harvey NC , McCloskey E et al (2017) . Archives of Osteoporosis, 12(1).
Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N, Hope S, Kanis JA, McCloskey EV, Poole KES , Reid DM et al (2017) . Archives of Osteoporosis, 12(1), 43-43.
Harvey NC, McCloskey E, Kanis JA, Compston J & Cooper C (2017) . The Lancet, 390(10109), 2243-2244.
Leslie WD, Lix LM, Majumdar SR, Morin SN, Johansson H, Odén A, McCloskey EV & Kanis JA (2017) . The Journal of Clinical Endocrinology & Metabolism, 102(11), 4242-4249.
Johansson H, Azizieh F, al Ali N, Alessa T, Harvey NC, McCloskey E & Kanis JA (2017) . Osteoporosis International, 28(11), 3099-3105.
Kanis JA, Cooper C, Rizzoli R, Abrahamsen B, Al-Daghri NM, Brandi ML, Cannata-Andia J, Cortet B, Dimai HP, Ferrari S , Hadji P et al (2017) . Osteoporosis International, 28(11), 3285-3286.
Kanis JA, Harvey NC, Johansson H, Odén A, Leslie WD & McCloskey EV (2017) . Journal of Clinical Densitometry, 20(3), 360-367.
McCloskey E, Kanis J, Reginster J, Cooper C, Rizzoli R, Cruz Jentoft A & Landi F (2017) . Innovation in Aging, 1(suppl_1), 693-693.
Kanis JA, Harvey NC, Johansson H, Odén A, McCloskey EV & Leslie WD (2017) . Journal of Clinical Densitometry, 20(3), 444-450.
Leslie WD, Majumdar SR, Morin SN, Lix LM, Johansson H, Oden A, McCloskey EV & Kanis JA (2017) . Osteoporosis International.
Bolton JM, Morin SN, Majumdar SR, Sareen J, Lix LM, Johansson H, Odén A, McCloskey EV, Kanis JA & Leslie WD (2017) . JAMA Psychiatry, 74(6), 641-648.
Metcalf LM, Aspray TJ & McCloskey EV (2017) . Bone, 99, 39-46.
Povoroznyuk VV, Grygorieva NV, Kanis JA, McCloskey EV, Johansson H, Harvey NC, Korzh MO, Strafun SS, Vaida VM, Klymovytsky FV , Vlasenko RO et al (2017) . Archives of Osteoporosis, 12.
McCloskey EV, Johansson H, Oden A, Harvey NC, Jiang H, Modin S, Fitzpatrick L & Kanis JA (2017) . Journal of Bone and Mineral Research, 32(8), 1625-1631.
Harvey NC, McCloskey E & Kanis JA (2017) . Revue du Rhumatisme, 84(3), 196-198.
Harvey NCW, McCloskey EV, Mitchell PJ, Dawson-Hughes B, Pierroz DD, Reginster J-Y, Rizzoli R, Cooper C & Kanis JA (2017) . Osteoporosis International, 28(5), 1507-1529.
Kanis JA, Cooper C, Rizzoli R, Abrahamsen B, Al-Daghri NM, Brandi ML, Cannata-Andia J, Cortet B, Dimai HP, Ferrari S , Hadji P et al (2017) . Osteoporosis International, 28(7), 2023-2034.
McCloskey EV (2017) . Osteoporos Int.
(2017) . American Journal of Gastroenterology, 112(6), 974-974.
Martineau P, Leslie WD, Johansson H, Oden A, McCloskey EV, Hans D & Kanis JA (2017) . Journal of Bone and Mineral Research.
Johansson H, Siggeirsdóttir K, Harvey NC, Odén A, Gudnason V, McCloskey E, Sigurdsson G & Kanis JA (2017) . Osteoporosis International, 28(3), 775-780.
Beaudart C, Dawson A, Shaw SC, Harvey NC, Kanis JA, Binkley N, Reginster JY, Chapurlat R, Chan DC, Bruyère O , Rizzoli R et al (2017) . Osteoporosis International, 28(6), 1817-1833.
Chan D-C, McCloskey EV, Chang C-B, Lin K-P, Lim LC, Tsai K-S & Yang R-S (2017) . Journal of the Formosan Medical Association, 116(3), 161-168.
McCloskey EV, Johansson H, Harvey NC, Compston J & Kanis JA (2017) . Osteoporosis International, 28(1), 71-76.
Kanis JA, Harvey NC, Cooper C, Johansson H, Odén A & McCloskey EV (2016) . Archives of Osteoporosis, 11(1).
Majumdar SR, Leslie WD, Lix LM, Morin SN, Johansson H, Oden A, McCloskey EV & Kanis JA (2016) . The Journal of Clinical Endocrinology & Metabolism, 101(11), 4489-4496.
Beaudart C, McCloskey E, Bruyère O, Cesari M, Rolland Y, Rizzoli R, Araujo de Carvalho I, Amuthavalli Thiyagarajan J, Bautmans I, Bertière M-C , Brandi ML et al (2016) . BMC Geriatrics, 16(1).
Harvey NC, McCloskey E & Kanis JA (2016) . Joint Bone Spine, 83(5), 477-478.
Leslie WD, Majumdar SR, Lix LM, Josse RG, Johansson H, Oden A, McCloskey EV & Kanis JA (2016) . Osteoporosis International, 27(9), 2689-2695.
Gossiel F, Hoyle C, McCloskey EV, Naylor KE, Walsh J, Peel N & Eastell R (2016) . Bone, 92, 94-99.
Leslie WD, Lix LM, Morin SN, Johansson H, Odén A, McCloskey EV & Kanis JA (2016) . Journal of Clinical Densitometry, 19(3), 326-331.
Bruyère O, Beaudart C, Reginster J-Y, Buckinx F, Schoene D, Hirani V, Cooper C, Kanis JA, Rizzoli R, McCloskey E , Cederholm T et al (2016) . European Geriatric Medicine, 7(3), 243-246.
McCloskey EV, Odén A, Harvey NC, Leslie WD, Hans D, Johansson H, Barkmann R, Boutroy S, Brown J, Chapurlat R , Elders PJM et al (2016) . Journal of Bone and Mineral Research, 31(5), 940-948.
McCloskey EV, Harvey NC, Johansson H & Kanis JA (2016) . Current Opinion in Rheumatology, 28(4), 433-441.
Robinson PC, Leo PJ, Pointon JJ, Harris J, Cremin K, Bradbury LA, Stebbings S, Harrison AA, Duncan EL, Evans DM , Wordsworth PB et al (2016) . npj Genomic Medicine, 1(1).
Gregson CL, Wheeler L, Hardcastle SA, Appleton LH, Addison KA, Brugmans M, Clark GR, Ward KA, Paggiosi M, Stone M , Thomas J et al (2016) . Journal of Bone and Mineral Research, 31(3), 640-649.
Reginster J-Y, Cooper C, Rizzoli R, Kanis JA, Appelboom G, Bautmans I, Bischoff-Ferrari HA, Boers M, Brandi ML, Bruyère O , Cherubini A et al (2016) . Aging Clinical and Experimental Research, 28(1), 47-58.
Cooper C, Bardin T, Brandi M-L, Cacoub P, Caminis J, Civitelli R, Cutolo M, Dere W, Devogelaer J-P, Diez-Perez A , Einhorn TA et al (2016) . Aging Clinical and Experimental Research, 28(1), 1-16.
Harvey NC, Johansson H, Odén A, Karlsson MK, Rosengren BE, Ljunggren Ö, Cooper C, McCloskey E, Kanis JA, Ohlsson C & Mellström D (2016) . Osteoporosis International, 27(1), 267-274.
McCloskey E (2016) . Osteoporosis International, 27(1), 417-419.
Robinson PC, Leo PJ, Pointon JJ, Harris J, Cremin K, Bradbury LA, Stebbings S, Harrison AA, Evans DM, Duncan EL , Wordsworth BP et al (2016) . Genes & Immunity, 17(1), 46-51.
Naylor KE, Jacques RM, Paggiosi M, Gossiel F, Peel NFA, McCloskey EV, Walsh JS & Eastell R (2016) . Osteoporosis International, 27(1), 21-31.
Naylor KE, Jacques RM, Paggiosi M, Gossiel F, Peel NF, McCloskey EV, Walsh JS & Eastell R (2016) . Osteoporosis International, 27(1), 37-37.
Reppe S, Wang Y, Thompson WK, McEvoy LK, Schork AJ, Zuber V, LeBlanc M, Bettella F, Mills IG, Desikan RS , Djurovic S et al (2015) . PLoS ONE, 10(12).
Kanis JA, Compston J, Cooper C, Harvey NC, Johansson H, Odén A & McCloskey EV (2015) . Calcified Tissue International, 98(5), 417-425.
Zerbini CAF, Szejnfeld VL, Abergaria BH, McCloskey EV, Johansson H & Kanis JA (2015) . Archives of Osteoporosis, 10(1).
Johansson H, Odén A, Lorentzon M, McCloskey E, Kanis JA, Harvey NC, Karlsson MK & Mellström D (2015) . Osteoporosis International, 26(11), 2617-2622.
Kanis JA, Harvey NC, Johansson H, Odén A, Leslie WD & McCloskey EV (2015) . Climacteric, 18(sup2), 2-9.
Harvey NC, Kanis JA, Odén A, Nakamura T, Shiraki M, Sugimoto T, Kuroda T, Johansson H & McCloskey EV (2015) . Osteoporosis International, 26(9), 2347-2353.
Odén A, McCloskey EV, Kanis JA, Harvey NC & Johansson H (2015) . Osteoporosis International, 26(9), 2243-2248.
Harvey NC, Kanis JA, Odén A, Burge RT, Mitlak BH, Johansson H & McCloskey EV (2015) . Osteoporosis International, 26(11), 2677-2684.
McCloskey E, Kanis JA, Johansson H, Harvey N, Odén A, Cooper A, Cooper C, Francis RM, Reid DM, Marsh D , Selby P et al (2015) . Osteoporosis International, 26(8), 2091-2099.
Harvey NC, Glüer CC, Binkley N, McCloskey EV, Brandi M-L, Cooper C, Kendler D, Lamy O, Laslop A, Camargos BM , Reginster J-Y et al (2015) . Bone, 78, 216-224.
Leslie WD, Lix LM, Morin SN, Johansson H, Odén A, McCloskey EV & Kanis JA (2015) . The Journal of Clinical Endocrinology & Metabolism, 100(5), 2063-2070.
Alonso N, Soares DC, V McCloskey E, Summers GD, Ralston SH & Gregson CL (2015) . Journal of Bone and Mineral Research, 30(4), 615-620.
McCloskey EV, Odén A, Harvey NC, Leslie WD, Hans D, Johansson H & Kanis JA (2015) . Calcified Tissue International, 96(6), 500-509.
McCloskey EV, Kanis JA, Odén A, Harvey NC, Bauer D, González-Macias J, Hans D, Kaptoge S, Krieg MA, Kwok T , Marin F et al (2015) . Osteoporosis International, 26(7), 1979-1987.
McCloskey EV, Harvey NC & Kanis JA (2015) . International Journal of Clinical Rheumatology, 10(1), 1-4.
(2015) . The Journal of Clinical Endocrinology & Metabolism, 100(8), 3219-3219.
Kanis JA, McCloskey EV, Harvey NC, Johansson H & Leslie WD (2015) . Journal of Bone and Mineral Research, 30(10), 1747-1753.
Duncan R, Francis RM, Jagger C, Kingston A, McCloskey E, Collerton J, Robinson L, Kirkwood TBL & Birrell F (2015) . Osteoporosis International, 26(1), 123-130.
(2015) . The Journal of Clinical Endocrinology & Metabolism, 100(8), 3219-3219.
Kanis JA, Johansson H, Oden A, Cooper C, McCloskey EV & Epidemiology and Quality of Life Working Group of IOF (2014) . Arch Osteoporos, 9, 166.
Leslie WD, Orwoll ES, Nielson CM, Morin SN, Majumdar SR, Johansson H, Odén A, McCloskey EV & Kanis JA (2014) . Journal of Bone and Mineral Research, 29(11), 2511-2519.
Johansson H, Kanis JA, Odén A, Leslie WD, Fujiwara S, Glüer CC, Kroger H, LaCroix AZ, Lau E, Melton LJ , Eisman JA et al (2014) . Calcified Tissue International, 95(5), 428-435.
Paggiosi MA, Peel N, McCloskey E, Walsh JS & Eastell R (2014) . Osteoporosis International, 25(12), 2729-2741.
Kanis JA, Svedbom A, Harvey N & McCloskey EV (2014) . J Bone Miner Res, 29(9), 1926-1928.
Leslie WD, Johansson H, Kanis JA, Oden A, McCloskey EV, Lamy O & Hans D (2014) . Osteoporosis International.
Kanis JA, Harvey NC & McCloskey E (2014) . BoneKEy Reports, 3.
Svedbom A, Wintzell V, Alekna V, Bianchi ML, Clark P, Díaz-Curiel M, Dimai HP, Lesnyak O, McCloskey E, Sanders KM , Tamulaitiene M et al (2014) . Value in Health, 17(3), A48-A49.
Leslie WD, Majumdar SR, Lix LM, Morin SN, Johansson H, Oden A, McCloskey EV & Kanis JA (2014) . JOURNAL OF BONE AND MINERAL RESEARCH, 29(5), 1074-1080.
Odén A, Kanis JA, McCloskey EV & Johansson H (2014) . J Bone Miner Res, 29(10), 2217-2223.
Zhang L, Choi HJ, Estrada K, Leo PJ, Li J, Pei Y-F, Zhang Y, Lin Y, Shen H, Liu Y-Z , Liu Y et al (2014) . Human Molecular Genetics, 23(7), 1923-1933.
Johansson H, Odén A, Kanis JA, McCloskey EV, Morris HA, Cooper C, Vasikaran S & IFCC-IOF Joint Working Group on Standardisation of Biochemical Markers of Bone Turnover (2014) . Calcif Tissue Int, 94(5), 560-567.
Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, McCloskey EV, Kanis JA & Bilezikian JP (2014) . Journal of Bone and Mineral Research, 29(3), 518-530.
Oei L, Estrada K, Duncan EL, Christiansen C, Liu C-T, Langdahl BL, Obermayer-Pietsch B, Riancho JA, Prince RL, van Schoor NM , McCloskey E et al (2014) Genome-wide association study for radiographic vertebral fractures: a potential role for the 16q24 BMD locus.. Bone, 59, 20-27.
Oei L, Estrada K, Duncan EL, Christiansen C, Liu C-T, Langdahl BL, Obermayer-Pietsch B, Riancho JA, Prince RL, van Schoor NM , McCloskey E et al (2014) . Bone, 59, 20-27.
Johansson H, Kanis JA, Odén A, McCloskey E, Chapurlat RD, Christiansen C, Cummings SR, Diez-Perez A, Eisman JA, Fujiwara S , Glüer C-C et al (2014) . Journal of Bone and Mineral Research, 29(1), 223-233.
Sund R, Honkanen R, Johansson H, Odén A, McCloskey E, Kanis J & Kröger H (2014) . Calcified Tissue International, 95(1), 39-45.
Johansson H, Odén A, Karlsson MK, McCloskey E, Kanis JA, Ohlsson C & Mellström D (2014) . Osteoporosis International, 25(7), 1831-1836.
Siggeirsdottir K, Aspelund T, Johansson H, Gudmundsson EF, Mogensen B, Jonsson BY, Gudnason V, McCloskey E, Oden A, Sigurdsson G & Kanis JA (2014) . Osteoporosis International, 25(10), 2445-2451.
Piscitelli P, Brandi M, Cawston H, Gauthier A, Kanis JA, Compston J, Borgström F, Cooper C & McCloskey E (2014) . Calcified Tissue International, 95(5), 419-427.
Brennan SL, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E & Kanis JA (2014) . Osteoporosis International, 25(1), 61-69.
Kanis JA, McCloskey E, Branco J, Brandi M-L, Dennison E, Devogelaer J-P, Ferrari S, Kaufman J-M, Papapoulos S, Reginster J-Y & Rizzoli R (2014) . Osteoporosis International, 25(11), 2533-2543.
Johansson H, Odén A, McCloskey EV & Kanis JA (2014) . Osteoporos Int, 25(1), 235-241.
Yang L, Udall WJM, McCloskey EV & Eastell R (2014) . Osteoporos Int, 25(1), 251-263.
Moayyeri A, Hsu Y-H, Karasik D, Estrada K, Xiao S-M, Nielson C, Srikanth P, Giroux S, Wilson SG, Zheng H-F , Smith AV et al (2014) . Human Molecular Genetics, 23(11), 3054-3068.
Svedbom A, Hernlund E, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B & Kanis JA (2013) . Archives of Osteoporosis, 8(1-2).
Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B & Kanis JA (2013) . Archives of Osteoporosis, 8(1-2).
Kanis JA, Borgström F, Compston J, Dreinhöfer K, Nolte E, Jonsson L, Lems WF, McCloskey EV, Rizzoli R & Stenmark J (2013) SCOPE: a scorecard for osteoporosis in Europe.. Archives of osteoporosis, 8(1-2), 144.
Kanis JA, Borgström F, Compston J, Dreinhöfer K, Nolte E, Jonsson L, Lems WF, McCloskey EV, Rizzoli R & Stenmark J (2013) . Archives of Osteoporosis, 8(1-2).
Grigorie D, Sucaliuc A, Johansson H, Kanis JA & McCloskey E (2013) . Calcified Tissue International, 92(5), 429-436.
Grigorie D, Sucaliuc A, Johansson H, Kanis JA & McCloskey E (2013) . Archives of Osteoporosis, 8(1-2).
Leslie WD, Brennan SL, Lix LM, Johansson H, Oden A, McCloskey E & Kanis JA (2013) . Archives of Osteoporosis, 8(1-2).
Ivergard M, Svedbom A, Hernlund E, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Masaryk P, Payer J , Jackuliak P et al (2013) Epidemiology and Economic Burden of Osteoporosis in Slovakia. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Lyritis GP, Makras P & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in Greece. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Ivergard M, Svedbom A, Hernlund E, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in UK. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Ivergard M, Svedbom A, Hernlund E, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Alekna V, Tamulaitiene M & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in Lithuania. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Ivergard M, Svedbom A, Hernlund E, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Hirsch M & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in Luxembourg. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Dreinhoefer K & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in Germany. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Abrahamsen B & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in Denmark. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Georgiades GL & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in Cyprus. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Bayer M & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in the Czech Republic. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Ivergard M, Svedbom A, Hernlund E, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Diez-Perez A & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in Spain. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Brandi ML, Silveri F , Rossini M et al (2013) Epidemiology and Economic Burden of Osteoporosis in Italy. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Ivergard M, Svedbom A, Hernlund E, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Akesson K & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in Sweden. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Ivergard M, Svedbom A, Hernlund E, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Papapoulos S & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in the Netherlands. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Ivergard M, Svedbom A, Hernlund E, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Kocjan T & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in Slovenia. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Borissova A-M, Kovacheva R , Shinkov A et al (2013) Epidemiology and Economic Burden of Osteoporosis in Bulgaria. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Ivergard M, Svedbom A, Hernlund E, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Monteiro J & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in Portugal. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Dimai HP & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in Austria A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Kroger H & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in Finland. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Hiligsmann M, Goemaere S , Reginster J-Y et al (2013) Epidemiology and Economic Burden of Osteoporosis in Belgium. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, O'Brien M & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in Ireland. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in France. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Ivergard M, Svedbom A, Hernlund E, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Czerwinski E, Badurski JE , Lorene RS et al (2013) Epidemiology and Economic Burden of Osteoporosis in Poland. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Ivergard M, Svedbom A, Hernlund E, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Rasa I, Pavlina I , Berza S et al (2013) Epidemiology and Economic Burden of Osteoporosis in Latvia. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Ivergard M, Svedbom A, Hernlund E, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Grigorie D & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in Romania. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Lakatos P, Szekeres L , Marton I et al (2013) Epidemiology and Economic Burden of Osteoporosis in Hungary. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Ivergard M, Svedbom A, Hernlund E, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Galea RP & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in Malta. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Maasalu K & Kanis JA (2013) Epidemiology and Economic Burden of Osteoporosis in Estonia. ARCHIVES OF OSTEOPOROSIS, 8(1-2).
McCloskey E (2013) Assessing fracture risk in patients with osteoporosis. Practitioner, 257(1765), 19-21.
Wintzell V, Ivergård M, Tankó LB, Barghout V, Svedbom A, Alekna V, Bianchi ML, Clark P, Díaz Curiel M, Dimai HP , Jürisson M et al (2013) . Value in Health, 16(7), A573-A574.
Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E & Kanis JA (2013) . Journal of Clinical Densitometry, 16(4), 570-578.
Leslie W, Kanis JA, Lamy O, Johansson H, McCloskey EV & Hans D (2013) . Journal of Clinical Densitometry, 16(3), 267-268.
Targownik LE, Bernstein CN, Nugent Z, Johansson H, Oden A, McCloskey E, Kanis JA & Leslie WD (2013) . Journal of Bone and Mineral Research, 28(5), 1007-1013.
McCloskey E, Compston J & Kanis J (2013) . BMJ, 346(mar12 3), f1427-f1427.
Goodyear SR, Barr RJ, McCloskey E, Alesci S, Aspden RM, Reid DM & Gregory JS (2013) . Bone, 53(1), 188-193.
Kaufman J-M, Reginster J-Y, Boonen S, Brandi ML, Cooper C, Dere W, Devogelaer J-P, Diez-Perez A, Kanis JA, McCloskey E , Mitlak B et al (2013) . Bone, 53(1), 134-144.
McCloskey E & Leslie WD (2013) . Journal of Bone and Mineral Research, 28(3), 439-441.
Borgström F, Lekander I, Ivergård M, Ström O, Svedbom A, Alekna V, Bianchi ML, Clark P, Curiel MD, Dimai HP , Jürisson M et al (2013) . Osteoporosis International, 24(3), 811-823.
Gregson CL, Paggiosi MA, Crabtree N, Steel SA, McCloskey E, Duncan EL, Fan B, Shepherd JA, Fraser WD, Smith GD & Tobias JH (2013) . The Journal of Clinical Endocrinology & Metabolism, 98(2), 818-828.
Francis R, Reid DM, Cooper A, McCloskey EV, Cooper C, Kanis JA, Compston J, Bowring C, Davies C, Marsh D & Selby P (2013) . Maturitas.
Francis R, Reid DM, Cooper A, McCloskey EV, Cooper C, Kanis JA, Compston J, Bowring C, Davies C, Marsh D & Selby P (2013) . Maturitas.
Wu C-H, Chang Y-F, McCloskey EV, Lee JK, Itabashi A, Prince R, Yu W, Li-Yu J, Chionh SB, Zhao Y , Shin CS et al (2013) . Journal of Clinical Densitometry.
Francis R, Reid DM, Cooper A, McCloskey EV, Cooper C, Kanis JA, Compston J, Bowring C, Davies C, Marsh D & Selby P (2013) . Maturitas.
Audran M, Jakob FJ, Palacios S, Brandi M-L, Bröll H, Hamdy NAT & Mccloskey EV (2013) . Rheumatology International, 1-9.
Peters B, Post F, Wierzbicki AS, Phillips A, Power L, Das S, Johnson M, Moyle G, Hughes L, Wilkins E , McCloskey E et al (2013) . HIV Medicine, 14, 1-11.
Kanis JA, Oden A, Johansson H & McCloskey E (2013) . Osteoporosis International, 24(1), 391-392.
Naylor KE, McCloskey EV, Eastell R & Yang L (2013) . J Bone Miner Res, 28(5), 1014-1021.
Odén A, McCloskey EV, Johansson H & Kanis JA (2013) . Calcif Tissue Int, 92(1), 42-49.
Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster J-Y & Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) . Osteoporos Int, 24(1), 23-57.
Tuzun S, Eskiyurt N, Akarirmak U, Saridogan M, Johansson H, McCloskey E & Kanis JA (2012) . Archives of Osteoporosis, 7(1-2), 229-235.
Lesnyak O, Ershova O, Belova K, Gladkova E, Sinitsina O, Ganert O, Romanova M, Khodirev V, Johansson H, McCloskey E & Kanis JA (2012) . Archives of Osteoporosis, 7(1-2), 67-73.
Shepstone L, Fordham R, Lenaghan E, Harvey I, Cooper C, Gittoes N, Heawood A, Peters TJ, O’Neill T, Torgerson D , Holland R et al (2012) . Osteoporosis International, 23(10), 2507-2515.
McCloskey E & Kanis JA (2012) . Current Opinion in Rheumatology, 24(5), 554-560.
Kanis JA, Johansson H, Odén A & McCloskey EV (2012) . J Bone Miner Metab, 30(6), 700-705.
McCloskey E, Johansson H, Oden A & Kanis JA (2012) . Clinical Biochemistry, 45(12), 887-893.
Kanis JA, Odén A, McCloskey EV, Johansson H, Wahl DA & Cooper C (2012) . Osteoporos Int, 23(9), 2401-2402.
Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E & Kanis JA (2012) . Journal of Bone and Mineral Research, 27(6), 1243-1251.
Johansson H, Odén A, Lerner UH, Jutberger H, Lorentzon M, Barrett-Connor E, Karlsson MK, Ljunggren Ö, Smith U, McCloskey E , Kanis JA et al (2012) . Journal of Bone and Mineral Research, 27(6), 1390-1396.
Johansson H, McCloskey E, Odén A & Kanis JA (2012) . Bone, 50, S14-S14.
McCloskey EV, Johansson H, Oden A, Austin M, Siris E, Wang A, Lewiecki EM, Lorenc R, Libanati C & Kanis JA (2012) . J Bone Miner Res, 27(7), 1480-1486.
Kanis JA, Odén A, McCloskey EV, Johansson H, Wahl DA, Cooper C & IOF Working Group on Epidemiology and Quality of Life (2012) . Osteoporos Int, 23(9), 2239-2256.
Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E & Kanis JA (2012) . Osteoporosis International, 23(3), 853-860.
Johansson H, Kanis JA, Oden A, Compston J & McCloskey E (2012) . Osteoporosis International, 23(3), 907-915.
Johansson H, Odén A, Kanis J, McCloskey E, Lorentzon M, Ljunggren Ö, Karlsson MK, Thorsby PM, Tivesten Å, Barrett-Connor E , Ohlsson C et al (2012) . Osteoporosis International, 23(3), 991-999.
Gregson CL, Steel SA, O’Rourke KP, Allan K, Ayuk J, Bhalla A, Clunie G, Crabtree N, Fogelman I, Goodby A , Langman CM et al (2012) . Osteoporosis International, 23(2), 643-654.
Kanis JA, Oden A, Johansson H & McCloskey E (2012) . Osteoporosis International, 23(2), 423-431.
Giangregorio LM, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E & Kanis JA (2012) . Journal of Bone and Mineral Research, 27(2), 301-308.
Gauthier A, Kanis JA, Jiang Y, Dreinhöfer K, Martin M, Compston J, Borgström F, Cooper C & McCloskey E (2012) . Archives of Osteoporosis, 7(1-2), 209-218.
Cawston H, Maravic M, Fardellone P, Gauthier A, Kanis JA, Compston J, Borgström F, Cooper C & McCloskey E (2012) . Archives of Osteoporosis, 7(1-2), 237-246.
Lekamwasam S, Adachi JD, Agnusdei D, Bilezikian J, Boonen S, Borgström F, Cooper C, Perez AD, Eastell R, Hofbauer LC , Kanis JA et al (2012) . Archives of Osteoporosis, 7(1-2), 25-30.
Lekamwasam S, Adachi JD, Agnusdei D, Bilezikian J, Boonen S, Borgström F, Cooper C, Diez Perez A, Eastell R, Hofbauer LC , Kanis JA et al (2012) . Osteoporosis International, 23(9), 2257-2276.
Estrada K, Styrkarsdottir U, Evangelou E, Hsu Y-H, Duncan EL, Ntzani EE, Oei L, Albagha OME, Amin N, Kemp JP , Koller DL et al (2012) . Nature Genetics, 44(5), 491-501.
Kanis JA, Odén A, McCloskey EV, Johansson H, Wahl DA & Cooper C (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporosis International, 1-18.
Lewiecki EM, Bilezikian JP, Jankowski LG, McCloskey EV, Miller PD, Morgan SL, Orwoll ES & Potts JT (2012) . Journal of Clinical Densitometry, 15(1), 1-20.
Kanis JA, McCloskey E, Johansson H, Oden A & Leslie WD (2012) . Calcified Tissue International, 90(1), 1-13.
Leslie WD, Majumdar SR, Lix LM, Johansson H, Oden A, McCloskey E & Kanis JA (2012) . Osteoporosis International, 23(1), 391-397.
Leslie WD, Morin S, Lix LM, Johansson H, Oden A, McCloskey E & Kanis JA (2012) . Osteoporosis International, 23(1), 75-85.
Stone B, McCloskey E, Bowman C & Dockrell D (2011) . Journal of Infection, 63(6), e39-e40.
Czerwinski E, Kanis JA, Osieleniec J, Kumorek A, Milert A, Johansson H, McCloskey EV & Gorkiewicz M (2011) . OSTEOPOROSIS INT, 22(9), 2507-2512.
Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Dawson-Hughes B, El-Hajj Fuleihan G , Johansson H et al (2011) . Osteoporos Int, 22(9), 2395-2411.
McCloskey EV, Vasikaran S, Cooper C & FRAX(®) Position Development Conference Members (2011) . J Clin Densitom, 14(3), 220-222.
McCloskey EV, Binkley N & FRAX(®) Position Development Conference Members (2011) . J Clin Densitom, 14(3), 181-183.
Kanis JA, Johansson H, Oden A & McCloskey EV (2011) . Osteoporos Int, 22(8), 2357-2358.
Johansson H, Odén A, Kanis J, McCloskey E, Lorentzon M, Ljunggren Ö, Karlsson MK, Orwoll E, Tivesten Å, Ohlsson C & Mellström D (2011) . Osteoporosis International, 22(5), 1411-1418.
Duncan EL, Danoy P, Kemp JP, Leo PJ, McCloskey E, Nicholson GC, Eastell R, Prince RL, Eisman JA, Jones G , Sambrook PN et al (2011) . PLoS Genetics, 7(4).
Leslie W, Lix L, Johansson H, McCloskey E & Kanis J (2011) . Journal of Clinical Densitometry, 14(2), 161-161.
Fraser L-A, Langsetmo L, Berger C, Ioannidis G, Goltzman D, Adachi JD, Papaioannou A, Josse R, Kovacs CS, Olszynski WP , Towheed T et al (2011) . Osteoporosis International, 22(3), 829-837.
Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E & Kanis JA (2011) . Osteoporosis International, 22(3), 839-847.
Leslie WD, Lix LM, Langsetmo L, Berger C, Goltzman D, Hanley DA, Adachi JD, Johansson H, Oden A, McCloskey E & Kanis JA (2011) . Osteoporosis International, 22(3), 817-827.
Borgström F, Ström O, Kleman M, McCloskey E, Johansson H, Odén A & Kanis JA (2011) . Osteoporosis International, 22(3), 955-965.
Coleman RE & McCloskey EV (2011) . Bone, 49(1), 71-76.
Kanis JA, Johansson H, Oden A & McCloskey EV (2011) . Osteoporos Int, 22(8), 2347-2355.
McCloskey E (2011) . Nature Reviews Endocrinology, 7(7), 383-384.
Kanis JA, Johansson H, Oden A & McCloskey EV (2011) . Osteoporos Int, 22(3), 809-816.
Gauthier A, Kanis JA, Jiang Y, Martin M, Compston JE, Borgström F, Cooper C & McCloskey EV (2011) . Archives of Osteoporosis, 6(1-2), 179-188.
Ström O, Borgström F, Kanis JA, Compston J, Cooper C, McCloskey EV & Jönsson B (2011) . Archives of Osteoporosis, 6(1-2), 59-155.
MacKey DC, Black DM, Bauer DC, McCloskey EV, Eastell R, Mesenbrink P, Thompson JR & Cummings SR (2011) . Journal of Bone and Mineral Research, 26(10), 2411-2418.
Leib ES, Saag KG, Adachi JD, Geusens PP, Binkley N, McCloskey EV & Hans DB (2011) . Journal of Clinical Densitometry, 14(3), 212-219.
Hans DB, Kanis JA, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Cooper C, Dawson-Hughes B, El-Hajj Fuleihan G , Leslie WD et al (2011) . Journal of Clinical Densitometry, 14(3), 171-180.
Gauthier A, Kanis JA, Jiang Y, Martin M, Compston JE, Borgström F, Cooper C & McCloskey EV (2011) Epidemiological burden of postmenopausal osteoporosis in the UK from 2010 to 2021: estimations from a disease model. Archives of Osteoporosis, 1-10.
Post FA, McCloskey EV, Compston JE, Bowman CA, Hay PE, Johnson MA, Mallon PWG, Peters BS, Samarawickrama A & Tudor-Williams G (2011) . Future Virology, 6(6), 769-782.
Kanis JA, Johansson H, Oden A & McCloskey EV (2011) Adjustment of the FRAX (R) for the Glucocorticoid Dosis. OSTEOLOGIE, 20(1), 82-83.
Johansson H, Clark P, Carlos F, Oden A, McCloskey EV & Kanis JA (2011) . Osteoporos Int, 22(8), 2359-2364.
Johansson H, Kanis JA, McCloskey EV, Odén A, Devogelaer J-P, Kaufman J-M, Neuprez A, Hiligsmann M, Bruyere O & Reginster J-Y (2011) . Osteoporos Int, 22(2), 453-461.
Gauthier A, Kanis JA, Martin M, Compston J, Borgström F, Cooper C & McCloskey E (2011) . Osteoporosis International, 22(3), 771-780.
McCloskey E (2010) Calculating fracture risk in primary care. Practitioner, 254(1725), 7.
Kanis JA, McCloskey EV, Jonsson B, Cooper A, Ström O & Borgström F (2010) . Archives of Osteoporosis, 5(1-2), 19-48.
Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E & Kanis JA (2010) . Journal of Bone and Mineral Research, 25(11), 2350-2358.
Ström O, Borgström F, Kleman M, McCloskey E, Odén A, Johansson H & Kanis JA (2010) . Bone, 47(2), 430-437.
Stone B, Dockrell D, Bowman C & McCloskey E (2010) HIV and bone disease. Archives of Biochemistry and Biophysics.
Kanis JA, Johansson H, Oden A & McCloskey EV (2010) . Bone, 47(4), 729-735.
Gregson C, Crabtree N, Steel S, Poole K, McCloskey E & Tobias JH (2010) . Bone, 47, S227-S227.
Johansson H, Oden A, Chines A, Kanis J & Mccloskey E (2010) . Bone, 47, S211-S211.
Goodyear SR, Gregory JS, Barr RJ, McCloskey EV, Alesci S, Lee JH, Aspden RM & Reid DM (2010) . Bone, 47, S163-S163.
Kanis JA, McCloskey EV, Johansson H, Oden A, Ström O & Borgström F (2010) . Osteoporos Int, 21 Suppl 2, S407-S413.
McCloskey E, Compston J & Cooper C (2010) . Osteoporosis International, 21(5), 885-885.
Clark EM, Hutchinson AP, McCloskey EV, Stone MD, Martin JC, Bhalla AK & Tobias JH (2010) . RHEUMATOLOGY, 49(3), 505-512.
Borgstrom F, Strom O, Coelho J, Johansson H, Oden A, McCloskey EV & Kanis JA (2010) . OSTEOPOROSIS INT, 21(3), 495-505.
McCloskey E, Paterson A, Kanis J, Tähtelä R & Powles T (2010) . European Journal of Cancer, 46(3), 558-565.
Borgström F, Ström O, Coelho J, Johansson H, Oden A, McCloskey E & Kanis JA (2010) . Osteoporosis International, 21(2), 339-349.
Kanis JA, McCloskey EV, Johansson H & Oden A (2010) , 605-611.
Stone B, Dockrell D, Bowman C & McCloskey E (2010) . Archives of Biochemistry and Biophysics, 503(1), 66-77.
Kanis JA, McCloskey EV, Jonsson B, Cooper A, Ström O & Borgström F (2010) An evaluation of the NICE guidance for the prevention of osteoporotic fragility fractures in postmenopausal women. Archives of Osteoporosis, 1-30.
Kanis JA, Johansson H, Oden A, Dawson-Hughes B, Melton LJ & McCloskey EV (2010) . Osteoporos Int, 21(1), 35-40.
Epstein S, Jeglitsch M & McCloskey E (2009) . Current Medical Research and Opinion, 25(12), 2951-2960.
Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F & Oden A (2009) . Best Pract Res Clin Rheumatol, 23(6), 711-726.
Glover SJ, Eastell R, McCloskey EV, Rogers A, Garnero P, Lowery J, Belleli R, Wright TM & John MR (2009) . Bone, 45(6), 1053-1058.
Kayan K, Johansson H, Oden A, Vasireddy S, Pande K, Orgee J, Kanis JA & McCloskey EV (2009) . Osteoporos Int, 20(12), 2055-2061.
Stevenson MD, Oakley JE, Lloyd Jones M, Brennan A, Compston JE, McCloskey EV & Selby PL (2009) . Med Decis Making, 29(6), 678-689.
Johansson H, Kanis JA, Oden A, Johnell O & McCloskey E (2009) . Osteoporosis International, 20(10), 1675-1682.
McCloskey EV, Johansson H, Oden A & Kanis JA (2009) . Curr Osteoporos Rep, 7(3), 77-83.
Kanis JA, Johansson H, Oden A & McCloskey EV (2009) . Eur J Radiol, 71(3), 392-397.
Kanis JA, McCloskey EV, Johansson H & Oden A (2009) . Nat Rev Rheumatol, 5(8), 425-431.
Kanis JA, Johansson H, Oden A & McCloskey EV (2009) . Bone, 44(6), 1049-1054.
Borgström F, Coelho J, Ström O, McCloskey E, Odén A, Johansson H & Kanis JA (2009) . Value in Health, 12(3), A67-A67.
Goodman K, Fraser WD, Selby P, McCloskey E, Hampson G, Gennari L, Brandi M, Del Pino J, Brown J, Hooper M , Walsh J et al (2009) . Bone, 44, S123-S124.
McCloskey EV, Johansson H, Oden A, Vasireddy S, Kayan K, Pande K, Jalava T & Kanis JA (2009) . Osteoporos Int, 20(5), 811-817.
Kanis JA, Oden A, Johansson H, Borgström F, Ström O & McCloskey E (2009) . Bone, 44(5), 734-743.
Aloumanis K, Murphy E, Williams G, Eastell R & McCloskey E (2009) A history of thyroid disease and body composition in elderly women. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 39, 4-4.
Compston J, Cooper A, Cooper C, Francis R, Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P & Wilkins M (2009) . Maturitas, 62(2), 105-108.
Neuprez A, Johansson H, Kanis JA, McCloskey EV, Odén A, Bruyère O, Hiligsmann M, Devogelaer JP, Kaufman JM & Reginster JY (2009) A FRAX® model for the assessment of fracture probability in belgium. Revue Medicale de Liege, 64(12), 612-619.
Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F & Oden A (2009) . Osteoporosis International, 20(3), 499-502.
Yang L, Peel N, Clowes JA, McCloskey EV & Eastell R (2009) . J Bone Miner Res, 24(1), 33-42.
Coleman RE, Guise TA, Lipton A, Roodman GD, Berenson JR, Body J-J, Boyce BF, Calvi LM, Hadji P, McCloskey EV , Saad F et al (2008) . Clin Cancer Res, 14(20), 6387-6395.
Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A & National Osteoporosis Guideline Group (2008) . Osteoporos Int, 19(10), 1395-1408.
Obermayer-Pietsch BM, Marin F, McCloskey EV, Hadji P, Farrerons J, Boonen S, Audran M, Barker C, Anastasilakis AD, Fraser WD , Nickelsen T et al (2008) . J BONE MINER RES, 23(10), 1591-1600.
McCloskey EV, Vasireddy S, Threlkeld J, Eastaugh J, Parry A, Bonnet N, Beneton M, Kanis JA & Charlesworth D (2008) . J Bone Miner Res, 23(10), 1561-1568.
Kanis JA & Compston JE (2008) . Osteoporosis International, 19(8), 1105-1107.
Yang L, Maric I, McCloskey EV & Eastell R (2008) . J Clin Densitom, 11(3), 373-382.
Kanis JA, Johnell O, Oden A, Johansson H & McCloskey E (2008) . Osteoporosis International, 19(4), 385-397.
Kanis JA, Oden A, Johansson H & McCloskey EV (2008) . OSTEOPOROSIS INT, 19(4), 593-594.
Kanis JA, Oden A, Johansson H & McCloskey E (2008) . IBMS BoneKEy, 5(3), 114-117.
Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ & Khaltaev N (2008) . Bone, 42(3), 467-475.
Schousboe JT, Taylor BC, Kiel DP, Ensrud KE, Wilson KE & McCloskey EV (2008) . J BONE MINER RES, 23(3), 409-416.
Paterson A, McCloskey E, Redzepovic J, Ott I & Gust R (2008) . Journal of International Medical Research, 36(3), 400-413.
Powles TJ, Howell A, Evans DG, McCloskey EV, Ashley S, Greenhalgh R, Affen J, Flook LA & Tidy A (2008) . Menopause International, 14(1), 6-12.
Yang L, Prevrhal S, McCloskey EV & Eastell R (2008) A method to estimate femoral neck cortical thickness from clinical QCT scans. CALCIFIED TISSUE INT, 82, S181-S182.
Reid DM, Doughty J, Eastell R, Heys SD, Howell A, McCloskey EV, Powles T, Selby P & Coleman RE (2008) . Cancer Treat Rev, 34 Suppl 1, S3-18.
McCloskey E (2007) . Menopause International, 13(4), 197-197.
McCloskey EV, Hannon RA, Lakner G, Fraser WD, Clack G, Miyamoto A, Finkelman RD & Eastell R (2007) . Eur J Cancer, 43(17), 2523-2531.
Brown JE, McCloskey EV, Dewar JA, Body JJ, Cameron DA, Harnett AN, Ruutu M, Purohit OP, Tähtelä R & Coleman RE (2007) . Calcif Tissue Int, 81(5), 341-351.
Brown JE, Ellis SP, Lester JE, Gutcher S, Khanna T, Purohit O-P, McCloskey E & Coleman RE (2007) . Clinical Cancer Research, 13(18), 5406-5410.
Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S , Eisman JA et al (2007) . Osteoporosis International, 18(8), 1033-1046.
Johansson H, Oden A, McCloskey E & Kanis J (2007) . Osteoporosis International, 18(8), 1141-1143.
McCloskey E, Hannon R, Lakner G, Clack G, Miyamoto A & Eastell R (2007) . Journal of Clinical Oncology, 25(18_suppl), 560-560.
Bonnet N, Gadois C, McCloskey E, Lemineur G, Lespessailles E, Courteix D & Benhamou CL (2007) . Bone, 40(5), 1209-1216.
Kanis JA, Stevenson M, McCloskey EV, Davis S & Lloyd-Jones M (2007) Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.. Health technology assessment (Winchester, England), 11(7).
Souberbielle B, Williams R & McCloskey E (2007) . Annals of Oncology, 18(2), 393-393.
McCloskey EV, Beneton M, Charlesworth D, Kayan K, deTakats D, Dey A, Orgee J, Ashford R, Forster M, Cliffe J , Kersh L et al (2007) . J Bone Miner Res, 22(1), 135-141.
Kanis JA, Stevenson M, McCloskey EV, Davis S & Lloyd-Jones M (2007) . Health Technol Assess, 11(7), iii-231.
Obermaier-Pietsch GB, Marin F, McCloskey EV, Hadji P, Simoes ME, Barker C, Oertel H, Nickelsen TN & Boonen S (2007) Effects of prior antiresorptive therapy on markers of bone formation after 6 months of teriparatide treatment in postmenopausal women with osteoporosis: Results from the eurofors trial. CALCIFIED TISSUE INT, 80, S137-S137.
McCloskey EV, Marin F, Obermayer-Pietsch GB, Simoes ME, Barker C, Lyritis G, Oertel H, Nickelsen TN & Boonen S (2007) Effects of prior antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis: Final results from the EUROFORS trial. CALCIFIED TISSUE INT, 80, S30-S30.
Johansson H, McCloskey EV, Oden A, Johnell O, De Laet C, Brow J, Eisman J, Fujiwara S, Goltzman D, Mellstrom D , Melton J et al (2007) Clinical risk factors enhance the performance of BMD in the prediction of fractures. CALCIFIED TISSUE INT, 80, S29-S29.
Yang L, Peel N, Clowes J, Wilson K, McCloskey EV & Eastell R (2007) Use of DXA-based structural engineering models of the proximal femur to predict hip fracture. CALCIFIED TISSUE INT, 80, S25-S26.
Tobias JH, Hutchinson AP, Hunt LP, McCloskey EV, Stone MD, Martin JC, Thompson PW, Palferman TG & Bhalla AK (2007) . OSTEOPOROSIS INT, 18(1), 35-43.
McCloskey E, Hannon R, Lakner G, Clack G, Miyamoto A & Eastell R (2006) . Journal of Clinical Oncology, 24(18_suppl), 555-555.
McCloskey E (2006) . Future Rheumatology, 1(3), 289-291.
McCloskey EV (2006) . BoneKEy-Osteovision, 3(6), 5-13.
Powles T, Paterson A, McCloskey E, Schein P, Scheffler B, Tidy A, Ashley S, Smith I, Ottestad L & Kanis J (2006) . Breast Cancer Research, 8(3).
McCloskey E (2006) . European Journal of Cancer, 42(8), 1044-1051.
van Hogezand RA, Banffer D, Zwinderman AH, McCloskey EV, Griffioen G & Hamdy NAT (2006) . OSTEOPOROSIS INT, 17(4), 535-542.
Coleman RE, Mccloskey EV, Guest JF, Ashford RU & Kanis JA (2006) , 415-426.
Coleman RE, Ashford RU, Mccloskey EV & Kanis JA (2006) , 399-414.
Powles T, Paterson A, McCloskey E, Schein P, Scheffler B, Tidy A, Ashley S, Smith I, Ottestad L & Kanis J (2006) . Breast Cancer Research, 8(2).
De Laet C, Kanis JA, Oden A, Johanson H, Johnell O, Delmas P, Eisman JA, Kroger H, Fujiwara S, Garnero P , McCloskey EV et al (2005) . OSTEOPOROSIS INT, 16(11), 1330-1338.
Kanis JA, Johansson H, Oden A, De Laet C, Johnell O, Eisman JA, McCloskey E, Mellstrom D, Pols H, Reeve J , Silman A et al (2005) . Osteoporosis International, 16(7), 799-804.
McCloskey E, Paterson AHG & Powles TJ (2005) . Journal of Clinical Oncology, 23(16_suppl), 535-535.
Guest JF, Clegg JP, Davie AM & McCloskey E (2005) . Current Medical Research and Opinion, 21(5), 805-815.
LESTER J, DODWELL D, MCCLOSKEY E & COLEMAN R (2005) . Cancer Treatment Reviews, 31(2), 115-142.
Pande KC, Pande SK, de Takats D & McCloskey EV (2005) . Journal of Orthopaedic Surgery, 13(1), 27-33.
Sanders DS, Patel D, Khan FB, Westbrook RH, Webber CV, Milford-Ward A & McCloskey EV (2005) . Dig Dis Sci, 50(3), 587-592.
Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA, Fujiwara S, Kroger H, McCloskey EV, Mellstrom D , Melton LJ et al (2005) . Osteoporos Int, 16(2), 155-162.
Toth E, Csupor E, Meszaros S, Ferencz V, Nemeth L, McCloskey EV & Horvath C (2005) . BONE, 36(1), 47-51.
Kanis JA, Johansson H, Oden A, Johnell O, De Laet C, Eisman JA, McCloskey EV, Mellstrom D, Melton LJ, Pols HAP , Reeve J et al (2004) . Bone, 35(5), 1029-1037.
Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H , McCloskey EV et al (2004) . Bone, 35(2), 375-382.
Powles T, Paterson A, McCloskey E, Kurkilahti M & Kanis J (2004) . Journal of Clinical Oncology, 22(14_suppl), 528-528.
Brown JE, McCloskey E, Dewar JA, Body J-J, Cameron DA, Purohit OP-K, Harnett A, Tahtela R, Kurkilahti M & Coleman RE (2004) . Journal of Clinical Oncology, 22(14_suppl), 8056-8056.
Powles T, Paterson A, McCloskey E, Kurkilahti M & Kanis J (2004) . Journal of Clinical Oncology, 22(14_suppl), 528-528.
Brown JE, McCloskey E, Dewar JA, Body J-J, Cameron DA, Purohit OP-K, Harnett A, Tahtela R, Kurkilahti M & Coleman RE (2004) . Journal of Clinical Oncology, 22(14_suppl), 8056-8056.
van der Klift M, de Laet CEDH, McCloskey EV, Johnell O, Kanis JA, Hofman A & Pols HAP (2004) . J BONE MINER RES, 19(7), 1172-1180.
Pande KC & McCloskey EV (2004) . Journal of Orthopaedic Surgery, 12(1), 133-133.
Johansson H, Oden A, Johnell O, Jonsson B, de Laet C, Oglesby A, McCloskey EV, Kayan K, Jalava T & Kanis JA (2004) . J BONE MINER RES, 19(6), 906-913.
Kanis JA, Johansson H, Oden A, Johnell O, de Laet C, Melton III LJ, Tenenhouse A, Reeve J, Silman AJ, Pols HAP , Eisman JA et al (2004) . J Bone Miner Res, 19(6), 893-899.
Vasireddy S, Reaney L, Charlesworth D, Kanis JA & McCloskey EV (2004) EFFECT OF MEDICAL RISK FACTORS ON DXA MEASUREMENTS AND METACARPAL RADIOGRAPHIC INDICES. RHEUMATOLOGY, 43, 56-56.
Ørstavik RE, Haugeberg G, Mowinckel P, Høiseth A, Uhlig T, Falch JA, Halse JI, McCloskey E & Kvien TK (2004) . Archives of Internal Medicine, 164(4), 420-420.
McCloskey EV, Dey A, Parr RM, Aras N, Balogh A, Bostock J, Borelli A, Krishnan S, Lobo G, Qin LL , Zhang Y et al (2004) Global variations in peak bone mass as studied by dual-energy X-ray absorptiometry. J RADIOANAL NUCL CH, 259(2), 341-345.
McCloskey E (2004) Re: generations (Correction concerning a cast member in a recent production of 'Measure for Measure'). TLS-THE TIMES LITERARY SUPPLEMENT(5287), 15-15.
Ralston SH, Coleman R, Fraser WD, Gallagher SJ, Hosking DJ, Iqbal JS, McCloskey E & Sampson D (2003) . Calcified Tissue International, 74(1), 1-11.
Ashford RU, Dey A, Kayan K, McCloskey EV & Kanis JA (2003) Oral clodronate as treatment of osteogenesis imperfecta. ARCH DIS CHILD, 88(10), 945-945.
Kayan K, de Takats D, Ashford R, Kanis JA & McCloskey EV (2003) . Postgrad Med J, 79(936), 581-584.
McCloskey EV, Bal S, Tähtelä R, Powles T, Paterson AG, Kanis JA, Ashley S, Tidy A, Atula S & Nevalainen J (2003) . European Journal of Cancer Supplements, 1(5), S127-S127.
Kayan K, Kanis J & McCloskey E (2003) . Age and Ageing, 32(5), 553-553.
McCloskey EV (2003) Clodronate in the management of breast cancer and multiple myeloma.. Ortop Traumatol Rehabil, 5(2), 227-233.
Vasireddy S, Cliffe J, Charlesworth DK, Jalava T, Kanis JA & McCloskey EV (2003) FRACTURE INCIDENCE IN ELDERLY WOMEN WITH SELF-REPORTED OSTEOARTHRTIS, RHEUMATOID ARTHRITIS OR CURRENT CORTICOSTEROID USE: ANALYSIS FROM THE MRC HIPS STUDY. RHEUMATOLOGY, 42, 112-112.
Sanders DS, Patel D, Stephenson TJ, Ward AM, McCloskey EV, Hadjivassiliou M & Lobo AJ (2003) . Eur J Gastroenterol Hepatol, 15(4), 407-413.
Atula S, Powles T, Paterson A, McCloskey E, Nevalainen J & Kanis J (2003) . Drug Safety, 26(9), 661-671.
Parr RM, Dey A, McCloskey EV, Aras N, Balogh A, Borelli A, Krishnan S, Lobo G, Qin LL, Zhang Y , Cvijetic S et al (2002) . Food and Nutrition Bulletin, 23(3_suppl1), 180-184.
Powles T, Paterson S, Kanis JA, McCloskey E, Ashley S, Tidy A, Rosenqvist K, Smith I, Ottestad L, Legault S , Pajunen M et al (2002) . Journal of Clinical Oncology, 20(15), 3219-3224.
Brumsen C, Papapoulos SE, Lips P, Geelhoed-Duijvestijn PHLM, Hamdy NAT, Landman JO, McCloskey EV, Netelenbos JC, Pauwels EKJ, Roos JC , Valentijn RM et al (2002) Daily oral pamidronate in women and men with osteoporosis: A 3-year randomized placebo-controlled clinical trial with a 2-year open extension. J BONE MINER RES, 17(6), 1057-1064.
Van Der Klift M, De Laet CEDH, McCloskey EV, Hofman A & Pols HAP (2002) The incidence of vertebral fractures in men and women: The Rotterdam Study. J BONE MINER RES, 17(6), 1051-1056.
Vasireddy S, Kayan K, Bal SK, Cliffe J, Hinch A, Kanis JA & McCloskey EV (2002) SELF REPORTED RHEUMATOID ARTHRITIS AND CURRENT STEROID USE INCREASE THE RISK OF OSTEOPOROTIC FRACTURES IN ELDERLY WOMEN: A HIPS STUDY INTERIM REPORT. RHEUMATOLOGY, 41, 99-99.
Vasireddy S, Kayan K, Bal SK, Cliffe J, Hinch A, Kanis JA & McCloskey EV (2002) SELF REPORTED OSTEOARTHRITIS IS ASSOCIATED WITH A REDUCED RISK OF OSTEOPOROTIC FRACTURES IN ELDERLY WOMEN: A HIPS STUDY INTERIM REPORT. RHEUMATOLOGY, 41, 100-100.
Sanders DS, Patel D, Stephenson TJ, Ward AM, McCloskey EV, Hadjivassiliou M & Lobo AJ (2002) The relationship of adult coeliac disease with irritable bowel syndrome, iron deficiency anaemia and fatigue: A primary care cross-sectional study. GUT, 50, A18-A18.
McCloskey EV & Kanis JA (2002) . Clinical Reviews in Bone and Mineral Metabolism, 1(2), 135-143.
Bal SK & McCloskey EV (2002) . Current Obstetrics and Gynaecology, 12(6), 354-357.
Banffer D, van Hoek B, McCloskey EV, Lamers CBHW & Hamdy NAT (2002) Prevalence of osteoporosis and vertebral fractures and effect of oral bisphosphonates in successful orthotopic liver transplantation. A one-year open study. OSTEOPOROSIS INT, 13, S132-S132.
Banffer D, McCloskey EV, Papapoulos SE & Hamdy NAT (2002) Similar deleterious skeletal effects of intermittent or continuous oral corticosteroids in patients with COPD also using inhalation corticosteroids. OSTEOPOROSIS INT, 13, S131-S131.
van Hogezand RA, Banffer D, McCloskey EV, Zwinderman AM, Papapoulos SE & Hamdy NAT (2002) Low prevalence of osteoporosis and fractures and no significant bone loss at a year's follow-up in well controlled Crohn's disease. OSTEOPOROSIS INT, 13, S132-S132.
van der Klift M, de Laet CEDH, McCloskey EV, Johnell O, Kanis JA, Hofman A & Pols HAP (2002) Risk factors for incident vertebral fractures in men and women: The Rotterdam study. OSTEOPOROSIS INT, 13, S67-S67.
Johnell O, De Laet C, Johansson H, Melton LJ, Eisman J, Reeve J, Tenenhouse A, McCloskey EV & Kanis JA (2002) Oral corticosteroids increase fracture risk independently of BMD. OSTEOPOROSIS INT, 13, S14-S14.
Kayan K, Bal S, Kohler B, Jalava T, Ball A, Cliff J, Charlesworth D, Bostock J, Kanis JA & McCloskey EV (2002) Clinical risk factors for prediction of hip osteoporosis in elderly women. OSTEOPOROSIS INT, 13, S8-S8.
Ashford RU, McCloskey EV, Purohit OP, Ingram CE, Grimer RJ & Coleman RE (2002) . Sarcoma, 6(4), 131-133.
Toth E, Meszaros S, Hosszu E, McCloskey EV & Horvath C (2001) Heel ultrasound discriminates osteoporotic males with or without vertebral fractures.. J BONE MINER RES, 16, S523-S523.
van Hogezand RA, Banffer D, Zwinderman AM, McCloskey EV, Papapoulos SE, Lamers CBH & Hamdy NAT (2001) Low prevalence of osteoporosis and fractures and no significant bone loss after one year follow-up in well controlled Crohn's disease.. J BONE MINER RES, 16, S522-S522.
Kayan K, Ashford RU, Dey A, Kohler B, Cliffe J, Hinch A, Ball A, Marples M, Jalava T, Kanis JA & McCloskey EV (2001) BMD independent risk factors for hip fractures in elderly women in England.. J BONE MINER RES, 16, S213-S213.
McCloskey EV, Dunn JA, Kanis JA, MacLennan IC & Drayson MT (2001) . Br J Haematol, 113(4), 1035-1043.
Ashford RU, Luchetti M, McCloskey EV, Gray RL, Pande KC, Dey A, Kayan K, Ralston SH & Kanis JA (2001) . Calcif Tissue Int, 68(6), 348-351.
Kayan K, McCloskey EV, Ashford RU, Dey A & Kanis JA (2001) Sit-to-stand test, a simple predictor of hip and other fractures in older women. BONE, 28(5), S93-S93.
Pande KC, Ashford RU, Dey A, Kayan K, McCloskey EV & Kanis JA (2001) . Joint Bone Spine, 68(3), 257-261.
McCloskey E, Selby P, de Takats D, Bernard J, Davies M, Robinson J, Francis R, Adams J, Pande K, Beneton M , Jalava T et al (2001) . Bone, 28(3), 310-315.
Pande KC, Ashford RU, Dey A, Kayan K, McCloskey EV & Kanis JA (2001) . Revue du Rhumatisme, 68(5), 439-444.
Powles TJ, Paterson AH, McCloskey E, Ashley S, Tidy VA, Kanis JA & Pylkkänen L (2001) A randomised placebo controlled trial to evaluate the effect of the bisphosphonate, clodronate, on the incidence of metastases and mortality in patients with primary operable breast cancer. Breast Cancer Research and Treatment, 69(3), 209.
Paterson AHG, Powles TJ, Kanis JA, McCloskey EV, Archambault WT, Kurman MR, McCarron T, Pruch JM & Webber DI (2001) Effect of clodronate on time to occurrence of skeletal complications in patients with breast cancer and bone metastases.. BREAST CANCER RES TR, 69(3), 305-305.
McCloskey EV, Guest JF & Kanis JA (2001) . Drugs, 61(9), 1253-1274.
Pande KC, de Takats D, Kanis JA, Edwards V, Slade P & McCloskey EV (2000) . Maturitas, 37(2), 75-81.
Dey A, Parr R, Aras N, Balogh A, Bostock J, Borelli A, Krishnan S, Lobo G, Lin QL, Zhang Y , Cvijetic S et al (2000) Young adult bone mineral density across diverse geographical and racial populations.. J BONE MINER RES, 15, S531-S531.
Ashford R, McGurk C, Ball A, Arnbjerg D, Kanis J & McCloskey EV (2000) Forearm BMD by digital X-ray radiogrammetry: Preliminary comparison of UK and US reference data.. J BONE MINER RES, 15, S531-S531.
De Laet CED, Van der Klift M, McCloskey EV, Kanis JA, Johnell O, Dawson A & Pols HAP (2000) Risk indicators for incident vertebral fractures in men and women.. J BONE MINER RES, 15, S159-S159.
McCloskey EV, Selby P, Davies M, Francis R, Robinson J, Kayan K, Beneton M, Jalava T, Pylkkanen L, Kenrali J & Kanis J (2000) Oral clodronate significantly reduces fracture risk in women with postmenopausal or secondary osteoporosis.. J BONE MINER RES, 15, S227-S227.
Kanis JA & McCloskey EV (2000) . Cancer, 88(12 Suppl), 3022-3032.
Cvijetić S, McCloskey E & Koršić M (2000) Vertebral osteophytosis and vertebral deformities in an elderly population sample. Wiener Klinische Wochenschrift, 112(9), 407-412.
Kayan K, de Takats D, Ashford RU, Dey A & McCloskey EV (2000) Clinical referral criteria for bone densitometry in younger women. OSTEOPOROSIS INT, 11, S1-S2.
de Takats D, Richardson A, Kayan K, Ashford RU, Dey A & McCloskey EV (2000) Social and geographical factors influencing local referrals for bone mineral densitometry. OSTEOPOROSIS INT, 11, S1-S1.
Pande KC, Bernard J, McCloskey EV, de Takats D & Kanis JA (2000) . Bone, 26(5), 525-528.
Hosszu E, Ferencz V, Meszaros S, Csupor E, Toth E, Bors K, McCloskey EV & Horvath C (2000) Age-related decrease in bone ultrasonometry in density-adjusted women. OSTEOPOROSIS INT, 11, S124-S124.
Beneton MNC, Robinson J, Dey A, Kayan K, Kanis JA & McCloskey EV (2000) Computing standardised bone mineral density with the Lunar Expert. OSTEOPOROSIS INT, 11, S70-S70.
McCloskey EV, de Takats D, Bernard J, Pande K, Ashford R, Beneton M, Jalava T, Kenraali J, Pylkkanen L & Kanis JA (2000) Comparative predictive ability of skeletal measurements for fragility fracture. OSTEOPOROSIS INT, 11, S100-S100.
Bazarra A, Castro Iglesias A & McCloskey E (2000) Osteoporosis. Hormone replacement therapy and breast cancer. Acta Ginecologica, 57(4), 99-100.
Pande KC, Ashford RU, Dey A, Kayan K, McCloskey EV & Kanis JA (2000) . The Foot, 10(3), 169-171.
Selby PL, McCloskey EV, Robinson J, Smith IG, Potts B, Beneton MNC & Kanis JA (2000) Is a calculated total hip BMD of clinical use?. OSTEOPOROSIS INT, 11(4), 368-371.
Dey A, McCloskey EV, Taube T, Cox R, Pande KC, Ashford RU, Forster M, de Takats D & Kanis JA (2000) . Osteoporos Int, 11(11), 953-958.
Lips P, Cooper C, Agnusdei D, Caulin F, Egger P, Johnell O, Kanis JA, Kellingray S, Leplege A, Liberman UA , McCloskey E et al (1999) . Osteoporosis International, 10(2), 150-160.
McCloskey EV, Bone H, Rodan G, McClung M, Wallach S, Lyles KW, Grauer A, Mautelan C, Gutteridge DH, Anderson , Hooper et al (1999) Newer bisphosphonates in the treatment of Paget's disease of bone: Where we are and where we want to go - Discussion. J BONE MINER RES, 14, 74-78.
Diel IJ, Lichinitser MR, Body JJ, Schlosser K, Moecks J, Cavalli F, Dornoff W, Gorbunova VA, McCloskey E, Weiß J & Kanis JA (1999) . European Journal of Cancer, 35, S83-S83.
McCloskey EV, de Takats D, Pande K, Bernard J, Beneton MN, Jalava T, Loyttyniemi E & Kanis JA (1999) Oral clodronate prevents bone loss in elderly women over 3 years of treatment.. J BONE MINER RES, 14, S525-S525.
Forster M, Pande K, de Takats D, McCloskey EV, de Vernijoul MC, Taboulet J, Frenkian M, Frendo JL & Kanis JA (1999) Calcitonin gene receptor polymorphism is not associated with fracture risk factors in a random population sample.. J BONE MINER RES, 14, S231-S231.
de Takats D, McCloskey EV, Bernard J & Kanis JA (1999) Questionnaire survey on current practice in renal osteodystrophy in the United Kingdom.. KIDNEY INT, 55(6), 2569-2569.
de Takats D, Pande K, McCloskey EV, Edwards V & Kanis JA (1999) Early renal and hepatic safety data for a shorter intravenous clodronate regimen in renal impairment.. KIDNEY INT, 55(6), 2595-2595.
de Takats D, Bernard J, McCloskey EV & Kanis JA (1999) Intravenous clodronate 300 mg x 5 days has no deleterious effect on creatinine clearance in mild to moderate renal impairment.. KIDNEY INT, 55(5), 2107-2107.
Bernard J, de Takats D, McCloskey EV, Wilkie M, Brown C, Edwards L, El-Nahas M & Kanis JA (1999) Preliminary comparison of tibial ultrasound velocity with bone mineral density in dialysis patients with marked hyperparathyroidism and with healthy volunteers.. KIDNEY INT, 55(5), 2101-2102.
O'Neill TW, McCloskey EV, Kanis JA, Bhalla AK, Reeve J, Reid DM, Todd C, Woolf AD & Silman AJ (1999) The distribution, determinants, and clinical correlates of vertebral osteophytosis: A population based survey. J RHEUMATOL, 26(4), 842-848.
Kanis JA & McCloskey EV (1999) . QJM, 92(3), 143-149.
Kanis JA, McCloskey EV, Powles T, Paterson AH, Ashley S & Spector T (1999) . Br J Cancer, 79(7-8), 1179-1181.
Bruce NJ, McCloskey EV, Kanis JA & Guest JF (1999) Economic impact of using clodronate in the management of patients with multiple myeloma. BRIT J HAEMATOL, 104(2), 358-364.
(1999) . European Journal of Surgical Oncology (EJSO), 25(1), 3-23.
Kanis JA, McCloskey EV, de Takats D & Pande K (1999) . Osteoporos Int, 9 Suppl 2, S24-S28.
Bishop HM, Cameron DA, Coleman R, Davies AM, Dewar JA, Evans A, Evans A, Harnett AN, McCloskey E, O'Donoghue D , Pullicino V et al (1999) The Guidelines for the management of metastatic bone disease in breast cancer in the United Kingdom. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 25(1), 4-23.
Bazarra A, Castro A, McCloskey E & Talbot JR (1998) How should osteoporosis during the postmenopause be approached?. GINEDIPS, 1(0), 25-27.
Kanis JA & McCloskey EV (1998) . Maturitas, 30(3), 229-233.
Orme S, Underwood JC, McCloskey E & Hendra TJ (1998) . Postgraduate Medical Journal, 74(877), 697-698.
Maggio D, McCloskey EV, Camilli L, Cenci S, Cherubini A, Kanis JA & Senin U (1998) Short-term reproducibility of proximal femur bone mineral density in the elderly. CALCIFIED TISSUE INT, 63(4), 296-299.
McCloskey EV, MacLennan ICM, Drayson MT, Chapman C, Dunn J & Kanis JR (1998) Oral clodronate reduces skeletal morbidity in multiple myeloma. BRIT J HAEMATOL, 102(1), 6-6.
Cohen CB & McCloskey EL (1998) . Kennedy Institute of Ethics Journal, 8(2), vii-x.
Powles TJ, Ashley S, Tidy VA, Nevantaus A, McCloskey E, Kanis J, Paterson AHG & Rosenqvist K (1998) . JNCI: Journal of the National Cancer Institute, 90(9), 704-708.
Bruce NJ, McCloskey EV, Kanis JA & Guest JF (1998) Economic impact of using clodronate in the management of patients with multiple myeloma. BRIT J HAEMATOL, 101, 46-46.
McCloskey EV, MacLennan ICM, Drayson MT, Chapman C, Dunn J, Kanis JA & MRC Working Party Leukaemia Adults (1998) A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. BRIT J HAEMATOL, 100(2), 317-325.
McCloskey EV & Libretto SE (1998) . Hematology, 3(4), 291-298.
Brace NJ, McCloskey EV, Kanis JA & Guest JF (1997) . European Journal of Cancer, 33, S25-S25.
Bruce NJ, McCloskey EV, Kanis JA & Guest JF (1997) Economic evaluation of the use of prophylactic Clodronate to treat multiple myeloma. EUR J CANCER, 33, PP29-PP29.
Kanis JA & McCloskey EV (1997) . Cancer, 80(8 Suppl), 1691-1695.
Kanis JA & McCloskey EV (1997) . Cancer, 80(8 Suppl), 1538-1545.
Khan SA, Kanis JA, Vasikaran S, Kline WF, Matuszewski BK, McCloskey EV, Beneton MN, Gertz BJ, Sciberras DG, Holland SD , Orgee J et al (1997) . J Bone Miner Res, 12(10), 1700-1707.
Powles TJ, McCloskey E, Paterson AHG, Ashley S, Tidy A & Kanis J (1997) . European Journal of Cancer, 33, S80-S80.
Bernard J, deTakats D, McCloskey EV & Kanis JA (1997) Ultrasound velocity and dexa in normal and pagetic bone.. J BONE MINER RES, 12, T682-T682.
Khan SA, Vasikaran S, McCloskey EV, Benéton MN, Rogers S, Coulton L, Orgee J, Coombes G & Kanis JA (1997) . Bone, 20(3), 263-271.
Nakatsuka K, Sirtori PL, McCloskey EV, Khan SA, Orgee JM, O'Neill TW, Dilsen G & Kanis JA (1997) . Journal of Bone and Mineral Metabolism, 15(4), 218-222.
Kanis JA, McCloskey EV & Beneton MN (1997) . Osteoporos Int, 7 Suppl 3, S179-S183.
Kanis JA, McCloskey EV, de Takats D, Bernard J & Zhang DM (1997) . Osteoporos Int, 7 Suppl 3, S140-S146.
Kanis JA, Powles T, Paterson AH, McCloskey EV & Ashley S (1996) . Bone, 19(6), 663-667.
Khan SA, Brennan P, Newman J, Gray RE, McCloskey EV & Kanis JA (1996) . Bone, 19(1), 47-50.
Masud T, Mootoosamy I, McCloskey EV, OSullivan MP, Whitby EP, King D, Matson MB, Doyle DV & Spector TD (1996) Assessment of osteopenia from spine radiographs using two different methods: The Chingford study. BRIT J RADIOL, 69(821), 451-456.
Kanis JA, McCloskey EV & Beneton MN (1996) . Maturitas, 23 Suppl, S81-S86.
Khan SA, McCloskey EV, Nakatsuka K, Orgee J, Coombes GM & Kanis JA (1996) . Bone, 18(2), 185-190.
Khan SA, McCloskey EV, Eyres KS, Nakatsuka K, Sirtori P, Orgee J, Coombes G & Kanis JA (1996) . J Bone Miner Res, 11(2), 178-182.
Luchetti M, McCloskey E, DeTakats D, Bernard J, Reaney L & Kanis J (1996) . Osteoporosis International, 6(S1), 134-134.
McCloskey E, Orgee J, Bernard J, deTakats D, Luchetti M, Beneton M, Charlesworth D & Kanis JA (1996) . Osteoporosis International, 6(S1), 217-217.
McCloskey E, Luchetti M, Bernard J, deTakats D, Brazier J, Nicholl J & Kanis J (1996) . Osteoporosis International, 6(S1), 271-271.
Kanis JA, McCloskey EV, Bernard J, de Takats D & Beneton MNC (1996) . Osteoporosis International, 6(S1), 89-89.
Orgee JM, Foster H, McCloskey EV, Khan S, Coombes G & Kanis JA (1996) . Osteoporos Int, 6(1), 1-7.
Kanis JA & McCloskey EV (1996) . Bone, 18(3 Suppl), 127S-132S.
Vasikaran SD, Khan S, McCloskey EV & Kanis JA (1995) Sustained response to intravenous alendronate in postmenopausal osteoporosis. BONE, 17(6), 517-520.
Paterson AH, Kanis JA, Powles TJ, McCloskey E, Hanson J & Ashley S (1995) Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.. The Canadian journal of oncology, 5 Suppl 1, 54-57.
McCloskey EV, MacLennan ICM, Drayson M, Chapman C, Dunn J & Kanis JA (1995) . European Journal of Cancer, 31, S162-S162.
O'Doherty DP, McCloskey EV, Vasikaran S, Khan S & Kanis JA (1995) . J Bone Miner Res, 10(7), 1094-1100.
Khan SA, Vasikaran S, McCloskey EV & Kanis JA (1995) . Bone, 16(6), 683-683.
Coombes GM, Nakatsuka K, Sirtori PL, McCloskey EV, O'Neill T & Kanis JA (1995) . Bone, 16(6), 691-692.
McCloskey EV, Sirtori P, Nakatsuka K, Beneton MNC, Khan S & Kanis J (1995) . Bone, 16(6), 692-692.
Orgee JM, Taube T, McCloskey EV, Coombes G, Khan S & Kanis JA (1995) . Bone, 16(6), 691-691.
KANIS JA & MCCLOSKEY EV (1995) EVENTS PER PERSON YEAR - A DECREASE IN MULTIPLE EVENTS MAY BE MISSED. BRIT MED J, 310(6992), 1469-1469.
Laitinen K (1995) . BMJ, 310(6992), 1469.
O'Rourke N, McCloskey E, Houghton F, Huss H & Kanis JA (1995) . Journal of Clinical Oncology, 13(4), 929-934.
CUMMINGS SR, MELTON LJ, FELSENBERG D, ALLANDER E, BLACK D, COOPER C, DUTTA SN, EASTELL R, EPSTEIN R, GENANT HK , LEIDIGBRUCKNER G et al (1995) ASSESSING VERTEBRAL FRACTURES. JOURNAL OF BONE AND MINERAL RESEARCH, 10(4), 518-523.
Hamdy NAT, McCloskey EV & Kanis JA (1994) Role of bisphosphonates in the medical management of hyperparathyroidism. Acta Chirurgica Austriaca, 26(SUPPL. 112), 6-7.
KANIS JA, OROURKE N & MCCLOSKEY EV (1994) CONSEQUENCES OF NEOPLASIA INDUCED BONE-RESORPTION AND THE USE OF CLODRONATE (REVIEW). INT J ONCOL, 5(4), 713-731.
Vasikaran SD, O'Doherty DP, McCloskey EV, Gertz B, Kahn S & Kanis JA (1994) . Bone Miner, 27(1), 51-56.
O'Rourke NP, McCloskey EV, Rosini S, Coleman RE & Kanis JA (1994) . Br J Cancer, 69(5), 914-917.
Vasikaran SD, McCloskey EV, Kahn S & Kanis JA (1994) . Ann Clin Biochem, 31 ( Pt 3), 272-276.
Davies KM, McCloskey EV & Kanis JA (1994) . Osteoporosis International, 4(2), 117-119.
MCCLOSKEY EV & KANIS JA (1994) ASSESSING VERTEBRAL DEFORMITIES. OSTEOPOROSIS INT, 4(2), 117-119.
DONNELLY S, DOYLE DV, DENTON A, ROLFE I, MCCLOSKEY EV & SPECTOR TD (1994) BONE-MINERAL DENSITY AND VERTEBRAL COMPRESSION FRACTURE RATES IN ANKYLOSING-SPONDYLITIS. ANN RHEUM DIS, 53(2), 117-121.
Khan S, McCloskey EV, Eyres KS, Fern ED & Kanis JA (1994) . Semin Arthritis Rheum, 23(4), 271.
Eyres KS, McCloskey EV, Fern ED, Khan S & Kanis JA (1994) . Semin Arthritis Rheum, 23(4), 270.
O'Rourke N, McCloskey E & Kanis J (1994) . Journal of Clinical Oncology, 12(1), 232-232.
OROURKE NP, MCCLOSKEY EV, NEUGEBAUER G & KANIS JA (1994) RENAL AND NONRENAL CLEARANCE OF CLODRONATE IN PATIENTS WITH MALIGNANCY AND RENAL IMPAIRMENT. DRUG INVEST, 7(1), 26-33.
O'Rourke NP, McCloskey EV & Kanis JA (1994) . Clin Oncol (R Coll Radiol), 6(3), 172-176.
Paterson AH, Powles TJ, Kanis JA, McCloskey E, Hanson J & Ashley S (1993) Double-blind trial of oral clodronate in breast cancer patients with bone metastases. Bulletin du cancer, 80(10 Suppl), 50-56.
Kanis JA, Aaron J, Benéton M & McCloskey E (1993) . Journal of Bone and Mineral Metabolism, 11(1), S17-S24.
SPECTOR TD, MCCLOSKEY EV, DOYLE DV & KANIS JA (1993) PREVALENCE OF VERTEBRAL FRACTURE IN WOMEN AND THE RELATIONSHIP WITH BONE-DENSITY AND SYMPTOMS - THE CHINGFORD STUDY. J BONE MINER RES, 8(7), 817-822.
Taube T, Beneton MN, Williams JL, McCloskey EV & Kanis JA (1993) . Br J Urol, 72(1), 98-103.
McCloskey EV, Spector TD, Eyres KS, Fern ED, O'Rourke N, Vasikaran S & Kanis JA (1993) . Osteoporos Int, 3(3), 138-147.
(1993) . Rheumatology, 32(suppl 1), 108-168.
KANIS JA, MCCLOSKEY EV, OROURKE N, KHAN S, FERN D, EYRES K, SITORI P, TAUBE T, POWLES T & PATERSON A (1993) CLODRONATE IN HYPERCALCEMIA AND OSTEOLYTIC BONE-DISEASE DUE TO BREAST-CANCER. SAUDI MED J, 14(2), 93-97.
O'Rourke NP, McCloskey EV, Vasikaran S, Eyres K, Fern D & Kanis JA (1993) . Br J Cancer, 67(3), 560-563.
SPECTOR TD, HALL GM, MCCLOSKEY EV & KANIS JA (1993) RISK OF VERTEBRAL FRACTURE IN WOMEN WITH RHEUMATOID-ARTHRITIS. BRIT MED J, 306(6877), 558-558.
Paterson AH, Powles TJ, Kanis JA, McCloskey E, Hanson J & Ashley S (1993) . Journal of Clinical Oncology, 11(1), 59-65.
PATERSON AHG, POWLES TJ, KANIS JA, MCCLOSKEY E, HANSON J & ASHLEY S (1993) DOUBLE-BLIND CONTROLLED TRIAL OF ORAL CLODRONATE IN PATIENTS WITH BONE METASTASES FROM BREAST-CANCER. BULLETIN DU CANCER, 80(10), 50-65.
Kanis JA, McCloskey EV, Sirtori P, Khan S, Fern D, Eyres K, Aaron J & Beneton MN (1993) . Osteoporos Int, 3 Suppl 2, S23-S28.
Taube T, Beneton MN, McCloskey EV, Rogers S, Greaves M & Kanis JA (1992) . Eur J Haematol, 49(4), 192-198.
EYRES KS, MCCLOSKEY EV, FERN ED, BENETON MNC, ROGERS S, ODOHERTY D & KANIS JA (1992) HAJDU-CHENEY SYNDROME - A REPORT OF 2 CASES. J ORTHOP RHEUMATOL, 5(3), 163-169.
Eyres KS, McCloskey EV, Fern ED, O'Rourke N, Vasikaran S, Risteli J, Risteli I & Kanis JA (1992) . Bone and Mineral, 17, S29-S29.
McCloskey EV, O'Rourke N, MacLennan I, Chapman C, Beneton M, Greaves M, Preston FE & Kanis JA (1992) . Bone and Mineral, 17, S27-S27.
O'Rourke N, McCloskey E, Eyres K, Vasikaran S & Kanis J (1992) . Bone and Mineral, 17, S28-S28.
Fern ED, Mccloskey EV, Eyres KS, Vasikaran S, Risteli J, Risteli L & Kanis JA (1992) . Bone and Mineral, 17, S21-S21.
Vasikaran SD, Gertz BJ, Sciberras DG, McCloskey EV, O'Rourke N & Kanis JA (1992) . Bone and Mineral, 17, S25-S25.
Eyres KS, Marshall P, McCloskey E, Douglas DL & Kanis JA (1992) . Drug Safety, 7(2), 162-165.
Kanis JA & McCloskey EV (1992) . Bone, 13 Suppl 2, S1-10.
Eyres KS, McCloskey EV, Fern ED, Rogers S, Beneton M, Aaron JE & Kanis JA (1992) . Bone, 13(6), 431-433.
Benéton MN, Yates AJ, Rogers S, McCloskey EV & Kanis JA (1991) . Clin Sci (Lond), 81(4), 543-549.
McCloskey EL (1991) . The Hastings Center Report, 21(5), S14-S14.
O'Doherty DP, Bickerstaff DR, McCloskey EV, Eyres KS & Kanis JA (1991) Radiographic healing of osteolytic Paget's disease in the tibia with alendronate. Journal of Orthopaedic Rheumatology, 4(3), 153-157.
Eyres KS, McCloskey EV, O'Doherty DP, Hamdy NAT, Fern ED & Kanis JA (1991) The use of the Mennen clamp-on plate in the management of a pathological fracture. Journal of Orthopaedic Rheumatology, 4(3), 145-151.
Bickerstaff DR, O'Doherty DP, McCloskey EV, Hamdy NA, Mian M & Kanis JA (1991) . Bone, 12(1), 17-20.
Kanis JA, McCloskey EV, Taube T & O'Rourke N (1991) . Bone, 12 Suppl 1, S13-S18.
O'Doherty DP, Bickerstaff DR, McCloskey EV, Hamdy NA, Beneton MN, Harris S, Mian M & Kanis JA (1990) . J Bone Miner Res, 5(5), 483-491.
McCloskey EV, Murray SA, Charlesworth D, Miller C, Fordham J, Clifford K, Atkins R & Kanis JA (1990) . Clin Sci (Lond), 78(2), 221-225.
O'Doherty DP, Bickerstaff DR, McCloskey EV, Atkins R, Hamdy NA & Kanis JA (1990) . Clin Sci (Lond), 78(2), 215-219.
McCloskey EV, Murray SA, Miller C, Charlesworth D, Tindale W, O'Doherty DP, Bickerstaff DR, Hamdy NA & Kanis JA (1990) . Clin Sci (Lond), 78(2), 227-233.
KANIS JA, MCCLOSKEY EV & PATERSON AHG (1990) USE OF DIPHOSPHONATES IN HYPERCALCEMIA DUE TO MALIGNANCY. LANCET, 335(8682), 170-171.
McCloskey EV, Murray SA, Charlesworth D, Hamdy NAT & Kanis JA (1990) . Bone, 11(5), 382-383.
Hamdy NA, McCloskey EV, Brown CB & Kanis JA (1990) . Nephron, 56(1), 6-12.
McCloskey EV, Galloway J, Morgan MA & Kanis JA (1989) . BMJ, 299(6712), 1381-1382.
Hamdy NAT, McCloskey EV, Tindale W, Harris S, Beneton MNC, Boletis J, Brown CB & Kanis JA (1989) . Bone, 10(6), 478-478.
McCloskey EV, Beneton M, Harris S, Greaves M, Preston FE & Kanis JA (1989) . Bone, 10(6), 476-477.
Hamdy NA, McCloskey EV, Naylor VA, Brown CB & Kanis JA (1989) Phosphate binding efficiency of a polyuronic acid in normal subjects.. Nephrol Dial Transplant, 4(9), 829-830.
McCloskey EV, Yates AJ, Gray RE, Hamdy NA, Galloway J & Kanis JA (1988) . Clin Sci (Lond), 74(6), 607-612.
Kanis JA, McCloskey EV, Thavarajah M, Evans D, Hamdy NA, Preston E & Greaves M (1988) . Hematol Oncol, 6(2), 115-117.
JONES PBB, MCCLOSKEY EV & KANIS JA (1987) TRANSIENT TASTE-LOSS DURING TREATMENT WITH ETIDRONATE. LANCET, 2(8559), 637-637.
Jones PBB, Mccloskey EV & Kanis JA (1987) . The Lancet, 330(8559), 637-637.
KANIS JA, GRAY RES & MCCLOSKEY EV (1987) TREATING PAGETS-DISEASE. BRIT MED J, 294(6587), 1612-1613.
KANIS JA, URWIN GH, GRAY RES, BENETON MNC, MCCLOSKEY EV, HAMDY NAT & MURRAY SA (1987) EFFECTS OF INTRAVENOUS ETIDRONATE DISODIUM ON SKELETAL AND CALCIUM-METABOLISM. AM J MED, 82(2A), 55-70.
Jones PBB, McCloskey EV & Kanis JA (1987) Transient taste-loss during treatment with etidronate. Acta Dermato-Venereologica, 67(4), 637.
Hamdy NAT, Gray RES, McCloskey E, Galloway J, Rattenbury JM, Brown CB & Kanis JA (1987) Clodronate in the medical management of hyperparathyroidism. Bone, 8(SUPPl. 1).
McCloskey EV, Yates AJ, Beneton MN, Galloway J, Harris S & Kanis JA (1987) Comparative effects of intravenous diphosphonates on calcium and skeletal metabolism in man.. Bone, 8 Suppl 1, S35-S41.
Urwin GH, Yates AJ, Gray RE, Hamdy NA, McCloskey EV, Preston FE, Greaves M, Neil FE & Kanis JA (1987) Treatment of the hypercalcaemia of malignancy with intravenous clodronate.. Bone, 8 Suppl 1, S43-S51.
YATES AJP, MCCLOSKEY EV & KANIS JA (1986) DO ALL DIPHOSPHONATES HAVE HYPERPHOSPHATEMIC EFFECTS IN MAN. BONE, 7(4), 312-312.
Liu E, Liu RY, Moraros J, McCloskey EV, Harvey NC, Lorentzon M, Johansson H & Kanis JA () . Osteoporosis International.
Bhattoa HP, Vasikaran S, Trifonidi I, Kapoula G, Lombardi G, Jørgensen NR, Pikner R, Miura M, Chapurlat R, Hiligsmann M , Haarhaus M et al () . Osteoporosis International.
Armutcu F & McCloskey E () . Calcified Tissue International, 116(1).
Fuggle N, Laslop A, Rizzoli R, Al-Daghri N, Alokail M, Balkowiec-Iskra E, Beaudart C, Bruyère O, Bemden AB-V, Burlet N , Cavalier E et al () . Drugs.
Kanis JA, Johansson H, McCloskey EV, Liu E, Schini M, Vandenput L, Åkesson KE, Anderson FA, Azagra R, Bager CL , Beaudart C et al () . Osteoporosis International.
Kanis JA, Johansson H, Lorentzon M, Harvey NC & McCloskey EV () . Calcified Tissue International, 116(1).
Curtis EM, Miguel M, McEvoy C, Ticinesi A, Torre C, Al-Daghri N, Alokail M, Bałkowiec-Iskra E, Bruyère O, Burlet N , Cavalier E et al () . Aging Clinical and Experimental Research, 37(1).
Cavalier E, Pikner R, Vasikaran SD, Bhattoa HP, Makris K, McCloskey EV, Harvey NC, Jørgensen NR & Lombardi G () . Osteoporosis International.
Ye C, Morin SN, Lix LM, McCloskey EV, Johansson H, Harvey NC, Kanis JA & Leslie WD () . JAMA Network Open, 7(12), e2448208-e2448208.
Lombardi G, Jørgensen NR, Harvey NC, McCloskey EV, Åkesson KE, Eastell R, Garnero P, Kanis JA, Khashayar P, Lane NE , McClung MR et al () . Clinical Chemistry and Laboratory Medicine (CCLM).
Borgström F, Lorentzon M, Johansson H, Harvey NC, McCloskey E, Willems D, Knutsson D & Kanis JA () . Osteoporosis International.
Ye C, Leslie WD, Al-Azazi S, Yan L, Lix LM, Czaykowski P, McCloskey EV, Johansson H, Harvey NC, Kanis JA & Singh H () . JAMA Oncology.
Berg K, Dockrell D, Colvin L, Fraser WD, Tang JCY, Aspray T, Dennison E, Divyateja H, Ghouri N, Hanison E , Keen R et al () . Calcified Tissue International.
Gostage J, Kostenuik P, Goljanek-Whysall K, Bellantuono I, McCloskey E & Bonnet N () . Current Osteoporosis Reports.
Armutcu F & McCloskey E () . Osteoporosis International.
Green O, Raju SA, Shiha MG, Nandi N, Bayley M, McCloskey E & Sanders DS () . Scandinavian Journal of Gastroenterology, 1-6.
Kanis JA, Harvey NC, Lorentzon M, Liu E, Schini M, Abrahamsen B, Adachi JD, Alokail M, Borgstrom F, Bruyère O , Carey JJ et al () . Osteoporosis International.
Kanis JA, Dawson-Hughes B, Campusano C, Cooper C, Ebeling PR, Halbout P, Harvey NC, McCloskey EV, McClung MR, Reginster J-Y , Saleh Y et al () . Osteoporosis International.
Westbury LD, Harvey NC, Beaudart C, Bruyère O, Cauley JA, Cawthon P, Cruz-Jentoft AJ, Curtis EM, Ensrud K, Fielding RA , Johansson H et al () . Aging Clinical and Experimental Research, 36(1).
McCloskey E, Tan ATH & Schini M () . Current Opinion in Endocrinology, Diabetes & Obesity.
Fuggle NR, Beaudart C, Bruyère O, Abrahamsen B, Al-Daghri N, Burlet N, Chandran M, Rosa MM, Cortet B, Demonceau C , Dere W et al () . Nature Reviews Rheumatology.
Gandham A, Gregori G, Johansson L, Johansson H, Harvey NC, Vandenput L, McCloskey E, Kanis JA, Litsne H, Axelsson K & Lorentzon M () . Journal of Bone and Mineral Research.
Vandenput L, Johansson H, McCloskey EV, Liu E, Schini M, Åkesson KE, Anderson FA, Azagra R, Bager CL, Beaudart C , Bischoff-Ferrari HA et al () . Osteoporosis International.
Brown J, Paggiosi MA, Rathbone E, Gregory W, Bertelli G, Din O, McCloskey E, Dodwell D, Cameron D, Eastell R & Coleman R () . Journal of Bone and Mineral Research.
Ye C, Schousboe JT, Morin SN, Lix LM, McCloskey EV, Johansson H, Harvey NC, Kanis JA & Leslie WD () . Journal of Bone and Mineral Research.
Armutcu F & McCloskey E () . Journal of Cellular Signaling, 5(2), 57-64.
Armutcu F, McCloskey E & Ince M () . Journal of Cellular Signaling, 5(4), 183-194.
Richards C, Stevens R, Lix LM, McCloskey EV, Johansson H, Harvey NC, Kanis JA & Leslie WD () . Rheumatology.
Schini M, Johansson H, Harvey NC, Lorentzon M, Kanis JA & McCloskey EV () . Journal of Endocrinological Investigation.
Leslie WD, Binkley N, Schousboe JT, McCloskey EV, Johansson H, Harvey NC & Kanis JA () . Journal of Bone and Mineral Research.
Ye C, Leslie WD, Morin SN, Lix LM, McCloskey EV, Johansson H, Harvey NC, Lorentzon M & Kanis JA () . JAMA Network Open, 6(8), e2329253-e2329253.
Kanis JA, Johansson H, McCloskey EV, Liu E, Åkesson KE, Anderson FA, Azagra R, Bager CL, Beaudart C, Bischoff-Ferrari HA , Biver E et al () . Osteoporosis International.
Jaiswal R, Johansson H, Axelsson KF, Magnusson P, Harvey NC, Vandenput L, McCloskey E, Kanis JA, Litsne H, Johansson L & Lorentzon M () . The Journal of Clinical Endocrinology & Metabolism.
Shevroja E, Reginster J-Y, Lamy O, Al-Daghri N, Chandran M, Demoux-Baiada A-L, Kohlmeier L, Lecart M-P, Messina D, Camargos BM , Payer J et al () . Osteoporosis International.
Moon RJ, Reginster J-Y, Al-Daghri NM, Thiyagarajan JA, Beaudart C, Bruyère O, Burlet N, Chandran M, da Silva MC, Conaghan PG , Dere WH et al () . Osteoporosis International.
Kanis JA, Johansson H, Harvey NC, Lorentzon M, Liu E, Vandenput L, Morin S, Leslie WD & McCloskey EV () . Osteoporosis International.
Gavilanez EL, Luis IN, Mario NG, Johansson H, Harvey NC, Lorentzon M, Liu E, Vandenput L, McCloskey EV & Kanis JA () . Archives of Osteoporosis, 18(1).
Kanis JA, Harvey NC, Liu E, Vandenput L, Lorentzon M, McCloskey EV, Bouillon R, Abrahamsen B, Rejnmark L, Johansson H , Sikjær T et al () . Osteoporosis International.
Svedbom A, Borgstöm F, Hernlund E, Alekna V, Bianchi ML, Clark P, Diaz-Curiel M, Dimai HP, Jürisson M, Lesnyak O , McCloskey E et al () . Quality of Life Research.
Kanis JA, McCloskey EV, Harvey NC, Cooper C, Rizzoli R, Dawson-Hughes B, Maggi S & Reginster J-Y () . Osteoporosis International.
Kline GA, Morin SN, Lix LM, McCloskey EV, Johansson H, Harvey NC, Kanis JA & Leslie WD () . The Journal of Clinical Endocrinology & Metabolism.
Kanis JA, Johansson H, Harvey NC, Gudnason V, Sigurdsson G, Siggeirsdottir K, Lorentzon M, Liu E, Vandenput L & McCloskey EV () . Osteoporosis International.
Lanz P, Wieczorek M, Sadlon A, de Godoi Rezende Costa Molino C, Abderhalden LA, Schaer DJ, Spahn DR, Freystätter G, Orav EJ, Egli A , Bischoff-Ferrari HA et al () . The journal of nutrition, health & aging.
Leslie WD, Morin SN, Lix LM, McCloskey EV, Johansson H, Harvey NC & Kanis JA () . Journal of Bone and Mineral Research.
Lorentzon M, Johansson H, Harvey NC, Liu E, Vandenput L, Crandall CJ, Cauley JA, LeBoff MS, McCloskey EV & Kanis JA () . Osteoporosis International.
McCloskey EV, Chotiyarnwong P, Harvey NC, Lorentzon M, Kanis JA, Prieto-Alhambra D, Abrahamsen B, Adachi JD, Borgström F, Bruyere O , Carey JJ et al () . Osteoporosis International.
Farzi M, Pozo JM, McCloskey E, Eastell R, Harvey NC, Frangi AF & Wilkinson JM () . Journal of Bone and Mineral Research.
Paskins Z, Babatunde O, Sturrock A, Toh LS, Horne R, Maidment I, McCloskey E, Paskins Z, Armstrong D, Curtis E , Edwards J et al () . Osteoporosis International.
Axelsson KF, Wallander M, Johansson H, Harvey NC, Vandenput L, McCloskey E, Liu E, Kanis JA, Litsne H & Lorentzon M () . JAMA Network Open, 5(6), e2215396-e2215396.
Stahl-Gugger A, de Godoi Rezende Costa Molino C, Wieczorek M, Chocano-Bedoya PO, Abderhalden LA, Schaer DJ, Spahn DR, Orav EJ, Vellas B, da Silva JAP , Kressig RW et al () . Aging Clinical and Experimental Research, 34(9), 2205-2215.
Javaid MK, Harvey NC, McCloskey EV, Kanis JA & Cooper C () . Osteoporosis International.
Leslie WD, Möller S, Skjødt MK, Yan L, Abrahamsen B, Lix LM, McCloskey EV, Johansson H, Harvey NC, Kanis JA & Rubin KH () . Osteoporosis International.
Leslie WD, Morin SN, Lix LM, McCloskey EV, Johansson H, Harvey NC & Kanis JA () . Journal of Bone and Mineral Research.
Bischoff-Ferrari HA, Freystätter G, Vellas B, Dawson-Hughes B, Kressig RW, Kanis JA, Willett WC, Manson JE, Rizzoli R, Theiler R , Hofbauer LC et al () . The American Journal of Clinical Nutrition.
Dowling L, McCloskey E, Cuthbertson DJ & Walsh JS () . The Journal of Frailty & Aging.
McCloskey EV, Harvey NC, Johansson H, Lorentzon M, Liu E, Vandenput L, Leslie WD & Kanis JA () . Climacteric, 1-7.
Povoroznyuk VV, Johansson H, Grygorieva NV, Kanis JA, Musiіenko АS, Lorentzon M, Harvey NC, McCloskey EV & Liu E () . PAIN, JOINTS, SPINE, 11(2), 53-61.
Soriano-Arroquia A, Gostage J, Bardell D, McCloskey E, Bellantuono I, Clegg P, McDonagh B & Goljanek-Whysall K () .
Larsson BAM, Johansson L, Mellström D, Johansson H, Axelsson KF, Harvey N, Vandenput L, McCloskey E, Liu E, Sundh D , Kanis JA et al () . Osteoporosis International.
Povoroznyuk V, Grygorieva N, Kanis JA, Johansson H & McCloskey EV () . PAIN, JOINTS, SPINE, 9(4), 212-221.
Povoroznуuk VV, Grуgorieva NV, Prostenko VV, Kanis JA, Johansson H & McCloskey EV () . Likarska sprava(5-6), 79-87.
Povorozniuk V, Grigoryeva N, Korzh M, Strafun S, Kanis J, McCloskey E, Vaida V, Klymovytsky F, Vlasenko R & Forosenko V () . ORTHOPAEDICS, TRAUMATOLOGY and PROSTHETICS, 0(4), 68-74.
Povoroznуuk VV, Grуgorieva NV, Kanis JA, McCloskey EV & Johansson H () . PAIN. JOINTS. SPINE, 0(3.23), 5-14.
Povoroznyuk VV, Grygorieva NV, Korzh MO, Strafun SS, Vaida VM, Klymovytsky FV, Vlasenko RO, Forosenko VS, Kanis JA, Johansson H & McCloskey EV () . TRAUMA, 17(5), 14-20.
Horvath C, Meszaros S, Acs O, Hosszu E, Nemeth J, Csupor E, Szathmari M, Acs N & McCloskey EV () . Endocrine Abstracts.
Zayed MG () . Clinical Cases in Mineral and Bone Metabolism.
Lesnyak OM, Yershova OB, Belova KY, Gladkova EN, Sinitsyna OS, Ganert OA, Romanova MA, Hodyrev VN, Johanson H, McCloskey EV & Kanis JA () . Osteoporosis and Bone Diseases, 17(3), 3-8.
Naylor K, Paggiosi M, Gossiel F, McCloskey E, Peel N, Walsh J & Eastell R () . Bone Abstracts.
Gossiel F, Hoyle C, McCloskey E, Walsh J, Peel N & Eastell R () . Bone Abstracts.
Gossiel F, Naylor K, McCloskey E, Peel N, Walsh J, Paggiosi M & Eastell R () . Bone Abstracts.
Zheng H-F, Tobias JH, Duncan E, Evans DM, Eriksson J, Paternoster L, Yerges-Armstrong LM, Lehtimäki T, Bergström U, Kähönen M , Leo PJ et al () . PLoS Genetics, 8(7), e1002745-e1002745.
Barker ME, McCloskey E, Saha S, Gossiel F, Charlesworth D, Powers HJ & Blumsohn A () . Journal of Bone and Mineral Research, 20(6), 913-920.
McCloskey E, Selby P, Davies M, Robinson J, Francis RM, Adams J, Kayan K, Beneton M, Jalava T, Pylkkänen L , Kenraali J et al () . Journal of Bone and Mineral Research, 19(5), 728-736.
Jalava T, Sarna S, Pylkkänen L, Mawer B, Kanis JA, Selby P, Davies M, Adams J, Francis RM, Robinson J & McCloskey E () . Journal of Bone and Mineral Research, 18(7), 1254-1260.
Patel S, Kwan JTC, McCloskey E, McGee G, Thomas G, Johnson D, Wills R, Ogunremi L & Barron J () . Journal of Bone and Mineral Research, 16(10), 1863-1870.
Kanis JA, Johansson H, Harvey NC, Gudnason V, Sigurdsson G, Siggeirsdottir K, Lorentzon M, Liu E, Vandenput L & McCloskey EV () . Osteoporosis International.

Chapters

Harvey NC, McCloskey EV, Rizzoli R, Kanis JA, Cooper C & Reginster J-Y (2024) , Reference Module in Biomedical Sciences Elsevier
Kanis JA, Harvey NC, Johansson H, Lorentzon M, Liu E, Leslie WD & McCloskey EV (2022) , Senior Trauma Patients (pp. 89-99). Springer International Publishing
McCloskey EV (2019) , Pocket Reference to Osteoporosis (pp. 21-29). Springer International Publishing
Harvey NCW, McCloskey EV, Rizzoli R, Kanis JA, Cooper C & Reginster J-Y (2019) , Encyclopedia of Endocrine Diseases (pp. 288-295). Elsevier
Kanis JA, McCloskey EV, Harvey NC & Leslie WD (2018) (pp. 331-339). Wiley
McCloskey EV, Leslie WD & Kanis JA (2018) , Osteoporosis: a lifecourse epidemiology approach to skeletal health (pp. 163-176). CRC Press
Kanis JA, Odén A, Johansson H & McCloskey EV (2013) , Osteoporosis: Fourth Edition (pp. 1611-1637).
Kanis JA, Odén A, Johansson H & McCloskey EV (2013) , Osteoporosis (pp. 1611-1637). Elsevier
Adler RA, Anderson DE, Arabi A, Arnett TR, Bachrach LK, Ballane G, Baran D, Barnes GL, Baron R, Bauer DC , Bauman WA et al (2013) , Osteoporosis (pp. xix-xxiii). Elsevier
Adler RA, Allen MR, Amin S, Antoniucci DM, Araujo AB, Armas LAG, Baroncelli GI, Bertelloni S, Bhasin S, Bilezikian JP , Binkley NC et al (2010) , Osteoporosis in Men (pp. ix-xii). Elsevier
Kanis JA, McCloskey EV, Johansson H & Oden A (2010) , Osteoporosis in Men (pp. 605-611). Elsevier
(2004) , Multiple Myeloma and Related Disorders (pp. 367-367). CRC Press
Kanis JA, McCloskey EV, O’Doherty D, Hamdy NAT, Bickerstaff D, Beneton M & Thavarajah M (1991) , Paget’s Disease of Bone (pp. 112-134). Springer US
Kanis JA, McCloskey EV, Eyres KS, O’Doherty DV & Aaron J (1990) , HRT and Osteoporosis (pp. 135-147). Springer London
Kanis JA & McCloskey EV () , Calcium Metabolism (pp. 89-136). S. Karger AG

Conference proceedings papers

Lorentzon M, Johansson H, Harvey N, Liu E, Schini M, Vandenput L, McCloskey E & Kanis J (2024) DIMINISHING RETURNS OF FALL PREVENTION ON HIP FRACTURE WITH AGE. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 36 (pp S12-S13)
Zoulakis M, Johansson H, Harvey NC, Axelsson KF, Litsne H, Johansson L, Liu E, Schini M, Vandenput L, McCloskey EV , Kanis JA et al (2024) EFFECT OF FRAXPLUS ADJUSTMENTS ON FRACTURE RISK RECLASSIFICATION IN OLDER SWEDISH WOMEN-RESULTS FROM THE SUPERB-STUDY. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 36 (pp S22-S23)
Johansson H, El Miedany Y, El Gaafary M, Gadallah N, Mahran S, Abu-Zaid M, Hassan W, Elwakil W, Harvey N, Schini M , Liu E et al (2024) EPIDEMIOLOGY OF HIP FRACTURE IN EGYPT AND DEVELOPMENT OF A COUNTRY-SPECIFIC FRAX MODEL. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 36 (pp S291-S292)
Johansson H, Kwang Y, Chandran M, Schini M, Lorentzon M, Vandenput L, Harvey N, McCloskey E, Kanis J & Liu E (2024) A SURROGATE FRAX MODEL FOR BRUNEI. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 36 (pp S292-S293)
Johansson H, Shahin A, Choudhury M, Chandran M, Schini M, Liu E, Lorentzon M, Vandenput L, Harvey N, McCloskey E & Kanis J (2024) A SURROGATE FRAX MODEL FOR BANGLADESH. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 36 (pp S293-S293)
Johansson H, Jaalkhorol M, Dashtseren A, Avirmed S, Bruyere O, Schini M, Liu E, Lorentzon M, Vandenput L, Harvey N , McCloskey E et al (2024) A SURROGATE FRAX MODEL FOR MONGOLIA. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 36 (pp S290-S291)
Clark P, Johansson H, Cerdas Perez S, Ortiz A, Cruz Pliego G, Harvey N, Schini M, Liu E, Vandenput L, Lorentzon M , McCloskey E et al (2024) EPIDEMIOLOGY OF HIP FRACTURE IN COSTA RICA AND DEVELOPMENT OF A COUNTRY-SPECIFIC FRAX MODEL. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 36 (pp S292-S292)
McCloskey EV, Johansson H, Liu E, Schini M, Vandenput L, Harvey NC, Lorentzon M, Leslie WD & Kanis JA (2024) FAMILY HISTORY OF FRACTURE AND FRACTURE RISK: A META-ANALYSIS TO UPDATE THE FRAX^® RISK ASSESSMENT TOOL. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 36 (pp S25-S26)
Harvey NC, Johansson H, McCloskey EV, Liu E, Schini M, Vandenput L, Lorentzon M, Leslie WD & Kanis JA (2024) SEX DEPENDENT ASSOCIATIONS BETWEEN BMI AND FRACTURE RISK: AN INTERNATIONAL META-ANALYSIS. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 36 (pp S26-S26)
Schini M, Johansson H, Harvey NC, Lorentzon M, Liu E, Vandenput L, Kanis JA & Mccloskey EV (2024) SMOKING HISTORY AND FRACTURE RISK: A META-ANALYSIS TO UPDATE THE FRAX^® RISK ASSESSMENT TOOL. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 36 (pp S23-S23)
Harvey NC, Kanis JA, Johansson H, McCloskey EV, Liu E, Schini M, Vandenput L, Lorentzon M & Leslie WD (2024) Is The Predictive Value of Rheumatoid Arthritis for Incident Fracture Dependent On Age, Sex, BMD or Follow-Up Time? An International MetaAnalysis of 1.6 Million Participants. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 39 (pp 380-380)
McCloskey EV (2024) FRACTURE PREVENTION: TIME TO MOVE BEYOND THE PRIMARY/SECONDARY DICHOTOMY?. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 36 (pp S1-S1)
Nedungayil SK, McCloskey EV & Davis S (2024) IMPLEMENTING IMPROVED TREATMENT FOR PATIENTS AT HIGH RISK OF FRACTURE IN PRIMARY CARE: EXPERIENCES FROM A HYBRID DIGITAL AND CLINICAL EVALUATION MODEL OF CARE. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 36 (pp S542-S542)
Green O, Raju S, Shiha M, Bayley M, McCloskey E & Sanders D (2023) . Poster presentations (pp A143.1-A143)
Vandenput L, Johansson H, McCloskey EV, Liu E, Schini M, Harvey NC, Lorentzon M, Leslie WD & Kanis JA (2023) A Meta-Analysis of Previous Falls and Subsequent Fracture Risk. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 242-242)
Mccloskey E, Johansson H, Harvey N, Lorentzon M, Morin S, Leslie W & Kanis J (2023) NUMBER OF PRIOR FALLS AND FRACTURE RISK-POTENTIAL ADJUSTMENT OF CONVENTIONAL FRAX PROBABILITIES. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S66-S66)
McCloskey E (2023) NEW INSIGHTS ON THE USE OF TBS IN CLINICAL PRACTICE. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S76-S76)
Schini M, Kanis J, Johansson H, Harvey N, Gudnason V, Sigurdsson G, Siggeirsdottir K, Lorenzon M, Liu E, Vandenput L & Mccloskey E (2023) ADJUSTING CONVENTIONAL FRAX ESTIMATES OF FRACTURE PROBABILITY ACCORDING TO THE NUMBER OF PRIOR FRACTURES. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S57-S57)
Johansson H, Albergaria BH, Zerbini CA, Vilaca T, Harvey NC, Enwu E, Vandenput L, Lorentzon M, Schini M, Mccloskey E & Kanis JA (2023) CHANGES IN HIP FRACTURE INCIDENCE IN BRAZIL AND IMPLICATIONS FOR FRAX. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S268-S269)
Johansson H, Latt TS, Chit TT, Chandran M, Schini M, Liu E, Lorentzon M, Vandenput L, Harvey NC, Mccloskey E & Kanis JA (2023) A SURROGATE FRAX MODEL FOR MYANMAR. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S270-S271)
Johansson H, Messina OD, Vidal M, Neira LFV, Liu E, Lorentzon M, Vandenput L, Schini M, Harvey NC, Mccloskey E & Kanis JA (2023) A SURROGATE FRAX MODEL FOR PERU. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S269-S269)
Ye C, Morin SN, Lix LM, McCloskey EV, Johansson H, Harvey NC, Kanis JA & Leslie WD (2023) Performance of FRAX in Men with Prostate Cancer: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 255-256)
McCloskey EV (2023) SHOULD THE PUNISHMENT FIT THE CRIME? OSTEOPOROSIS TREATMENT IN RELATION TO FRACTURE RISK. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S39-S39)
Ye C, Leslie WD, Al-Azazi S, Yan L, Lix LM, Czaykowski P, McCloskey EV, Harvey NC, Johansson H, Kanis JA & Singh H (2023) FRAX Underestimates Major Osteoporotic Fracture Risk in Cancer Survivors: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 76-76)
McCloskey EV, Johansson H, Harvey NC, Lorentzon M, Liu E, Vandenput L, Leslie WD, Schini M & Kanis JA (2023) FRAXPLUS-POST HOC EXPLORATION OF IMPACT OF ADDITIONAL RISK FACTOR INFORMATION ON FRAX PROBABILITY CALCULATIONS. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S52-S52)
Vandenput L, Lorentzon M, Harvey NC, Liu E, Mccloskey EV, Kanis JA, Abrahamsen B, Rejnmark L & Johansson H (2023) EFFECTS OF PARATHYROIDECTOMY ON RISK OF FRACTURE BY SEVERITY OF PRIMARY HYPERPARATHYROIDISM: A DANISH REGISTER STUDY. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S46-S46)
McCloskey EV (2023) COMPARATIVE EFFECTIVENESS AND CARDIOVASCULAR SAFETY OF ABALOPARATIDE AND TERIPARATIDE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN REAL WORLD USE. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S581-S582)
Harvey NC, Liu E, Vandenput L, Lorentzon M, Mccloskey EV, Kanis JA, Abrahamsen B, Rejnmark L & Johansson H (2023) DIFFERENTIAL EFFECTS ON RISK OF FRACTURE AND DEATH BY SEVERITY OF PRIMARY HYPERPARATHYROIDISM: A DANISH REGISTER STUDY. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S64-S65)
Vandenput L, Lorentzon M, Harvey NC, Liu E, Mccloskey EV, Kanis JA, Abrahamsen B, Rejnmark L & Johansson H (2023) EFFECTS OF PARATHYROIDECTOMY ON RISK OF FRACTURE BY SEVERITY OF PRIMARY HYPERPARATHYROIDISM: A DANISH REGISTER STUDY. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S331-S331)
Kanis JA, Vandenput L, Lorentzon M, Harvey NC, Liu E, McCloskey EV & Johansson H (2023) OSTEOPOROSIS IN MEN: SCREENING, DIAGNOSIS AND IDENTIFICATION OF PATIENTS TO BE TREATED. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S76-S76)
Gandham A, Gregori G, Johansson L, Johansson H, Harvey C, Vandenput L, Mccloskey E, Kanis J, Litsne H, Axelsson K & Lorentzon M (2023) SARCOPENIA DEFINITIONS AND THEIR ASSOCIATION WITH FRACTURE RISK IN OLDER SWEDISH WOMEN. THE SAHLGRENSKA UNIVERSITY HOSPITAL PROSPECTIVE EVALUATION OF RISK OF BONE FRACTURES (SUPERB) STUDY. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 35 (pp S59-S59)
Ye C, Morin S, Lix L, McCloskey E, Johansson H, Harvey N, Kanis J & Leslie W (2023) Rethinking Fragility Fracture Age Cut-offs: Fractures Beget Fractures Regardless of the Age at Which They Occur. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 241-242)
Leslie W, Goel H, Binkley N, McCloskey E & Hans D (2023) FRAX^® Adjustment Using Renormalized Trabecular Bone Score (TBS) from L1 Alone is Optimal for Fracture Prediction: The Manitoba BMD Registry. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 169-169)
Leslie W, Binkley N, Schousboe J, McCloskey E, Johansson H, Harvey N & Kanis J (2023) Effect of BMI-Discordant Abdominal Tissue Thickness on Fracture Probability: The Manitoba BMD Registry. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 242-242)
Leslie W, Goel H, Binkley N, McCloskey E & Hans D (2023) Adjusting for Level-specific Trabecular Bone Score (TBS) Differences Reduces FRAX®-based Treatment Reclassification in Patients with Vertebral Exclusions Due to Structural Artifact: The Manitoba BMD Registry. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 345-346)
Leslie W, Schousboe J, Morin S, Lix L, McCloskey E, Johansson H, Harvey N & Kanis J (2023) FRAX® Predicts Cardiovascular Risk in Women Undergoing Osteoporosis Screening: The Manitoba BMD Registry. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 78-79)
McCloskey E, Harvey N, Johansson H, Lorentzon M & Kanis J (2023) Antacid Use and Reduced Oral Clodronate Anti-fracture Efficacy: an Exploratory Analysis of Different Drug Classes. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 277-278)
Leslie W, Morin S, Lix L, McCloskey E, Johansson H, Harvey N, Lorentzon M & Kanis J (2023) Adjusting FRAX Estimates of Fracture Probability Based Upon a Positive Vertebral Fracture Assessment: The Manitoba BMD Registry. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 7-7)
Richards C, Stevens R, Lix L, McCloskey E, Johansson H, Harvey N, Kanis J & Leslie W (2023) Fracture Risk Prediction in Rheumatoid Arthritis From the Modern Era: Validation of FRAX© with Bone Mineral Density for Incident Major Osteoporotic Fractures. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 7-7)
Jones C, Sachdeva A, Murphy L, Murray M, Brown L, McCloskey E, Brown J, Attard G, Parmar M, James N , Sydes M et al (2023) CLINICAL FRACTURE INCIDENCE IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) AND RISK-REDUCTION FOLLOWING ADDITION OF ZOLEDRONIC ACID TO ANDROGEN DEPRIVATION THERAPY (ADT) WITH OR WITHOUT DOCETAXEL (DOC): LONG-TERM RESULTS FROM 2 PHASE 3 TRIALS FROM THE STAMPEDE PLATFORM PROTOCOL. JOURNAL OF UROLOGY, Vol. 209 (pp E129-E129)
Gandham A, Gregori G, Johansson L, Johansson H, Harvey N, Vandenput L, McCloskey E, Kanis J, Schini M, Litsne H , Axelsson K et al (2023) Sarcopenia definitions And their Association with Non-fracture injurious Falls in older Swedish women From the SUPERB study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 386-386)
McCloskey E, Johansson H, Harvey N, Liu E, Schini M, Vandenput L, Lorentzon M, Leslie W & Kanis J (2023) Parental History of Hip Fracture and Future Fracture Risk: an International Meta-analysis to Inform Updates of FRAX. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 345-345)
Tan A, McCloskey E, Zheng Z, Harvey N, Lorentzon M, Kanis J & Schini M (2023) Medications, Fracture Risk and Oral Bisphosphonate Efficacy - Evidence from a Well-Characterized Prospective Clinical Trial in Older Women. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 63-63)
Harvey N, Johansson H, McCloskey E, Liu E, Schini M, Vandenput L, Lorentzon M, Leslie W & Kanis J (2023) The Association Between Body Mass Index and Fracture is Dependent on Femoral Neck BMD: An International Meta-Analysis. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 166-166)
McCloskey E, Johansson H, Harvey N, Liu E, Schini M, Vandenput L, Lorentzon M, Leslie W & Kanis J (2023) Previous Fracture and Subsequent Fracture Risk: A Meta-analysis to Update FRAX. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 57-57)
Bhatia P, Shreef H, Johansson H, Harvey N, Lorentzon M, Kanis J & McCloskey E (2022) Fracture Risk in Parkinson's Disease - the Role of Bone Density, Falls Risk and Muscle Strength. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 37 (pp 67-67)
Leslie W, Morin S, Lix L, McCloskey E, Johansson H, Harvey N & Kanis J (2022) The Effect of Recent Fracture on 10-year Fracture Probability: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 37 (pp 194-194)
Leslie W, Morin S, Lix L, McCloskey E, Johansson H, Harvey N & Kanis J (2022) Discordance in Hip DXA Subregions Affects Incident Fracture Risk Independent of Fracture Probability: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 37 (pp 27-27)
McCloskey E, Harvey NC, Lorentzon M, Vandenput L, Liu E, Kanis JA & Johansson H (2022) CONCOMITANT PPI USE NEGATES ORAL BISPHOSPHONATE ANTI-FRACTURE EFFICACY: A POST HOC ANALYSIS FROM A RANDOMIZED CONTROLLED TRIAL OF CLODRONATE. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 34(SUPPL 1) (pp S41-S41)
Leslie W, Morin S, Lix L, McCloskey E, Johansson H, Harvey N & Kanis J (2022) Discordance in Hip DXA Subregions Affects Incident Fracture Risk Independent of Fracture Probability: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 37 (pp 247-247)
Johansson L, Johansson H, Harvey N, Liu E, Leslie W, Vandenput L, Mccloskey E, Kanis J & Lorentzon M (2022) IMPROVED FRACTURE RISK PREDICTION BY ADDING VFA-IDENTIFIED VERTEBRAL FRACTURE DATA TO BMD BY DXA AND CLINICAL RISK FACTORS USED IN FRAX. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 34(SUPPL 1) (pp S42-S43)
McCloskey E (2022) ADDED VALUE OF THE NEW VERSION OF THE FRAX (R) ALGORITHM. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 34(SUPPL 1) (pp S37-S38)
Leslie W, Moller S, Skjodt M, Yan L, Abrahamsen B, Lix L, McCloskey E, Johansson H, Harvey N, Kanis J & Rubin K (2022) FREM Affects Incident 10-year Fracture Risk Independent of FRAX (R) Probability: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 37 (pp 305-306)
Kanis JA, Harvey NC, Mccloskey E, Veronese N, Lorentzon M, Cooper C, Rizzoli R, Adib G, Al-Daghri N, Campusano C , Chandran M et al (2022) ALGORITHM FOR THE MANAGEMENT OF PATIENTS AT LOW, HIGH AND VERY HIGH RISK OF OSTEOPOROTIC FRACTURES. OSTEOPOROSIS INTERNATIONAL, Vol. 33(SUPPL 1) (pp S24-S24)
Kanis JA, Johansson H, Harvey NC, Gudnason V, Sigurdsson G, Siggeirsdottir K, Lorentzon M, Liu M, Vandenput L & Mccloskey E (2022) EAST VS. WEST: RECENCY OF SENTINEL FRACTURES AND ITS IMPACT ON CONVENTIONAL ESTIMATES OF FRACTURE PROBABILITY USING FRAX. OSTEOPOROSIS INTERNATIONAL, Vol. 33(SUPPL 1) (pp S33-S34)
Vandenput L, Johansson H, Mccloskey EV, Liu E, Harvey NC, Lorentzon M, Leslie WD & Kanis JA (2022) UPDATE OF THE FRACTURE RISK PREDICTION TOOL FRAX: A SYSTEMATIC REVIEW OF POTENTIAL COHORTS AND ANALYSIS PLAN. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 34(SUPPL 1) (pp S256-S256)
Harvey NC, Liu E, Vandenput L, Lorentzon M, Mccloskey EV, Kanis JA, Abrahamsen B, Rejnmark L & Johansson H (2022) PRIMARY HYPERPARATHYROIDISM, BONE MINERAL DENSITY AND INCIDENT FRACTURE RISK: A DANISH REGISTER STUDY. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 34(SUPPL 1) (pp S43-S43)
Gupta A, Maslen C, Vindlacheruvu M, Abel R, Bhattacharya P, Bromiley P, Clark E, Compston J, Crabtree N, Gregory J , Kairki E et al (2022) Digital Health Interventions for Osteoporosis and Post-Fragility Fracture Care. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 37 (pp 184-184)
Johansson H, Abdulla N, Alsaed OS, Lutf A, Alam F, Abdulmomen I, Al Emadi S, Harvey N, Liu E, Vandenput L , Lorentzon M et al (2022) EPIDEMIOLOGY OF HIP FRACTURE IN QATAR AND DEVELOPMENT OF A COUNTRY SPECIFIC FRAX MODEL. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 34(SUPPL 1) (pp S235-S235)
Johansson H, Poiana C, Barbu C, Pascanu I, Gasparik AI, Dobre R, Harvey N, Liu E, Vandenput L, Lorentzon M , Mc Closkey E et al (2022) CHANGES IN HIP FRACTURE INCIDENCE IN ROMANIA AND IMPLICATIONS FOR FRAX. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 34(SUPPL 1) (pp S235-S236)
Johansson H, Harvey N, Liu E, Vandenput L, Leslie W, Lorentzon M, Mc Closkey E & Kanis J (2022) FRAXPLUS. AGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 34(SUPPL 1) (pp S236-S237)
Zheng Z, Johansson H, Harvey NC, Lorentzon M, Kanis JA & McCloskey EV (2021) MIGHT NSAID USE INTERACT WITH BISPHOSPHONATE EFFICACY? EXPLORATORY ANALYSIS FROM THE CLODRONATE HIP STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S56-S56)
Povoroznyuk V, Johansson H, Grygorieva N, Lorentzon M, Musienko A, Harvey NC, McCloskey EV, Liu E & Kanis JA (2021) FRAX BASED OSTEOPOROSIS MANAGEMENT PATHWAY FOR UKRAINIAN MEN. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S278-S278)
McCloskey EV (2021) THE EFFECTIVENESS WORKING GROUP OF THE ROYAL OSTEOPOROSIS SOCIETY OSTEOPOROSIS AND BONE RESEARCH ACADEMY. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S74-S75)
Lorentzon M, McCloskey EV, Johansson H, Harvey NC, Gudnason V, Sigurdsson G, Siggeirsdottir K, Liu E, Vandenput L, Leslie W & Kanis JA (2021) RECENT SENTINEL FRACTURES AND SUBSEQUENT FRACTURE PROBABILITIES OVER TWO, FIVE AND 10-YEAR TIMEFRAMES. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S41-S41)
Leroy S, Saunders-Hastings P, Eusebi P, Taieb V, Abrahamsen B, McCloskey EV, Fujiwara S, Libanati C & Moayyeri A (2021) TREATMENT GAP AMONG PATIENTS WITH PRIMARY OSTEOPOROSIS: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S189-S190)
McCloskey EV, Harvey NC, Johansson H, Lorentzon M, Liu E, Vandenput L & Kanis JA (2021) IDENTIFICATION OF PATIENTS AT LOW, HIGH AND VERY HIGH RISK OF OSTEOPOROTIC FRACTURES IN THE UK USING FRAX. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S54-S55)
McCloskey EV (2021) SCREENING FOR HIGH FRAC TUR E RISK IN PRIMARY CARE. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S91-S92)
Axelsson KF, Wallander M, Johansson H, Harvey NC, Vandenput L, McCloskey EV, Enwu L, Kanis JA, Litsne H & Lorentzon M (2021) PARATHYROIDECTOMY IS ASSOCIATED WITH REDUCED RISK OF FRACTURE AND CARDIOVASCULAR EVENTS IN PATIENTS DIAGNOSED WITH PRIMARY HYPERPARATHYROIDISM - A NATIONAL, RETROSPECTIVE COHORT STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S47-S47)
Johansson H, Pandey D, Liu E, Lorentzon M, Vandenput L, Harvey NC, McCloskey EV & Kanis JA (2021) A SURROGATE FRAX MODEL FOR NEPAL. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S383-S383)
Johansson H, Hailu S, Liu E, Lorentzon M, Vandenput L, Harvey NC, McCloskey EV & Kanis JA (2021) A SURROGATE FRAX MODEL FOR ETHIOPIA. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S380-S380)
Bhattia P, Shreef H, Johansson H, Lorentzon M, Harvey NC, Kanis JA & McCloskey EV (2021) FRACTURE RISK IN PARKINSON'S DISEASE: DRIVEN BY LOW BONE STRENGTH, MUSCLE WEAKNESS OR FALLS?. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S42-S43)
Johansson H, Saleh Y, Liu E, Lorentzon M, Vandenput L, Harvey NC, McCloskey EV & Kanis JA (2021) EPIDEMIOLOGY OF HIP FRACTURES IN SAUDI ARABIA: DEVELOPMENT OF A COUNTRY SPECIFIC FRAX MODEL. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S383-S384)
Johansson H, Liu E, Lorentzon M, Vandenput L, Harvey NC, McCloskey EV, Paruk F, Ferrand R, Ndhlovu C, Dela S , Gregson C et al (2021) A SURROGATE FRAX MODEL IN ZIMBABWE. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S381-S382)
Povoroznyuk V, Johansson H, Grygorieva N, Lorentzon M, Musienko A, Harvey NC, McCloskey EV, Liu E & Kanis JA (2021) FRAX BASED OSTEOPOROSIS MANAGEMENT PATHWAY FOR UKRAINIAN MEN. OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S86-S86)
Leslie W, Morin S, Lix L, McCloskey E, Johansson H, Harvey N & Kanis J (2020) Adjusting Fracture Probability for Prior Falls: A Registry-Based Cohort Study.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 316-316)
McCloskey E, Harvey N, Johansson H, Lorentzon M, Vandenput L, Liu E & Kanis J (2020) Global impact of COVID-19 on osteoporosis management: A retrospective, longitudinal descriptive analysis of access to online MAX fracture risk assessments.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 212-212)
Leslie W, Morin S, Lix L, McCloskey E, Johansson H, Harvey N & Kanis J (2020) General Comorbidity Indicators Contribute to Fracture Risk Independent of FRAX: A Registry-Based Cohort Study.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 197-197)
Abrahamsen B, Rubio JB, Langdahl B, Ferrari S, De Ferrari G & McCloskey E (2020) BUILDING A STRONGER FUTURE FOR POSTMENOPAUSAL WOMEN WITH SEVERE OSTEOPOROSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S623-S623)
Lorentzon M, Johansson H, Harvey N, Liu E, Vandenput L, Crandall C, McCloskey E & Kanis J (2020) Hormone therapy reduces the risk of fracture regardless of baseline FRAX probability or prior falls - results from the Women's Health Initiative hormone therapy trials. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 249-249)
Leslie W, Morin S, Lix L, McCloskey E, Johansson H, Harvey N & Kanis J (2020) Adjusting Fracture Probability for the Effects of Recent Fracture: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 199-199)
Papaioannou A, Mccloskey E, Tan M, Bell A, Ngui D, Mehan U, Goldin L & Langer A (2020) ELECTRIC MEDICAL RECORD DASHBOARD INITIATIVE FOR QUALITY IMPROVEMENT IN THE MANAGEMENT OF PATIENTS WITH OSTEOPOROSIS (ADVANTAGE OP). OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S314-S314)
Zakroyeva A, Lesnyak O, Cazac V, Groppa L, Russu E, Chislari L, Rotaru L, Johansson H, Harvey C, Mccloskey E , Lorentzon M et al (2020) EPIDEMIOLOGY OF OSTEOPOROTIC FRACTURE IN MOLDOVA AND DEVELOPMENT OF A COUNTRY-SPECIFIC FRAX MODEL. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S253-S253)
Almog Y, Rai A, Mishra A, Moulaison A, Powell R, Weinberg K, Hamilton C, Oates M, McCloskey E & Cummings SR (2020) Crystal Bone: Personalized, Shot term Fracture Risk Prediction With Natural Language Processing, Methods. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 200-200)
McCloskey E, Coyne M, Tiwari P, Stad R, O'Kelly J & Papapoulos S (2020) PREVALENCE OF FRAX RISK FACTORS IN PRIMARY CARE FROM 8 EUROPEAN COUNTRIES. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S508-S509)
McCloskey E, Coyne M, Tiwari P, Stad R, O'Kelly J & Papapoulos S (2020) THE IMPACT OF CLINICAL RISK FACTORS FOR FRACTURE ON TREATMENT OF OSTEOPOROSIS (OP) IN PRIMARY CARE. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S509-S510)
Ferrari S, Diez-Perez A, Ojeda C & McCloskey EV (2020) A CHRONIC DISEASE: GOING BEYOND TODAY WITH OSTEOPOROSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S625-S625)
McCloskey EV (2020) ALGORITHM FOR THE ASSESSMENT OF ANTI-OSTEOPOROSIS TREATMENTS BY BONE TURNOVER MARKERS. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S66-S67)
Lorentzon M, Branco J, Brandi ML, Bruyere O, Chapurlat R, Cooper C, Cortet B, Diez-Perez A, Ferrari S, Gasparik A , Herrman M et al (2020) CLINICAL APPLICATION OF BONE TURNOVER MARKERS IN POST-MENOPAUSAL OSTEOPOROSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S65-S66)
Johansson H, Kanis JA, Harvey NC, Gudnason V, Sigurdson G, Siggeirsdottir K, Lorentzon M, Liu E, Vandenput L, Leslie WD & McCloskey EV (2020) Comparison of Short:Term and 10-year Probabilities to Characterise Fracture Risk After a Recent Sentinel Fracture. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 198-198)
Kanis JA, Harvey NC, Mccloskey EV, Bruyere O, Veronese N, Lorentzon M, Cooper C, Rizzoli R, Adib G, Al-Daghri N , Campusano C et al (2020) ESCEO-IOF ALGORITHM FOR THE MANAGEMENT OF PATIENTS AT LOW/HIGH/VERY HIGH RISK OF FRACTURE. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S33-S33)
McCloskey EV (2020) DIFFERENCES IN CLINICAL GUIDELINES. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S37-S37)
Borgstrom F, Norton NV, Karlsson L, Ortsater G, Harvey NC, Mccloskey EV & Kanis JA (2020) DISABILITY-ADJUSTED LIFE YEARS RELATED TO FRAGILITY FRACTURES. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S320-S321)
Povoroznyuk V, Grygorieva N, Musienko A, Johansson H, Lorentzon M, Harvey N-C, Mccloskey E-V, Liu E & Kanis J-A (2020) FRAX BASED INTERVENTION THRESHOLDS FOR UKRAINE. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S480-S480)
Harvey N, Orwoll E, Cauley J, Kwok T, Karlsson M, Rosengren B, Ribom E, Cawthon P, Ensrud K, Liu E , Ward K et al (2020) pQCT Muscle Density Predicts Hip Fractures Independent of FRAX, Falls and BMD in the Osteoporotic Fractures in Men (MrOS) Study: a Meta-Analysis. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 159-159)
McCloskey E, Harvey N, Johansson H, Cooper C & Kanis J (2020) HIGH RISK OF HIP FRACTURE AND HIP FRACTURES SAVED IN THE SCOOP STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S54-S54)
Leslie W, Moller S, Skjodt M, Yan L, Abrahamsen B, Lix L, McCloskey E, Johansson H, Harvey N, Kanis J & Rubin K (2020) External Validation of in 74,828 Patients from Manitoba, Canada: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 35 (pp 202-202)
Parsons CM, Harvey N, Shepstone L, Kanis JA, Lenaghan E, Clarke S, Fordham R, Gittoes N, Harvey I, Holland R , Redmond NM et al (2020) . Osteoporosis International, Vol. 31(1) (pp 67-75)
Söreskog E, Borgström F, Shepstone L, Clarke S, Cooper C, Harvey I, Harvey NC, Howe A, Johansson H, Marshall T , O’Neill TW et al (2020) . Osteoporosis International, Vol. 31(8) (pp 1499-1506)
Brown JE, Handforth C, Walsh J, Pezaro C, Sydes MR, Clarke NW, James ND & McCloskey E (2019) . Annals of Oncology, Vol. 30(Suppl 5) (pp v334-v335). Barcelona, Spain, 27 September 2019 - 1 October 2019.
Forgetta V, Forest M, Bhatnagar S, Morris JA, Greenwood CMT, Richards B, Keller-Baruch J, Durand A, Pineau J, Nethander M , Kemp J et al (2019) Genetic Risk Scores to Improve Osteoporosis Screening: Validation in External Cohorts. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 210-210)
Johansson H, Siggeirsdottir K, Harvey NC, Mccloskey EV, Gudnason V, Sigurdsson G, Lorentzon M, Liu E & Kanis JA (2019) ADJUSTING FRAX FOR IMMINENT RISK. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S166-S167)
Borgstrom F, Norton N, Karlsson L, Ortsater G, Harvey NC, McCloskey EV & Kanis JA (2019) BURDEN OF FRAGILITY FRACTURES IN 6 EUROPEAN COUNTRIES. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S686-S686)
Harvey NC, Kanis JA, Liu E, Cooper C, Lorentzon M, Crandall C, Johansson H & McCloskey EV (2019) APPENDICULAR LEAN MASS DOES NOT PREDICT INCIDENT FRACTURES INDEPENDENTLY OF BMD: RESULTS FROM THE WOMEN'S HEALTH INITIATIVE (WHI) COHORT. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S356-S357)
Chotiyarnwong P & McCloskey EV (2019) FRAX (R) TOOL WEBSITE USAGE IN THAILAND. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S374-S374)
Lorentzon M, Johansson H, Harvey NC, Liu E, Crandall J, McCloskey EV & Kanis JA (2019) HORMONE THERAPY REDUCES THE RISK OF FRACTURE IN FALLERS AND IN NON-FALLERS: RESULTS FROM THE WOMEN'S HEALTH INITIATIVE HORMONE THERAPY TRIALS. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S163-S163)
McCloskey EV, Roux C, Papapoulos S & Borgermans L (2019) IMPROVING OSTEOPOROSIS CARE - GETTING CLOSER TO THE PATIENT. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S782-S782)
Zakroyeva AG, Lesnyak OM, Cazac V, Groppa L, Russu E, Rotaru L, Chislari L, Johansson H, Harvey NC, McCloskey EV & Kanis JA (2019) EPIDEMIOLOGY OF OSTEOPOROTIC NONVERTEBRAL FRACTURES IN MOLDOVA. POPULATION-BASED LONGITUDINAL STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S450-S451)
McCloskey EV, Eastell R, Mcclung M, Pannacciulli N, Wang C, Yue S & Cummings SR (2019) A POOLED ANALYSIS OF FALL INCIDENCE FROM PLACEBO-CONTROLLED TRIALS OF DENOSUMAB. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S179-S180)
Johansson H, Matijevic R, Harhaji V, McCloskey EV, Harvey NC, Lorentzon M, Liu E & Kanis JA (2019) TEN-YEAR FRACTURE PROBABILITY IN SERBIA ACCORDING TO AGE AND OTHER FRAX MODELS IN THE REGION. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S489-S490)
McCloskey EV, Rathi J, Heijmans S, Blagden M, Koukakis R, Stad R, O'Kelly J & Papapoulos S (2019) OSTEOPOROSIS (OP) DIAGNOSIS AND TREATMENT OF WOMEN AGED >= 70 YEARS IN PRIMARY CARE: RESULTS FROM A LARGE EUROPEAN CROSS-SECTIONAL STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S685-S686)
Johansson H, Adib G, McCloskey EV, Harvey NC, Lorentzon M, Liu E & Kanis JA (2019) TEN-YEAR FRACTURE PROBABILITY IN SYRIA USING A SURROGATE MODEL. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S489-S489)
Johansson H, Gavilanez EL, Grijalva MN, McCloskey EV, Harvey NC, Lorentzon M, Liu E & Kanis JA (2019) SECULAR CHANGES IN HIP FRACTURE INCIDENCE IN ECUADOR AND IMPLICATIONS FOR FRAX. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S490-S491)
Johansson H, Harvey C, Oden A, Orwoll E, Kwok T, Karlsson M, Rosengren B, Ribom E, Cawthon P, Ensrud K , Cooper C et al (2019) DO DEFINITIONS OF SARCOPENIA PREDICT FRACTURE RISK INDEPENDENT OF FRAX, FALLS AND BMD? A META-ANALYSIS OF THE OSTEOPOROTIC FRACTURES IN MEN (MROS) STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S52-S52)
Stone B, Dockrell D & McCloskey E (2019) FRAX is a good predictor of bone mineral density in people living with HIV of black ethnicity and/or low fracture risk. HIV MEDICINE, Vol. 20 (pp 39-40)
Lorentzen M, Johansson H, Harvey NC, Liu E, Crandall CJ, McCloskey EV & Kanis J (2019) Hormone therapy decreases the risk of fracture both in fallers and non-fallers - data from the combined Women's Health Initiative Hormone Therapy Trials. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 363-363)
Koromani F, Oei L, Trajanoska K, Schoufour J, Muka T, Franco O, Ikram A, Zillikens C, Uitterlinden A, Krestin G , Oei E et al (2019) Type 2 Diabetes Mellitus and the risk of osteoporotic vertebral fractures: a meta-analysis of summary and individual participant data from 852,705 individuals. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 102-102)
McCloskey E, Rathi J, Heijmans S, Blagden M, Koukakis R, Stad R, O'Kelly J & Papapoulos S (2019) Osteoporosis (OP) diagnosis and treatment of women aged >= 70 years in primary care: results from a large Europeal cross-sectional study. SWISS MEDICAL WEEKLY (pp 10S-10S)
McCloskey E, Lorentzon M, Johansson H, Kanis J & Harvey N (2019) A POST HOC ANALYSIS OF ROMOSOZUMAB EFFICACY AND BASELINE FRACTURE RISK - GREATER REDUCTION IN FRACTURE OUTCOMES IN PATIENTS AT HIGHER RISK. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 112-112)
Leslie W, Lix L, Schousboe J, Morin S, Martineau P, Johansson H, Kanis J, McCloskey E & Harvey N (2019) Subsequent Fracture Risk Following Traumatic versus Non-traumatic Fracture: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 53-53)
Leslie W, Lix L, Schousboe J, Morin S, Martineau P, Johansson H, Kanis J, McCloskey E & Harvey N (2019) Measured Height Loss Predicts Incident Clinical Fractures Independently from FRAX: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 100-100)
Johansson H, Liu E, Kanis JA, Siggeirsdottir K, Gudnason V, Sigurdson G, Harvey NC, McCloskey E & Lorentzon M (2019) Potential Impact of Recent Clinical Vertebral Fracture on FRAX 10year Probability. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 155-155)
Leslie W, Schousboe J, Morin S, Martineau P, Lix L, Johansson H, McCloskey E, Harvey N & Kanis J (2019) Loss in DXA-Estimated Total Body Lean Mass but not Fat Mass Predicts Incident Major Osteoporotic Fracture and Hip Fracture Independently from FRAX: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 21-21)
Svedbom A, Borgstrom F, Hernlund E, Alekna V, Bianchi ML, Clark P, Curiel DM, Dimai HP, Jurisson M, Olga L , McCloskey E et al (2019) EXPERIENCE AND PREFERENCE-BASED EQ-5D-3L VALUE SET DERIVED FROM LONGITUDINAL DATA: RESULTS FROM THE INTERNATIONAL COSTS AND UTILITIES OF OSTEOPOROTIC FRACTURES STUDY (ICUROS). VALUE IN HEALTH, Vol. 22 (pp S705-S706)
Bauer J, Cruz-Jentoft AJ, Bauer JM, Cruz-Jentoft AJ, Fielding RA, Kanis JA, Reginster J-Y, Bruyere O, Cesari M, Chapurlat R , Al-Daghri N et al (2019) OSTEOSARCOPENIC OBESITY: ENOUGH EVIDENCE FOR A DISTINCT ENTITY?. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S191-S192)
McCloskey E (2019) WHEN AND WHY USE A BONE-FORMING AGENT?. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S157-S157)
Povoroznyuk V, Grygorieva N, Korzh M, Strafun S, Vayda V, Klymovytsky F, Vlasenko R, Forosenko V, Kanis JA, Johansson H & Mccloskey E (2019) EPIDEMIOLOGY OF HIP FRACTURES IN UKRAINE: RESULTS OF STOP-STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 30 (pp S83-S83)
Harvey N, Cooper C, Kanis JA, Liu E, Lorentzon M, Bea JW, Carbone L, Feliciano EMC, Laddu DR, Schnatz PF , Shadyab AH et al (2019) DXA appendicular lean mass, FRAX, BMD and incident fractures: Findings from the Women's Health Initiative (WHI). JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 155-155)
Borgstrom F, Jonsson E, Harvey N, Shepstone L, Lenaghan E, Clarke S, Gittoes N, Harvey I, Holland R, Heawood A , Redmond N et al (2018) Cost-effectiveness Evaluation of a Screening Programme for Fracture Risk in UK. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 398-399)
Ugur A, Gossiel F, Naylor K, Walsh J, Peel N, Mccloskey E & Eastell R (2018) Apparent Response Rate by PINP to Oral Bisphosphonates in Clinical Practice and Clinical Trial Settings. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 319-319)
Forgetta V, Keller-Baruch J, Forest M, Durand A, Bhatnagar S, Kemp J, Morris J, Kanis J, Kiel D, Mccloskey E , Johansson H et al (2018) Genomic Prediction of Osteoporosis Using 426,000 Individuals from UK Biobank. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 39-39)
Harvey NC, Oden A, Orwoll E, Lapidus J, Kwok T, Karlsson M, Rosengren B, Ljunggren O, Coopers C, Cawthon PM , Kanis JA et al (2018) PHYSICAL PERFORMANCE OR FUNCTION, BUT NOT APPENDICULAR LEAN MASS, PREDICT INCIDENT FRACTURES INDEPENDENTLY OF FRAX PROBABILITY AND BMD: RESULTS FROM THE OSTEOPOROTIC FRACTURES IN MEN (MROS) COHORT. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S69-S70)
Aram P, Trela-Larsen L, Sayers A, Hills AF, Blom AW, McCloskey EV, Kadirkamanathan V & Wilkinson JM (2018) . Osteoarthritis and Cartilage, Vol. 26(Supplement 1) (pp S281-S281). Liverpool, United Kingdom, 26 April 2018 - 29 April 2018.
Ferrari S, McCloskey E, Bouxsein M, De Schepper J & Reginster J-Y (2018) AGN1 LOCAL OSTEO-ENHANCEMENT PROCEDURE (LOEP): AN EMERGING, MINIMALLY-INVASIVE SURGICAL TREATMENT TO ADDRESS OSTEOPOROSIS-RELATED BONE LOSS IN PROXIMAL FEMURS. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S568-S569)
Farzi M, Pozo JM, McCloskey E, Eastell R, Wilkinson JM & Frangi AF (2018) (pp 720-728)
Mccloskey E, Johansson H, Harvey N, Compston J, Cooper C & Kanis J (2018) Inappropriate Use of Cost-effectiveness Thresholds as Intervention Thresholds - Potential for Overtreatment of Low Risk Individuals. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 108-108)
Harvey N, Oden A, Orwoll E, Kwok T, Karlsson M, Rosengren B, Ribom E, Cawthon P, Ensrud K, Cooper C , Kanis J et al (2018) Definitions of sarcopenia as predictors of fracture risk independent of FRAX, falls and BMD: A meta-analysis of the Osteoporotic Fractures in Men (MrOS) Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 13-14)
McCloskey E, Harvey N, Johansson H, Shepstone L, Lenaghan E, Cooper C & Kanis J (2018) WOMEN IDENTIFIED AT HIGH RISK OF HIP FRACTURE BASED ON FRAX ARE RESPONSIVE TO APPROPRIATE OSTEOPOROSIS MANAGEMENT: ANALYSIS FROM THE SCOOP STUDY OF POPULATION SCREENING. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp 613-614)
McCloskey E, Johansson H, Oden A, Harvey N, Compston J, Cooper C & Kanis JA (2018) DANGER OF OVERTREATMENT OF OSTEOPOROSIS WITH INAPPROPRIATE USE OF INTERVENTION THRESHOLDS DERIVED BY COST-EFFECTIVENESS ANALYSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S73-S73)
Johansson H, Kanis JA, Oden A, Harvey NC, Gudnason V, Sanders K, Sigurdsson G, Siggeirsdottir K, Fitzpatrick L, Lorentzon M , Borgstrom F et al (2018) Comparing Utility Loss Due to Fractures, in Cohorts With and Without a Previous Fracture. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 392-393)
Leslie W, Morin S, Lix L, Mccloskey E, Johansson H, Harvey N & Kanis J (2018) Fracture Risk Assessment in Women with Breast Cancer Initiating Aromatase Inhibitor Therapy: A Registry-Based Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 47-48)
Lorentzon M, Johansson H, Harvey NC, Oden A, Sanders K, Borgstrom F, Svedbom A, Mccloskey E & Kanis J (2018) Treatment gap following clinical vertebral fracture in the International Cost and Utility Related to Osteoporosis Fractures Study (ICUROS). JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 33 (pp 115-115)
Johansson H, Azizieh F, Al Ali N, Thamer A, Harvey N, Mccloskey E & Kanis J (2018) INTERVENTION THRESHOLD BASED ON FRAX AND BMD. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S504-S504)
Johansson H, Seeman E, Siggeirsdottir K, Harvey N, Oden A, Gudnason V, Lorentzon M, Mccloskey E, Sanders K, Sigurdsson G & Kanis J (2018) A MISSED OPPORTUNITY: WHAT PROPORTION OF FRACTURE PATIENTS HAVE HAD A PRIOR FRACTURE?. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S534-S534)
McCloskey E (2018) AN UPDATE ON RISK ASSESSMENT AND FRACTURE PREVENTION IN EUROPEAN NATIONS. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S119-S120)
Johansson H, Kanis I, Oden A, Harvey N, Gudnason V, Sanders K, Sigurdsson G, Siggeirsdottir K, Fitzpanick L, Lorentzon M , Borgstrom F et al (2018) UTILITY LOSS AFTER A SENTINEL FRACTURE. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S72-S73)
McCloskey E (2018) INFLAMMATION AND MUSCULOSKELETAL AGING. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S45-S45)
Johansson H, Siggeirsdottir K, Harvey N, Oden A, Gudnason V, Mccloskey E, Sigurdsson G & Kanis J (2018) IMPACT OF RECENT FRACTURE ON 10-YEAR PROBABILITY OF FRACTURE. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S478-S478)
Johansson H, Oden A, Harvey N, Sanders K, Borgstrom F, Svedbom A, Lorentzon M, Mccloskey E & Kanis J (2018) TREATMENT GAP FOLLOWING HIP FRACTURE IN THE INTERNATIONAL COST AND UTILITY RELATED TO OSTEOPOROSIS FRACTURES STUDY (ICUROS). OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S534-S534)
Parsons C, Harvey N, Shepstone L, Kanis J, Lenaghan E, Clarke S, Fordham R, Gittoes N, Harvey I, Holland R , Heawood A et al (2018) SYSTEMATIC SCREENING USING FRAX LEADS TO INCREASED USE OF, AND ADHERENCE TO, ANTI-OSTEOPOROSIS MEDICATIONS: THE UK SCOOP TRIAL. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp 613-613)
Sahakyan S, Lesnyak O, Zakroyeva A, Bilezikian J, Hutchings N, Babalyan V, Galstyan R, Lebedev A, Johansson H, Harvey NC , Mccloskey E et al (2018) EPIDEMIOLOGY OF FRACTURES IN ARMENIA: DEVELOPMENT OF A COUNTRY-SPECIFIC FRAX MODEL AND COMPARISON TO ITS SURROGATE. OSTEOPOROSIS INTERNATIONAL, Vol. 29 (pp S423-S423)
Gossiel F, Flintham L, Naylor K, Walsh J, Peel N, McCloskey E & Eastell R (2017) Offset of Effect of Oral Bisphosphonates on Tartrate-Resistant Acid Phosphatase in Postmenopausal Osteoporosis: the TRIO Study.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S379-S379)
Cooper C, Parsons C, Harvey NC, Shepstone L, Kanis JA, Lenaghan E, Clarke S, Fordham R, Gittoes N, Harvey I , Holland R et al (2017) Effect of fracture risk assessment on anti-osteoporosis medication use and adherence: Findings from the SCOOP Trial.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S108-S108)
Harvey NC, Oden A, Orwoll E, Lapidus J, Kwok T, Karlsson M, Rosengren B, Ljunggren O, Cooper C, Kanis JA , Ohlsson C et al (2017) MOBILITY RELATED RISK FACTORS PREDICT INCIDENT FRACTURES INDEPENDENTLY OF FRAX: THE OSTEOPOROTIC FRACTURES IN MEN (MROS) STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S61-S61)
McCloskey EV (2017) SKELETAL DETERMINANTS OF FRACTURE RISK - CAN WE DO BETTER?. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S118-S118)
McCloskey EV (2017) WHEN IS IT TIME TO STOP OSTEOPOROSIS TREATMENT?. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S46-S47)
McCloskey EV, Harvey NC, Johansson H, Shepstone L, Lenaghan E, Cooper C & Kanis JA (2017) WOMEN IDENTIFIED AT HIGH RISK BASED ON FRAX HIP FRACTURE PROBABILITY ARE RESPONSIVE TO APPROPRIATE OSTEOPOROSIS MANAGEMENT: ANALYSIS FROM THE SCOOP STUDY OF POPULATION SCREENING. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S60-S60)
Johansson H, McCloskey E, Oden A, Harvey NC, Jiang H, Modin S, Fitzpatrick LA & Kanis JA (2017) THE EFFICACY OF ABALOPARATIDE-SC IS INDEPENDENT OF BASELINE BMD. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S519-S519)
Harvey N, Oden A, Orwoll E, Lapidus J, Kwok T, Karlsson M, Rosengren B, Ljunggren S, Cooper C, Cawthon P , Kanis J et al (2017) Measures of physical performance or function, but not appendicular lean mass, predict new fractures independently of FRAX probability: Findings from MrOS.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S30-S30)
McCloskey E, Harvey N, Johansson H, Shepstone L, Lenaghan E, Cooper C & Kanis J (2017) Women Identified at High Risk of Hip Fracture based on FRAX are Responsive to Appropriate Osteoporosis Management: Results from the SCOOP Study of Population Screening.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S30-S30)
Harvey NC, Oden A, Orwoll E, Lapidus J, Kwok T, Karlsson M, Rosengren B, Ljunggren O, Cooper C, McCloskey E , Kanis JA et al (2017) PRIOR FALLS PREDICT INCIDENT FRACTURES INDEPENDENTLY OF FRAX: THE OSTEOPOROTIC FRACTURES IN MEN (MROS) STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S259-S259)
Leslie W, Majumdar S, Morin S, Lix L, Johannson H, Oden A, McCloskey E & Kanis J (2017) FRAX for Fracture Prediction Shorter and Longer Than Ten Years: The Manitoba BMD Registry.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S29-S29)
Martineau P, Leslie W, Johannson H, Oden A, McCloskey E, Kanis J & Hans D (2017) In Which Patient Populations Does Lumbar Spine Trabecular Bone Score (TBS) Have the Largest Effect on Fracture Prediction?.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S244-S244)
Johansson H, Siggeirsdottir K, Harvey NC, Oden A, Gudnason V, McCloskey E, Sigurdsson G & Kanis JA (2017) Risk of Hip Fracture After Recent Fracture - Comparison of Sentinel Fracture Sites (Reykjavik Study).. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S251-S251)
Leslie W, Shevroja E, Johansson H, Oden A, McCloskey E, Kanis J & Hans D (2017) "Risk-Equivalent" T-score Adjustment Using Lumbar Spine Trabecular Bone Score (TBS): The Manitoba BMD Registry. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S93-S93)
Johansson H, McCloskey E, Oden A, Harvey NC, Black DM, Cauley J & Kanis JA (2017) THE EFFECT OF ALENDRONATE ON VERTEBRAL FRACTURE RISK IS INDEPENDENT OF BASELINE FRAX FRACTURE PROBABILITY: A POST HOC ANALYSIS OF THE FIT STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S619-S619)
Povoroznyuk VV, Grygorieva NV, Korzh MO, Strafun SS, Vaida VM, Klymovytsky FV, Vlasenko RO, Forosenko VS, Kanis JA, Johansson H & McCloskey E (2017) EPIDEMIOLOGY OF HIP FRACTURES IN UKRAINE: RESULTS OF STOP-STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S570-S570)
McCloskey E (2017) TREATMENT BASED ON FRACTURE RISK - HEALTH ECONOMIC IMPLICATIONS. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S101-S101)
Johansson H, Siggeirsdottir K, Harvey NC, Oden A, Gudnason V, McCloskey E, Sigurdsson G & Kanis JA (2017) IMMINENT RISK OF HIP FRACTURE AFTER RECENT ( SENTINEL) FRACTURE - COMPARISON OF SENTINEL FRACTURE SITES (REYKJAVIK STUDY). OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S61-S62)
McCloskey E, Fitzpatrick LA, Hu M & Kanis JA (2017) ABALOPARATIDE-SC DECREASES VERTEBRAL, NONVERTEBRAL, MAJOR OSTEOPOROTIC, AND WRIST FRACTURES IN A SUBSET OF POSTMENO-PAUSAL WOMEN AT HIGH RISK OF FRACTURE BY FRAX SCORE. OSTEOPOROSIS INTERNATIONAL, Vol. 28 (pp S49-S50)
Koromani F, Oei L, Muka T, Shevroja E, Schoufour J, Franco O, Zillikens C, Mc Closkey E, Leslie W, Lamy O , Oei E et al (2017) Type 2 Diabetes Is Associated With Lower Prevalence Of Vertebral Fractures: A Meta-Analysis of Prospective Studies. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 32 (pp S95-S96)
McCloskey E, Lenaghan E, Clarke S, Fordham R, Gittoes N, Harvey I, Holland R, Howe A, Marshal T, Peters T , Kanis J et al (2016) SCREENING BASED ON FRAX FRACTURE RISK ASSESSMENT REDUCES THE INCIDENCE OF HIP FRACTURES IN OLDER COMMUNITY-DWELLING WOMEN - RESULTS FROM THE SCOOP STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp 624-624)
McCloskey E, Chiu S, Lenaghan E, Shepstone L, Birrell F & Harvey N (2016) IMPACT OF FALLS ON FRACTURES AND MORTALITY - AN OPPORTUNITY FOR INTERVENTION AND ENHANCEMENT OF FRACTURE PREDICTION?. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp 617-617)
McCloskey EV (2016) WHAT IS THE PROFILE OF PATIENTS AT IMMINENT HIGH RISK OF FRACTURE?. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S692-S692)
McCloskey EV (2016) TREAT-TO-TARGET IN OSTEOPOROSIS AND OTHER CHRONIC DISORDERS: OPPORTUNITIES AND CHALLENGES. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S696-S696)
Kanis JA, Harvey N, Johansson H, McCloskey EV & Oden A (2016) TOWARDS AN OPERATIONAL DEFINITION OF SARCOPENIA. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S688-S689)
Brown J, Dakin P, Hadji P, McClung M, Miller P, Reginster J-Y, Wagman R, Wang A & McCloskey E (2016) Can we use Bone Turnover Markers as Targets for Antiresorptive Treatment in Postmenopausal Osteoporosis? An Analysis from the DECIDE and STAND Clinical Trials. JOURNAL OF RHEUMATOLOGY, Vol. 43(6) (pp 1208-1209)
McCloskey E, Harvey NC, Oden A, Jiang H, Modin S, Fitzpatrick LA, Kanis JA & Johansson H (2016) EFFECT OF INVESTIGATIONAL TREATMENT ABALOPARATIDE FOR PREVENTION OF MAJOR OSTEOPOROTIC FRACTURE OR ANY FRACTURE IS NOT ALTERED BY BASELINE FRACTURE PROBABILITY. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S44-S45)
Shepstone L, Lenaghan E, Clarke S, Fordham R, Gittoes N, Harvey I, Holland R, Howe A, Marshall T, McCloskey E , Peters T et al (2016) A RANDOMIZED CONTROLLED TRIAL OF SCREENING IN THE COMMUNITY TO REDUCE FRACTURES IN OLDER WOMEN IN THE UK (THE SCOOP STUDY). OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S42-S43)
Farzi M, Pozo JM, McCloskey EV, Wilkinson JM & Frangi AF (2016) (pp 291-299)
McCloskey E, Compston JE, Cooper C, Harvey NC, Johansson H, Oden A & Kanis JA (2016) IMPACT OF FRACTURE RISK ASSESSMENT TOOLS ON PROPORTIONS OF WOMEN WITHOUT PRIOR FRACTURE IDENTIFIED AT RISK AND TREATED - LESSONS FROM THE SIGN GUIDANCE. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S382-S383)
Johansson H, Siggeirsdottir K, Harvey N, Oden A, Gudnason V, McCloskey E, Sigurdsson G & Kanis J (2016) IMMINENT MAJOR OSTEOPOROTIC AND CLINICAL VERTEBRAL FRACTURE RISK AFTER FRACTURE (REYKJAVIK STUDY). OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S699-S700)
Kanis JA, Harvey N, Johansson H, McCloskey E & Oden A (2016) FRAX IN THE WORLD TODAY. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S563-S563)
McCloskey E (2016) FRAX IN EUROPE - DEVELOPMENT AND THE NEXT STEPS. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S564-S565)
McCloskey E, Johansson H, Harvey NC, Compston JE & Kanis JA (2016) ONLINE USAGE OF FRAX FRACTURE RISK ASSESSMENT AND NATIONAL OSTEOPOROSIS GUIDELINE GROUP GUIDANCE BY UK CLINICAL PRACTITIONERS. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S345-S345)
Svedbom A, Hernlund E, Alekna V, Bianchi M-L, Clark P, Diaz-Curiel M, Dimai H-P, Lesnyak OM, McCloskey E, Sanders KM , Silverman SL et al (2016) QUALITY OF LIFE UP TO 18 MONTHS AFTER DISTAL FOREARM FRACTURE: RESULTS FROM THE ICUROS. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S61-S62)
Johansson H, Oden A, Karlsson M, Lorentzon M, Kanis JA, Rosengren B, Mellstrom D, Ljunggren O, OhIsson C, Harvey NC & McCloskey E (2016) FEMORAL NECK BMD IS STILL THE PREFERRED SITE IN THE ASSESSMENT OF HIP FRACTURE IN ELDERLY MEN (10-YEAR FOLLOW-UP OF MROS SWEDEN). OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S58-S59)
Johansson H, Vala CH, Oden A, Lorentzon M, McCloskey E, Kanis JA, Lohmander S, Karrholm J & Mellstrom D (2016) SWEDISH FARMERS HAVE LOWER RISK FOR HIP FRACTURE THAN EXPECTED FROM ECONOMIC STATUS, EDUCATION AND LOCATION. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S56-S57)
Harvey NC, Johansson H, Siggeirsdottir K, Oden A, Gudnason V, McCloskey E, Sigurdsson G & Kanis JA (2016) IMMINENT RISK OF MAJOR OSTEOPOROTIC FRACTURE AFTER FRACTURE (REYKJAVIK STUDY). OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S59-S59)
McCloskey E (2016) OFFSET OF FRACTURE RISK AFTER TREATMENT CESSATION, A BASE FOR TRANSIENT TREATMENT INTERRUPTION. OSTEOPOROSIS INTERNATIONAL, Vol. 27 (pp S33-S34)
Brown JP, Dakin P, Hadji P, McClung MR, Miller PD, Reginster J-Y, Wagman RB, Wang A & McCloskey E (2015) Can We Use Bone Turnover Markers As Targets for Antiresorptive Treatment in Postmenopausal Osteoporosis? an Analysis from Two Phase 3 Clinical Trials. ARTHRITIS & RHEUMATOLOGY, Vol. 67
Reginster J-Y, Cooper C, Rizzoli R, Kanis JA, Appelboom G, Bautmans I, Bischoff-Ferrari HA, Boers M, Brandi ML, Bruyere O , Cherubini A et al (2015) RECOMMENDATIONS FOR THE REGISTRATION OF DRUGS TO TREAT SARCOPENIA. OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S62-S62)
Harvey NC, Oden A, Johansson H, Burge R, Mitlak B, Kanis JA & McCloskey EV (2015) EFFICACY OF TERIPARATIDE FOR PREVENTION OF VERTEBRAL AND NONVERTEBRAL FRACTURE IS NOT ALTERED BY BASELINE FRACTURE PROBABILITY. OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S203-S204)
Leslie WD, Lix LM, Morin SN, Johansson H, Oden A, McCloskey EV & Kanis JA (2015) HIP AXIS LENGTH IS A FRAX AND BONE DENSITY INDEPENDENT RISK FACTOR FOR HIP FRACTURE IN MEN AND WOMEN. OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S50-S51)
Harvey NC, Johansson H, Oden A, Karlsson MK, Rosengren B, Ljunggren O, Cooper C, McCloskey EV, Kanis JA, Ohlsson C & Mellstrom D (2015) THE PREDICTIVE VALUE OF PAST FALLS FOR INCIDENT FALLS DECREASES, BUT THAT OF FRAX REMAINS STABLE, WITH INCREASING FOLLOW-UP TIME: FINDINGS FROM MROS SWEDEN. OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S143-S143)
Johansson H, McCloskey EV, Kanis JA, Harvey NC & Oden A (2015) WORLDWIDE BURDEN OF HIGH FRACTURE PROBABILITY. OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S151-S152)
Johansson H, Harvey NC, Oden A, McCloskey EV, Kanis JA, Nicholson G & Sanders KM (2015) FRAX PREDICTS INCIDENT FALLS IN ELDERLY WOMEN: FINDINGS FROM AUSTRALIA. OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S152-S152)
Kanis JA, Oden A, Harvey NC, Leslie WD, Hans D, Johansson H, Barkmann R, Boutroy S, Brown JP, Chapurlat RD , Elders P et al (2015) A META-ANALYSIS OF TRABECULAR BONE SCORE IN FRACTURE RISK PREDICTION AND ITS INTERACTION WITH FRAX. OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S46-S46)
Johansson H, Harvey NC, Oden A, Karlsson MK, Rosengren B, Ljunggren O, Cooper C, McCloskey EV, Kanis JA, Ohlsson C & Mellstrom D (2015) WANING LONG-TERM PREDICTIVE VALUE OF FALLS HISTORY FOR INCIDENT FRACTURE: MROS SWEDEN. OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S42-S42)
Akesson K, Harvey NC, Oden A, McCloskey EV, Kanis JA & Johansson H (2015) WANING LONG-TERM PREDICTIVE VALUE OF SERUM CTX FOR INCIDENT FRACTURE (OPRA COHORT). OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S364-S364)
Harvey NC, Kanis JA, Johansson H, Oden A, Cooper A, Cooper C, Francis RM, Reid DM, Selby P, Compston JE & McCloskey E (2015) FRAX-BASED ASSESSMENT AND INTERVENTION THRESHOLDS: AN EXPLORATION OF THRESHOLDS IN WOMEN AGED 50 YEARS AND OLDER IN THE UK. OSTEOPOROSIS INTERNATIONAL, Vol. 26 (pp S54-S54)
McCloskey EV, Kanis JA, Johansson H, Harvey N, Oden A & Compston J (2014) ASSESSMENT AND INTERVENTION THRESHOLDS IN THE UK - AN EXPLORATION OF ALTERNATIVE NOGG THRESHOLDS IN OLDER POSTMENOPAUSAL WOMEN. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S673-S674)
McCloskey EV, Johansson H, Oden A, Kanis JA, Morris HA, Cooper C & Vasikaran S (2014) A META-ANALYSIS OF REFERENCE MARKERS OF BONE TURNOVER FOR PREDICTION OF FRACTURE. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S314-S315)
Johansson H, Leslic WD, Kanis JA, Lamy O, Oden A, Mccloskey EV & Hans D (2014) DERIVATION OF A LUMBAR SPINE TRABECULAR BONE SCORE (TBS) ADJUSTMENT RATIO FOR FRAX: THE MANITOBA BMD COHORT. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S408-S409)
Kanis JA, Johansson H, Oden A, McCloskey EV, Cooper C, Rizzoli R & Reginster J-Y (2014) A META-ANALYSIS OF THE EFFECT OF STRONTIUM RANELATE ON THE RISK OF VERTEBRAL AND NON-VERTEBRAL FRACTURE IN POSTMENOPAUSAL OSTEOPOROSIS: THE IMPACT OF SEVERE OSTEOPOROSIS AND CONTRAINDICATIONS. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S120-S121)
McCloskey EV, Oden A, Nakamura T, Kuroda T, Eto M, Shiraki M, Sugimoto T, Tanaka S, Kanis JA & Johansson H (2014) EFFICACY OF TERIPARATIDE ON THE RISK OF VERTEBRAL FRACTURE AND THE INTERACTION WITH FRAX. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S324-S324)
Oden A, McCloskey EV, Johansson H & Kanis JA (2014) DECLINING HIP FRACTURE RISK IN SWEDEN. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S318-S319)
Svedbom A, Wintzell V, Alekna V, Tamulaitiene M, Bianchi ML, Clark P, Diaz-Curiel M, Dimai HP, Lesnyak O, McCloskey EV , Sanders KM et al (2014) HOSPITALIZED AND NONHOSPUIALIZED VERTEBRAL FRACTURES: COMPARISON OF PATIENT DEMOGRAPHICS AND HEALTH RELATED QUALITY OF LIFE IMPLICATIONS. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S109-S110)
Johansson H, Oden A, McCloskey EV, Kanis JA, Karlsson M, Lorenton M & Mellstrtom D (2014) WHICH FRAX MODEL IS APPROPRIATE FOR SWEDISH IMMIGRANTS?. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S122-S122)
Grigorie D, Sucaliuc A, Johansson H, Kanis JA & Mccloskey EV (2014) WAYS TO REDUCE OSTEOPOROSIS TREATMENT GAP IN ROMANIA. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S229-S230)
McCloskey EV, Kanis JA, Oden A, Bauer DC, Glueer CC, Hans D, Kaptoge SK, Khaw KT, Krieg MA, Kwok A , Lau E et al (2014) QUANTITATIVE ULTRASOUND (QUS) IS ASSOCIATED WITH FRACTURE RISK: A META-ANALYSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S108-S108)
Johansson H, Siggeirsdottir K, Aspelund T, Gudmundsson E, Mogensen B, Jonsson BY, Gudnason V, McCloskey EV, Sigurdsson G & Kanis JA (2014) THE INCIDENCE OF A FIRST MAJOR OSTEOPOROTIC FRACTURE IN ICELAND AND IMPLICATIONS FOR FRAX. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S316-S316)
Chakhtoura M, Cheung AM, Kanis JA, Leslie WD, McCloskey EV, Mcclung M & El-Hajj Fuleihan G (2014) FRAX BASED GUIDELINES: IS A UNIVERSAL MODEL APPROPRIATE?. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S121-S122)
McCloskey EV (2014) GOAL ORIENTED TREATMENT IN OSTEOPOROSIS: LESSONS FROM OTHER DISEASES AREAS. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S144-S144)
McCloskey EV (2014) PREVENTION OF BONE METASTASES. OSTEOPOROSIS INTERNATIONAL, Vol. 25 (pp S152-S152)
Harvey N, Johansson H, Oden A, Bauer D, Glueer C-C, Hans D, Kaptoge S, Krieg M-A, Kwok T, Marin F , Moayyeri A et al (2014) Performance Characteristics of Heel Quantitative Ultrasound (QUS) for the Assessment of Fracture Risk; an Individual-level Meta-analysis.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 29 (pp S177-S177)
Kanis J, Oden A, Johansson H, Burge R, Mitlak B & McCloskey E (2014) FRAX and the effect of teriparatide on vertebral and non-vertebral fracture. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 29 (pp S321-S321)
Johansson H, Oden A, Lorentzon M, McCloskey E, Harvey N, Kanis J, Karlsson M & Mellstrom D (2014) Is the Swedish FRAX Model Appropriate for Immigrants to Sweden?.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 29 (pp S305-S305)
McCloskey E, Johansson H, Oden A, Harvey N, Compston J & Kanis J (2014) Assessment and Intervention Thresholds for FRAX probabilities in the UK - An Evaluation of adjusting Thresholds in Older Postmenopausal Women.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 29 (pp S46-S46)
Kanis JA, Johansson H, Oden A & McCloskey EV (2013) COUNTRY, CULTURE & RISK IN ASIA-PACIFIC. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S515-S515)
Chan D-C, McCloskey EV, Lin K-P, Wen C-J, Tsou H-H, Lim LC, Hwang J-S, Tsai K-S & Yang R-S (2013) COST-EFFECTIVE FRAX PROBABILITY THRESHOLDS FOR ALENDRONIC ACID USE IN TAIWAN. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S587-S588)
Johansson H, Leslie WD, Kanis JA, Lamy O, Oden A, McCloskey EV & Hans D (2013) DERIVATION OFA LUMBAR SPINE TRABECULAR BONE SCORE (TBS) ADJUSTMENT RATIO FOR FRAX: THE MANITOBA BMD COHORT. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S624-S625)
Leslie WD, Johansson H, Kanis JA, Lamy O, Oden A, McCloskey EV & Hans D (2013) LUMBAR SPINE TEXTURE FROM TBS ENHANCES FRACTURE RISK ASSESSMENT IN CLINICAL PRACTICE: THE MANITOBA BMD COHORT. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S555-S556)
McGowan B, Silke C, Doherty J, Johannsen H, McCloskey E, Kanis J & Whelan B (2013) Development of the FRAX model for Ireland. IRISH JOURNAL OF MEDICAL SCIENCE, Vol. 182 (pp S103-S103)
Brennan S, Leslie W, Lix L, Johansson H, Oden A, McCloskey E & Kanis J (2013) Is lower income associated with an increased likelihood of qualification for treatment for osteoporosis in Canadian women?. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 28
Brennan S, Leslie W, Lix L, Johansson H, Oden A, McCloskey E & Kanis J (2013) The Performance of FRAX (R) According to Different Levels of Socioeconomic Status. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 28
Hans D, Kanis JA, Johansson H, Oden A, McCloskey E & Leslie WD (2013) LUMBAR SPINE TRABECULAR BONE SCORE (TBS) IS A FRAX INDEPENDENT RISK FACTOR FOR FRACTURE: THE MANITOBA BMD COHORT. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S308-S308)
Johansson H, Kanis JA, Oden A & McCloskey E (2013) MILD MORPHOMETRIC VERTEBRAL FRACTURES PREDICT VERTEBRAL FRACTURES BUT NOT NONVERTEBRAL FRACTURES. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S310-S311)
Johansson H, Oden A, McCloskey E & Kanis JA (2013) THE WORLDWIDE BURDEN OF HIP FRACTURES AND THE IMPACT OF OSTEOPOROSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S270-S270)
Mellstrom D, Johansson H, Oden A, Karlsson M, McCloskey E & Kanis JA (2013) BONE AREA OF THE RADIUS CONTRIBUTES TO HIP FRACTURE RISK INDEPENDENTLY OF BMD. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S268-S269)
Johansson H, Oden A, Mccloskey E & Kanis JA (2013) THE EFFECT OF LATITUDE AND SEASONAL VARIATION ON THE RISK OF HIP FRACTURE IN SWEDEN. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S46-S47)
McCloskey E (2013) ASSESSMENT OF OSTEOPOROSIS: EUROPEAN GUIDANCE FOR THE DIAGNOSIS, ASSESSMENT AND TREATMENT OF OSTEOPOROSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S80-S81)
Johansson H, Oden A, Karlsson M, Ljunggren O, Mccloskey E, Kanis JA, Ohlsson C & Mellstrom D (2013) ADIPONECTIN AND 10-YEAR PROBABILITY OF FRACTURE IN ELDERLY MEN: MR OS SWEDEN. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S47-S47)
McCloskey E (2013) SECONDARY PREVENTION: A CALL TO ACTION. OSTEOPOROSIS INTERNATIONAL, Vol. 24 (pp S28-S29)
Ivergard M, Wintzell V, Tanko LB, Barghout V, Svedbom A, Alekna V, Bianchi ML, Clark P, Diaz Curiel M, Dimai HP , Juerisson M et al (2013) The Quality Of Life and Resource Use Related To Hip Fractures Based On Data From The International Costs and Utilities Related To Osteoporotic Fractures Study.. ARTHRITIS AND RHEUMATISM, Vol. 65 (pp S520-S520)
Krakauer AH, Blundell M, Scanlan T, Wechsler M, Mccloskey E, Yu J & Patricelli GL (2013) Successful Sage-grouse Show Greater Laterality in Social Behaviors. INTEGRATIVE AND COMPARATIVE BIOLOGY, Vol. 53 (pp E313-E313)
Johansson H, Oden A, Karlsson M, Rosengren B, Ljunggren O, McCloskey E, Kanis J, Ohlsson C & Mellstrom D (2013) FRAX (R) Predicts Future Falls in Elderly Men. MrOs Sweden. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 28
Leslie W, Kanis J, Lamy O, Johansson H, Oden A, McCloskey E & Hans D (2013) Lumbar Spine Trabecular Bone Score (TBS) combined with FRAX improves fracture prediction: The Manitoba BMD Cohort. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 28
Leslie W, Lix L, Morin S, Majumdar S, Johansson H, McCloskey E, Oden A & Kanis J (2013) Can Changes in FRAX Probability Be Used to "Treat-to-Target"? A Clinical Feasibility Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 28
Johansson H, Oden A, Karlsson M, McCloskey E, Kanis J, Ohlsson C & Mellstrom D (2013) Could Fracture Risk Assessment in Elderly Men Be Improved by Adiponectin? Mr Os Sweden. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 28
McCloskey E, Oden A, Kanis J & Johansson H (2013) Markers of Bone Turnover for Prediction of Fracture: a Meta-analysis. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 28
Leslie W, Orwoll E, Nielson C, Morin S, Majumdar S, Johansson H, McCloskey E, Oden A & Kanis J (2013) Total Body Lean Mass and Fat Mass Differentially Affect Hip BMD and Strength Index in Women and Men But Are Not FRAX Independent Risk Factors for Fracture: A Large Clinical Cohort Study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 28
Udall W, Eastell R, McCloskey E, Paggiossi M & Yang L (2012) STRUCTURE ANALYSIS OF THE HIP QCT SCANS AND HIP FRACTURE RISK IN OLDER WOMEN. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S579-S579)
Johansson⁎ H, Kanis JA, Odén A, McCloskey E, Leslie WD, Eisman JA, Fujiwara S, Gluer CC, Kroger H, La Croix AZ , Lau E et al (2012) . Bone, Vol. 50 (pp S52-S53)
Zheng⁎ H-F, Duncan E, Eriksson J, Bergström U, Yerges-Armstrong L, Leo P, Vandenput L, Nicholson G, Ladouceur M, Prince R , Leslie W et al (2012) . Bone, Vol. 50 (pp S33-S34)
Kanis JA, Johansson H, Oden A & McCloskey EV (2012) FRAX: WHERE ARE WE NOW?. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S54-S54)
McCloskey EV (2012) CURRENT CONTROVERSIES IN PRIMARY AND SECONDARY FRACTURE PREVENTION. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S53-S53)
McCloskey EV, Kanis JA, Oden A, Johansson H, Diez-Perez A, Jaeisman JA, Nguyen TV, Center JR, Hans D, Krieg M-A & Prior JC (2012) A META-ANALYSIS OF THE ASSOCIATION BETWEEN FALLS AND HIP FRACTURE RISK. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S80-S81)
Johansson H, Kanis JA, Oden A, McCloskey E, Chapurlat RD, Christiansen C, Cummings SR, Diez-Perez A, Eisman JA, Fujiwara S , Gluer CC et al (2012) HIGH BODY MASS INDEX, ADJUSTED FOR BMD, IS A RISK FACTOR FOR FRACTURE IN WOMEN. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S311-S312)
Johansson H, Kanis JA, Oden A, McCloskey E, Leslie WD, Eisman JA, Fujiwara S, Gluer CC, Kroger H, LaCroix AZ , Lau E et al (2012) IMPACT OF LUMBAR SPINE BMD ON FRAX IN WOMEN. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S65-S66)
Zheng H-F, Duncan E, Eriksson J, Bergstrom U, Yerges-Armstrong LM, Leo PJ, Vandenput L, Nicholson G, Ladouceur M, Prince RL , Leslie WD et al (2012) WNT16 IS ASSOCIATED WITH BONE MINERAL DENSITY, OSTEOPOROTIC FRACTURE AND BONE STRENGTH: A LARGE-SCALE META-ANALYSIS OF GENOMEWIDE ASSOCIATION STUDIES. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S402-S403)
Harvey NC, Cushnaghan J, Lawrence W, Ntani G, Collins K, Lenaghan L, Shepstone L, McCloskey E, Kanis J & Cooper C (2012) IS ANXIETY ASSOCIATED WITH FRACTURE RISK AND ADHERENCE TO TREATMENT? FINDINGS FROM THE MRC SCOOP TRIAL. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S200-S200)
Kanis J, Compston J, Cooper C, Hernlund E, Ivergard M, Johansson H, McCloskey E, Oden A, Stenmark J, Svedbom A & Jonsson B (2012) THE ECONOMIC BURDEN OF FRACTURES IN THE EUROPEAN UNION IN 2010. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S57-S57)
Harvey N, Cushnaghan J, Lawrence W, Ntani G, Collins K, Lenaghan L, Shepstone L, McCloskey E, Kanis J & Cooper C (2012) ANXIETY, FRACTURE RISK AND ADHERENCE TO TREATMENT: THE MRC SCOOP TRIAL. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S531-S531)
McCloskey E, Johansson H, Oden A & Kanis JA (2012) PITFALLS IN THE VALIDATION OF FRACTURE RISK ASSESSMENT TOOLS. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S302-S303)
McCloskey E, Johansson H, Oden A, Kanis JA & Leslie WD (2012) FRAX (R) WITHOUT BMD. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S305-S305)
Kanis JA, Johansson H, Oden A & McCloskey E (2012) EVIDENCE BASED EVALUATION OF CLINICAL RISK FACTORS USED IN THE ASSESSMENT OF FRACTURE RISK. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S309-S310)
Johansson H, Oden A, Lerner UH, Jutberger H, Lorentzon M, Barrett-Connor E, Karlsson MK, Ljunggren O, Smith U, McCloskey E , Kanis JA et al (2012) HIGH SERUM ADIPONECTIN PREDICTS INCIDENT FRACTURES IN ELDERLY MEN: MR OS SWEDEN. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S306-S307)
Oden A, Johansson H, McCloskey E & Kanis JA (2012) LIMITATIONS OF AREA UNDER THE ROC CURVE. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S196-S196)
Johansson H, Oden A, McCloskey E & Kanis JA (2012) COMPARING OUTPUTS OF THE FRAX AND GARVAN FRACTURE RISK ASSESSMENT TOOLS. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S306-S306)
Jakob FJ, Palacios S, Audran M, Brandi ML, Broll J, Hamdy N & McCloskey E (2012) FINAL RESULTS OF A 3 YEARS PROSPECTIVE OBSERVATIONAL COHORT STUDY OF PATIENTS TREATED WITH STRONTIUM RANELATE. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S73-S73)
Kanis JA, Oden A, McCloskey E, Johansson H, Wahl DA & Cooper C (2012) A SYSTEMATIC REVIEW OF HIP FRACTURE INCIDENCE AND PROBABILITY OF FRACTURE WORLDWIDE. OSTEOPOROSIS INTERNATIONAL, Vol. 23 (pp S308-S308)
Neilly E, Gregory JS, Yoshida K, McCloskey E, Reid DM & Barr RJ (2011) . Osteoarthritis and Cartilage, Vol. 19 (pp S179-S179)
Gregson C, Poole K, Steel S, Ayuk J, McCloskey E, Fraser W & Tobias J (2011) . Bone, Vol. 48 (pp S71-S72)
Breart G, Jacob FJ, Palacios S, Audran M, Brandi ML, Broll J, Hamdy NA & McCloskey EV (2011) NEW INTERIM ANALYSIS OF A PROSPECTIVE OBSERVATIONAL COHORT STUDY OF PATIENTS (N=13,069) TREATED WITH STRONTIUM RANELATE. OSTEOPOROSIS INTERNATIONAL, Vol. 22 (pp 269-270)
McCloskey EV, Oden A, Johansson H & Kanis JA (2011) FRAX (R) 2 YEARS AFTER ITS LAUNCH. OSTEOPOROSIS INTERNATIONAL, Vol. 22 (pp 94-94)
McCloskey E, Lewiecki M, Kanis J, Johansson H, Oden A, Austin M, Siris E, Wang A, Libanati C, Chapurlat R & Lorenc R (2011) DENOSUMAB REDUCES THE RISK OF CLINICAL OSTEOPOROTIC FRACTURES IN POSTMENOPAUSAL WOMEN, PARTICULARLY IN THOSE WITH MODERATE TO HIGH FRACTURE RISK AS ASSESSED WITH FRAX (R). OSTEOPOROSIS INTERNATIONAL, Vol. 22 (pp 103-103)
McCloskey E (2011) Care of the elderly: Preventing osteoporotic fractures in older people. Practitioner, Vol. 255(1736) (pp 19-22)
Strom O, Borgstrom F, Kanis J, Compston J, Cooper C, Stenmark J, McCloskey E, Oden A, Johansson H, Olson M & Jonsson B (2011) THE BURDEN OF FRACTURES IN FRANCE, GERMANY, ITALY, SPAIN, SWEDEN, AND THE UK. OSTEOPOROSIS INTERNATIONAL, Vol. 22 (pp 97-97)
Johansson H, Clark P, Carlos F, Olden A, McCloskey E & Kanis J (2011) Increasing Age and Sex Specific Rates of Hip Fracture in Mexico. Projections for 2050. JOURNAL OF RHEUMATOLOGY, Vol. 38(6) (pp 1197-1197)
McCloskey E (2011) KEEPING UP TO DATE: CLINICAL DECISION MAKING - WHAT IS THE EVIDENCE? OSTEOPOROSIS. RHEUMATOLOGY, Vol. 50 (pp 3-3)
McCloskey E, Johansson H, Compston J, Oden A & Kanis J (2011) A COMPARISON OF CASE-FINDING STRATEGIES FOR THE MANAGEMENT OF OSTEOPOROSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 22 (pp 270-270)
Johansson H, Oden A, McCloskey EV & Kanis JA (2010) GUIDANCE FOR THE ADJUSTMENT OF FRAX (R) ACCORDING TO THE DOSE OF GLUCOCORTICOIDS. OSTEOPOROSIS INTERNATIONAL, Vol. 21 (pp S771-S772)
Johansson H, Oden A, Kanis JA, McCloskey EV, Lorentzon M, Ljunggren O, Karlsson MK, Tivesten A, Barrett-Connor E, Ohlsson C & Mellstrom D (2010) LOW VITAMIN D IS RELATED TO INCREASED RISK OF DEATH IN ELDERLY MEN: MROS SWEDEN. OSTEOPOROSIS INTERNATIONAL, Vol. 21 (pp S772-S772)
Gauthier A, Kanis J, Martin M, Compston J, Borgstrom F, Cooper C & McCloskey E (2010) DEVELOPMENT AND VALIDATION OF AN EPIDEMIOLOGICAL MODEL TO ESTIMATE THE BURDEN OF POST-MENOPAUSAL OSTEOPOROSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 21 (pp 20-20)
Johansson H, McCloskey E, Oden A, Kanis J, Lorentzon M, Ljunggren O, Karlsson MK, Orwoll E, Tivesten A, Ohlsson C & Mellstrom D (2010) THE PATTERN OF MORTALITY ASSOCIATED WITH BONE MINERAL DENSITY IN ELDERLY MEN - MROS SWEDEN. OSTEOPOROSIS INTERNATIONAL, Vol. 21 (pp 101-102)
McCloskey E, Kanis J, Johansson H & Oden A (2010) FRAX (R) AND THE EFFECT OF RALOXIFENE ON VERTEBRAL AND NON-VERTEBRAL FRACTURE. OSTEOPOROSIS INTERNATIONAL, Vol. 21 (pp 22-22)
Johansson H, Oden A, Kanis J, Borgstrom F, Strom O, Mellstrom D & McCloskey E (2010) A TRANSLATIONAL APPROACH TO CLINICAL GUIDELINE DEVELOPMENT WITH FRAX (R) BASED ON THE GUIDELINES FOR SWEDEN. OSTEOPOROSIS INTERNATIONAL, Vol. 21 (pp 331-331)
McCloskey E, Johansson H, Oden A, Chines A & Kanis J (2010) BAZEDOXIFENE REDUCES NON-VERTEBRAL FRACTURES IN PATIENTS AT HIGH PROBABILITY OF FRACTURE. OSTEOPOROSIS INTERNATIONAL, Vol. 21 (pp 205-206)
McCloskey E, Johansson H, Oden A, Compston J & Kanis J (2010) A COMPARISON OF CASE-FINDING STRATEGIES FOR THE MANAGEMENT OF OSTEOPOROSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 21 (pp 330-330)
McCloskey E, Johansson H, Chines A, Oden A & Kanis J (2010) . Bone, Vol. 46 (pp S26-S26)
Breart G, Jakob FJ, Palacios S, Audran M, Brandi ML, Broll J, Hamdy NA & McCloskey EV (2010) NEW INTERIM ANALYSIS OF A PROSPECTIVE OBSERVATIONAL COHORT STUDY OF PATIENTS TREATED WITH STRONTIUM RANELATE. OSTEOPOROSIS INTERNATIONAL, Vol. 21 (pp 166-166)
Clark⁎ EM, Hutchinson A, McCloskey E, Stone M, Martin J, Bhalla A & Tobias J (2009) . Bone, Vol. 44 (pp S375-S376)
Yang L, Chen L, Rotter JM, Eastell R, McCloskey EV & Chen J (2009) . BONE, Vol. 44(2) (pp S382-S383)
McCloskey EV (2009) . BONE, Vol. 44(2) (pp S205-S205)
Clark E, Hutchinson A, McCloskey E, Stone M, Martin J, Bhalla A & Tobias J (2009) NOVEL ANALYSIS OF MARGOLIS DIAGRAM ALLOWS IDENTIFICATION OF UNDERLYING VERTEBRAL FRACTURE. OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp S269-S269)
Clark E, Hutchinson A, McCloskey E, Stone M, Martin J, Bhalla A & Tobias J (2009) NOVEL ANALYSIS OF MARGOLIS PAIN DIAGRAM ALLOWS IDENTIFICATION OF UNDERLYING VERTEBRAL FRACTURE. RHEUMATOLOGY, Vol. 48 (pp I12-I12)
Aloumanis K, Eastell R & McCloskey EV (2009) The effect of a history of thyroid disease in skeletal and muscle health and the risk of fractures in elderly women. EUR J CLIN INVEST, Vol. 39 (pp 3-3)
Compston J, McCloskey E & Kanis J (2009) ASSESSMENT AND INTERVENTION THRESHOLDS FOR THE UK USING FRAX (R). OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp S281-S281)
McCloskey E, Johansson H, Oden A & Kanis J (2009) IMPACT OF VARYING BMD RESOURCES ON PREDICTION OF HIP FRACTURE USING FRAX. OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp S266-S266)
Johansson H, Kanis JA, Oden A, Johnell O & McCloskey E (2009) IMPACT OF VARYING BMD RESOURCES ON PREDICTION OF HIP FRACTURE USING FRAX. OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp S200-S200)
McCloskey E, Johansson H, Oden A & Kanis JA (2009) BAZEDOXIFENE REDUCES ALL CLINICAL FRACTURES AND MORPHOMETRIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN AT INCREASED FRACTURE RISK ASSESSED BY FRAX. OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp S199-S200)
Epstein S & McCloskey E (2009) EFFICACY OF ONCE-MONTHLY ORAL BISPHOSPHONATES (IBANDRONATE AND RISEDRONATE) IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp 146-146)
Breart G, Audran M, Brandi ML, Broell J, Hamdy N, Jakob F, McCloskey E & Palacios S (2009) GOOD SAFETY AND PERSISTENCE OF STRONTIUM RANELATE IN A PROSPECTIVE OBSERVATIONAL COHORT STUDY. OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp 94-94)
McCloskey E (2009) FRAX (R): WHAT IT IS AND WHAT IT ISN'T. OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp 183-183)
McCloskey E, Johansson H, Oden A, Johnell O & Kanis JA (2009) IMPACT OF VARYING BMD RESOURCES ON PREDICTION OF HIP FRACTURE USING FRAX (R). OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp 32-32)
McCloskey E, Johansson H, Oden A & Kanis JA (2009) BAZEDOXIFENE REDUCES ALL CLINICAL FRACTURES AND MORPHOMETRIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN AT INCREASED FRACTURE RISK ASSESSED WITH FRAX (R). OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp 16-17)
Strom O, Coelho J, Borgstrom F, Mccloskey E, Oden A, Johansson H & Kanis J (2009) COST-EFFECTIVENESS OF BAZEDOXIFENE IN THE UK AND SWEDEN INCORPORATING THE FRAX (R)-ALGORITHM. OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp 13-13)
Compston J, McCloskey E, Johansson H, Strom O, Borgstrom F, Oden A & Kanis JA (2009) CASE FINDING FOR THE MANAGEMENT OF OSTEOPOROSIS WITH FRAX® - ASSESSMENT AND INTERVENTION THRESHOLDS FOR THE UK. OSTEOPOROSIS INTERNATIONAL, Vol. 20 (pp 19-19)
Yang L, Peel N, Clowes J, McCloskey EV & Eastell R (2008) Use of DXA-based structural engineering models of the proximal femur to predict hip fracture. CALCIFIED TISSUE INT, Vol. 83(1) (pp 5-6)
Boonen S, Marin F, Obermayer-Pietsch B, Simoes ME, Barker C, Glass EV, Hadji P, Lyritis G, Oertel H, Nickelsen T , McCloskey EV et al (2008) . JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, Vol. 93(3) (pp 852-860)
McCloskey E, Johansson H, Oden A & Kanis JA (2008) Impact of Varying BMD Resources on Prediction of Hip Fracture using FRAX (TM). JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 23 (pp S305-S305)
Compston JE, McCloskey E, Johansson H, Strom O, Borgstrorn F, Oden A & Kanis J (2008) Case Finding for the Management of Osteoporosis with FRAX - Assessment and Intervention Thresholds for the UK. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 23 (pp S82-S82)
Stroem O, Borgstroem F, McCloskey E, Anders O, Johansson H & Kanis JA (2008) Incorporating FRAX (TM) Algorithms in Models of Cost-effectiveness. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 23 (pp S8-S8)
Johansson H, Kayan K, Oden A, Kanis JA & McCloskey E (2008) Can fall risk be incorporated into fracture risk assessment algorithms?: A pilot study of responsiveness to bisphosphonates. CALCIFIED TISSUE INTERNATIONAL, Vol. 83(1) (pp 18-18)
Johansson H, Oden A, Kayan K, Kanis J & McCloskey E (2008) Can fall risk be incorporated into fracture risk assessment algorithms: A pilot study of responsiveness to bisphosphonates. CALCIFIED TISSUE INTERNATIONAL, Vol. 82 (pp S54-S54)
McCloskey E, Johansson H, Oden A, Aropuu S, Jalava T & Kanis J (2008) Efficacy of clodronate on fracture risk in women selected by 10-year fracture probability. OSTEOPOROSIS INTERNATIONAL, Vol. 19(11) (pp 1675-1675)
McCloskey E (2008) Vertebral deformities in men: How many are osteoporotic?. OSTEOPOROSIS INTERNATIONAL, Vol. 19(11) (pp 1664-1664)
Yan L, Peel N, Clowes J, McCloskey EV & Eastell R (2007) Use of DXA-Based structural engineering models of the proximal femur to predict hip fracture. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 22 (pp S116-S116)
Schousboe JT, Taylor BC, Kiel DP, Ensrud KE, Wilson KE & McCloskey EV (2007) Abdominal Aortic Calcification (AAC) on Vertebral Fracture Assessment (VFA) images predicts incident myocardial infarction and stroke independent of clinical cardiovascular disease risk factors. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 22 (pp S22-S22)
McCloskey E, Hannon R, Clack G, Miyamoto A & Eastell R (2007) Interaction between body mass index and bone turnover during aromatase inhibition: Evidence from the Letrozole (L), Exemestane (E), and Anastrozole (A) Pharmacodynamics (LEAP) trial. BONE, Vol. 40(6) (pp S161-S162)
Hadji P, Nickelsen T, Marin F, Farrerons J, McCloskey EV, Audran M, Boonen S, Anastasilakis A, Barker C & Obermaier-Pietsch GB (2007) Bone mineral density response to 2 years of continuous treatment with teriparatide: Final results from the EUROFORS study. OSTEOPOROSIS INTERNATIONAL, Vol. 18 (pp S7-S7)
McCloskey E, Johansson H, Oden A, Aropuu S, Jalava T & Kanis J (2007) Efficacy of clodronate on fracture risk in women selected by 10-year fracture probability. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 22 (pp S17-S17)
McCloskey E (2007) Assessment of absolute fracture risk. ANNALS OF THE RHEUMATIC DISEASES, Vol. 66 (pp 29-29)
McCloskey E, Johansson H, Oden A & Kanis JA (2007) Comparison of European and WHO strategies for the identification of women at risk of hip fracture. OSTEOPOROSIS INTERNATIONAL, Vol. 18 (pp S23-S23)
McCloskey E, Hannon R, Lakner G, Clack G, Miyamoto A & Eastell R (2007) Interaction between body mass index and bone turnover during aromatase inhibition: Evidence from the letrozole (L), exemestane (E), and anastrozole (A) pharmacodynamics (LEAP) trial. JOURNAL OF CLINICAL ONCOLOGY, Vol. 25(18)
Bolton CE, Pettit RJ, Stone MD, McCloskey EV, Ionescu AA, Edwards PH, Evans WD & Shale DJ (2006) Bone thinning: Prevalent in COPD but early detection allows treatment opportunity before vertebral fracture occurs. THORAX, Vol. 61 (pp II83-II83)
Tobias JH, Hutchinson AP, Hunt LP, McCloskey EV, Stone MD, Martin JC, Thompson PW, Palferman TG & Bhalla AK (2006) Use of clinical risk factors to identify postmenopausal women with vertebral fractures.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 21 (pp S275-S275)
McCloskey E, Beneton M, Charlesworth D, Orgee J, Pande K, Kersh L, Cliffe J, Peel N, Aropuu S, Jalava T & Kanis J (2006) Offset of effect of bisphosphonates on fracture incidence - Evidence from a prospective controlled trial of clodronate.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 21 (pp S71-S71)
McCloskey E, Hannon R, Lakner G, Clack G, Finkelman RD & Eastell R (2006) The letrozole (L), exemestane (E), and anastrozole (A) pharmacodynamics (LEAP) trial: A direct comparison of bone biochemical measurements between aromatase inhibitors (AIs) in healthy postmenopausal women.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 21 (pp S71-S71)
Yang L, McCloskey EV & Eastell R (2006) A DXA-based composite beam model of the proximal femur for stress estimation. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 21(7) (pp 1161-1161)
McCloskey E, Hannon R, Lakner G, Clack G, Miyamoto A & Eastell R (2006) The letrozole (L), exemestane (E), and anastrozole (A) pharmacodynamics (LEAP) trial: A direct comparison of bone biochemical measurements between aromatase inhibitors (AIS) in healthy postmenopausal women. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 21(7) (pp 1160-1160)
McCloskey E, Hannon R, Lakner G, Clack G, Miyamoto A & Eastell R (2006) The letrozole (L), exemestane (E), and anastrozole (A) pharmacodynamics (LEAP) trial: A direct comparison of bone biochemical measurements between aromatase inhibitors (AIs) in healthy postmenopausal women.. JOURNAL OF CLINICAL ONCOLOGY, Vol. 24(18) (pp 16S-16S)
Johnell O, Kanis JA, Johansson A, Oden A, Delmas PD, Eisman JA, Fujiwara S, Gluer C, Kroger H, McCloskey EV , Mellstrom D et al (2006) A comparison of bone mineral measurements for fracture prediction: A meta-analysis. OSTEOPOROSIS INTERNATIONAL, Vol. 17 (pp S162-S162)
Johnell O, Kanis JA, Johansson H, Oden A, Delmas PD, Eisman JA, Fujiwara S, Kroger H, McCloskey EV, Melton LJ , Pols H et al (2006) Prior clinical vertebral fractures are a particularly strong predictor of hip fracture: A meta-analysis. OSTEOPOROSIS INTERNATIONAL, Vol. 17 (pp S131-S131)
Tobias J, Hutchinson A, Hunt L, McCloskey E, Bhalla A & Stone M (2006) (Poster prize nominee - highly commended) - Use of clinical risk factors to identify postmenopausal women with vertebral fractures. OSTEOPOROSIS INTERNATIONAL, Vol. 17 (pp 408-409)
Kanis JA, Johnell O, Johansson H, Oden A, Delmas PD, Eisman JA, Fujiwara S, Gluer C, Kroger H, McCloskey EV , Melstrom D et al (2006) A comparison of bone mineral measurements for fracture prediction: A meta-analysis. OSTEOPOROSIS INTERNATIONAL, Vol. 17 (pp S9-S9)
McCloskey E, Hannon R, Lakner G, Clack G, Miyamoto A, Finkelman R & Eastell R (2006) Complete data from the letrozole (L), exemestane (E), and anastrozole (A) pharmacodynamic (PD) 'LEAP' trial: direct comparison of safety parameters between aromatase inhibitors (Als) in healthy postmenopausal women.. BREAST CANCER RESEARCH AND TREATMENT, Vol. 100 (pp S111-S111)
Obermayer-Pietsch B, Nickelsen T, Marin F, Barker C, Hadji P, Farrerons J, Audran M, Boonen S, Anastasilakis A & McCloskey E (2006) Response of BMD to 24 months of teriparatide (rhPTH 1-34) in patients with and without prior antiresorptive treatment: Final results from the EUROFORS study.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 21 (pp S43-S43)
McCloskey E, deTakats D, Beneton M, Cliffe J, Reaney L, McGurk C, Charlesworth D, Jalava T & Kanis J (2006) Mild primary hyperparathyroidism is associated with low BMD, but not fracture risk, quality of life or mortality in community dwelling elderly women. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 21(7) (pp 1149-1149)
McCloskey E (2006) Using risk factors for the diagnosis and treatment of osteoporosis. OSTEOPOROSIS INTERNATIONAL, Vol. 17 (pp S113-S114)
(2006) A DXA-based composite beam model of the proximal femur for stress estimation. CALCIFIED TISSUE INTERNATIONAL, Vol. 78 (pp S165-S165)
Yang L, McCloskey EV & Eastell R (2005) The cross section geometry of the femoral neck.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 20(9) (pp S65-S65)
Johnell O, Kanis JA, Oden A, Johansson H, Gluer C, Fujiwara S, McCloskey EV, Melton LJ & Delmas P (2005) A comparison of total hip BMD as a predictor of fracture risk: A meta-analysis. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 20(9) (pp S4-S4)
McCloskey EV, Paterson AHG & Powles TJ (2005) Effects of oral clodronate (BONEFOS (R)) therapy on bone turnover and skeletal metastases in women with primary breast cancer.. BREAST CANCER RESEARCH AND TREATMENT, Vol. 94 (pp S21-S21)
McCloskey E, Eastell R, Hannon RA, Lakner G, Miyamoto A & Clack G (2005) Initial results from the LEAP Study: the first direct comparison of safety parameters between aromatase inhibitors (AIs) in healthy postmenopausal women. BREAST CANCER RESEARCH AND TREATMENT, Vol. 94 (pp S101-S102)
McCloskey E, Powles T & Paterson A (2005) Skeletal protective effect of clodronate in primary breast cancer-bone mass, bone turnover, and skeletal-related events (SRE's). EJC SUPPLEMENTS, Vol. 3(2) (pp 97-97)
McCloskey E, deTakats D, Orgee J, Aropuu S, Jalava T, Cliffe J, Reaney L, McGurk C, Charlesworth D & Kanis JA (2005) Characteristics associated with non-persistence during daily therapy - Experience from the placebo wing of a community-based clinical trial.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 20(9) (pp S282-S282)
McCloskey E, Charlesworth D, Bostock J, Eastaugh J, Bonnet N, Beneton M, Jalava T & Kanis J (2005) Utility of MXA for detecting prevalent fractures - Experience from a large epidemiological study. BONE, Vol. 36 (pp S116-S116)
McCloskey E, Paterson AHG & Powles TJ (2005) Oral clodronate maintains bone mass in women with primary breast cancer.. JOURNAL OF CLINICAL ONCOLOGY, Vol. 23(16) (pp 12S-12S)
McCloskey E (2005) Vertebral deformities in men: How many are osteoporotic?. OSTEOPOROSIS INTERNATIONAL, Vol. 16(5) (pp S6-S7)
McCloskey E, Selby P, Davies M, Robinson J, Francis RM, Adams J, Beneton M, Charlesworth D, Rosnell J & Kanis J (2004) Early offset of the action of clodronate after 3 years of treatment in osteoporosis. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S55-S56)
Kanis JA, Johansson H, Oden A, De Laet C, Johnell O, Eisman JA, McCloskey EV, Mellstom D, Pols H, Reeve J , Silman A et al (2004) A meta-analysis of milk intake and fracture risk. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 19 (pp S429-S429)
Johnell O, Kanis JA, Johansson H, Oden A, De Laet C, Eisman JA, McCloskey EV, McCloskey EV, Mellstrom D, Melton LJ , Pols HAP et al (2004) A family history of fracture and fracture risk: A meta-analysis.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 19 (pp S91-S91)
Barker ME, McCloskey EV, Saha S, Gossiel F, Powers HJ & Blumsohn A (2004) Plasma retinol and retinyl esters as predictors of incident osteoporotic fracture in elderly women.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 19 (pp S6-S6)
Brown JE, McCloskey E, Dewar JA, Body JJ, Cameron DA, Purohit OPK, Harnett A, Tahtela R, Kurkilahti M & Coleman RE (2004) A double blind, parallel, placebo controlled, dose ranging study on efficacy and safety of oral clodronate in cancer induced osteolysis measured by biochemical markers of bone resorption.. JOURNAL OF CLINICAL ONCOLOGY, Vol. 22(14) (pp 743S-743S)
McCloskey EV, Vasireddy S, Cliffe J, Reaney L, Charlesworth D, McGurk C, Jalava T, Beneton MNC & Kanis JA (2004) Fractures and all-cause mortality in a population sample of elderly women; Observations from the MRC HIP study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 19(6) (pp 1032-1032)
Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA, Fujiwara S, Kroger H, McCloskey EV, Mellstrom D , Melton LJ et al (2004) Smoking and fracture risk: A meta-analysis. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S10-S10)
Vasireddy S, Cliffe J, Reaney L, Charlesworth D, McGurk C, Jalava T, Beneton MNC, Kanis JA & McCloskey EV (2004) Fractures and all-cause mortality in a population sample of elderly women: Observations from the MRC HIP study. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S9-S9)
Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Garnero P, Fujiwara S, Kroger H , McCloskey EV et al (2004) A meta-analysis of BMD as a predictor of fracture risk. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S5-S5)
McCloskey E, de Takats D, Beneton M, Cliffe J, Reaney L, McGurk C, Charlesworth D, Jalava T & Kanis J (2004) Mild primary hyperparathyroidism is associated with low BMD but not fracture risk, quality of life or mortality in community dwelling elderly women.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 19 (pp S102-S102)
Powles T, Paterson A, McCloskey E, Kurkilahti M & Kanis J (2004) Oral clodronate for adjuvant treatment of operable breast cancer: Results of a randomized, double-blind, placebo-controlled multicenter trial. JOURNAL OF CLINICAL ONCOLOGY, Vol. 22(14) (pp 9S-9S)
Vasireddy S, Kayan K, Jalava T, McGurk C, Reaney L, Kanis J & McCloskey E (2004) EFFECT OF MEDICAL RISK FACTORS, MUSCLE STRENGTH AND FALLS HISTORY ON FRACTURE INCIDENCE. RHEUMATOLOGY, Vol. 43 (pp 56-56)
Powles T, McCloskey E & Paterson A (2004) Oral clodronate (BONEFOS (R)) reduces skeletal complications and mortality in breast cancer patients with bone metastases: retrospective analysis of patients from a randomized, placebo-controlled trial. BREAST CANCER RESEARCH AND TREATMENT, Vol. 88 (pp S131-S131)
Bal S, McCloskey E, Selby P, Davies M, Robinson J, Francis RM, Adams J, Dey A, Ashford R, deTakats D , Beneton M et al (2003) Offset of the action of Clodronate (Bonefos (R)) after 3 years of treatment in women with osteoporosis.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18 (pp S159-S159)
Csupor E, Toth E, Ferencz V, Szucs J, Lakatos P, Horanyi J, Perner F, McCloskey EV & Horvath C (2003) Does the location of the parathyroid adenoma influence kidney stone formation in primary hyperparathyroidism?. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18 (pp S391-S391)
Kanis JA, Oden A, Johansson H, De Laet C, McCloskey EV, Kayan K, Jalava T, Oglesby A & Johnell O (2003) The use of BMD for therapeutic decision making.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18 (pp S57-S57)
McCloskey E, Jalava T, Oden A, Johansson H, Kayan K, Beneton M, Brazier J, Nicholl J, Richards A, Cliffe J , Reaney L et al (2003) The efficacy of clodronate (Bonefos (R)) to reduce the incidence of osteoporotic fractures in elderly women is independent of the underlying BMD.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18 (pp S92-S92)
Vasireddy S, Bal SK, Reaney L, Kanis JA & McCloskey EV (2003) Semi-automated metacarpal morphometry (metacarpal cortical index) predicts fracture risk in elderly women. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18(7) (pp 1374-1374)
Pande KC, Pande SK, DeTakats D & McCloskey EV (2003) The use of plain radiograph of the calcaneum for evaluation of osteoporosis?. BONE, Vol. 32(5) (pp S179-S179)
Kanis JA, Oden A, Johansson H, De Laet C, McCloskey EV, Kayan K, Jalava T & Johnell O (2003) Optimisation of case finding with bone mineral density. BONE, Vol. 32(5) (pp S142-S142)
Kanis JA, Delmas P, Reeve J, Garnero P, Tenenhouse A, Melton JL, Oden A, McCloskey EV, Pols H & De Laet C (2003) A meta-analysis of previous fracture and fracture risk. BONE, Vol. 32(5) (pp S84-S84)
Bal SK, Powles T, Paterson S, Kanis JA, Ashley S, Tidy A, Beneton M, Atula S, Nevalainen J, Pylkkanen L & McCloskey EV (2003) Adjuvant clodronate therapy in primary operable breast cancer - Duration and offset of effects on bone mineral density. OSTEOPOROSIS INTERNATIONAL, Vol. 14 (pp S10-S10)
Sanders DS, Patel D, Khan FB, Westbrook RH, Webber CV, Ward AM, Lobo AJ & McCloskey EV (2003) The prevalence of unrecognised adult coeliac disease in patients with reduced bone mineral density: A case finding approach. GUT, Vol. 52 (pp A38-A38)
Vasireddy S, Haigh C, Adams JE, Jalava T, McCloskey E & Grp VOTS (2003) Digital X-ray radiogrammetry (DXR) of the metacarpals in the prediction of vertebral fracture and monitoring bone density in a study of Clodronate therapy. OSTEOPOROSIS INTERNATIONAL, Vol. 14 (pp S6-S6)
McCloskey E, Jalava T, Vasireddy S, Bal S, Beneton M, Charlesworth D, Kanis J & Blumsohn A (2003) Relative importance of BMD, markers of bone turnover, height and body weight as predictors of hip fracture - A prospective case-control study.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18 (pp S84-S84)
Vasireddy S, Bal S, Reaney L, McGurk C, Kanis J & McCloskey E (2003) Metacarpal BMD and cortical index are significant predictors of hip fracture.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18 (pp S65-S65)
De Laet CED, Johansson H, Johnell O, Kanis J, McCloskey EV, Mellstrom D, Melton LJ, Oden A, Delmas P, Garnero P , Oglesby A et al (2003) A meta-analysis of body mass index (BMI) as a predictor of fracture risk. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18 (pp S21-S21)
Bal SK, Tahtela R, Paterson A, Powles T, Atula S, Kanis J, Vasireddy S, Nevalainen J & McCloskey E (2003) Biochemical markers of bone turnover are associated with risk of bone metastases in women with primary operable breast cancer. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18(7) (pp 1362-1362)
Bal SK, Kayan K, Richards A, Vasireddy S, Cliffe J, Hinch A, McGurk C, Jalava T, Beneton M, Kanis JA & McCloskey EV (2002) Maternal hip fracture and current smoking are not associated with hip fracture risk in elderly women in the UK.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 17 (pp S462-S462)
Toth E, Meszaros S, Ferencz V, Csupor E, Bors K, McCloskey EV & Horvath C (2002) Nasal calcitonin increases spinal bone density in male osteoporosis without vertebral deformity.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 17 (pp S275-S275)
Horvath C, Hosszu E, Meszaros S, Ferencz V, Bors K & McCloskey EV (2002) Senile defect in the renal activation of vitamin D.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 17 (pp S277-S277)
Vasireddy S, Haigh C, Reaney L, Adams J, Selby PL, Bal SK, Ashford R, Charlesworth D, Kanis JA, Jalava T , Beneton M et al (2002) Digital X-ray radiogrammetry indices,particularly MCI, can predict vertebral fracture risk in osteoporotic women.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 17 (pp S186-S186)
Haigh C, Reaney L, Adams J, Davies M, Selby PL, Robinson J, Francis R, Dey A, Kanis JA, Bostock J , Horvath C et al (2002) Digital X-ray radiogrammetry indices are sensitive to clodronate treatment in women with osteoporosis.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 17 (pp S231-S231)
McCloskey E, Kanis J, Paterson A, Powles T, Beneton M, Tahtela R, Atula S & Nevalainen J (2002) Serum PINP, an index of bone turnover, but not bone mineral density, may be predictive of bone metastases in women with primary operable breast cancer.. BREAST CANCER RESEARCH AND TREATMENT, Vol. 76 (pp S142-S142)
Adams JE, Haigh C, Reaney L, Davies M, Javala T & McCloskey E (2002) Changes can be monitored by digital X-ray radiogrammetry (DXR) in women on clodronate treatment for osteoporosis. RADIOLOGY, Vol. 225 (pp 419-419)
Powles T, McCloskey E, Paterson A, Kanis J, Ashley S, Tidy A, Rosenqvist K, Smith I, Ottestad L, Legault S , Pajunen M et al (2002) Clodronate decreases the incidence of skeletal metastases in primary breast cancer - A randomised, placebo-controlled study.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 17 (pp S185-S185)
Atula S, Kants J, McCloskey E, Paterson A, Pylkkanen L, Nevalamen J & Powles T (2002) Safety profile of oral clodronate during long-term use in breast cancer patients. BONE, Vol. 30(3) (pp 46S-46S)
Ashford RU, Dey A, Kayan K, Delaney H, Nissen DS, Ambjerg D, Reaney L, McGurk C & McCloskey E (2001) Digital X-ray Radiogrammetry predicts hip fracture in elderly women.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 16 (pp S194-S194)
Ashford RU, Powles T, Paterson S, Beneton M, Kanis J, Spector T, Pylkkanen L, Nevalainen J & McCloskey E (2001) BMD at diagnosis of primary operable breast doesn't influence the incidence of skeletal metastases.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 16 (pp S455-S455)
Kayan K, Ashford RU, Dey A, Charlesworth D, Bostock J & McCloskey EV (2001) HIP axis length a predictor of HIP fracture in elderly women in England. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 16(6) (pp 1182-1182)
Patel S, Kwan JTC, McCloskey E, McGee G, Thomas G, Johnson D, Wills R, Ogunremi L & Barron J (2000) Prevalence and causes of low bone density and fractures in kidney transplant patients.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 15 (pp S571-S571)
Jalava T, Mawer B, Sarna S, Pylkkanen L, Kanis JA & McCloskey E (2000) Health and vitamin D status in osteoporotic patients with and without vertebral fracture. OSTEOPOROSIS INTERNATIONAL, Vol. 11 (pp S97-S97)
Kanis JA, McCloskey EV, de Takats D & Pande K (1999) Clinical assessment of bone mass, quality and architecture. OSTEOPOROSIS INTERNATIONAL, Vol. 9 (pp 24-28)
deTakats D, McCloskey E, Bernard J, Orgee J, Coombes G, Khan S, Nicholl J, Brazier J, Beneton M, Charlesworth D & Kanis J (1997) Effects of clodronate on hip BMD in community-dwelling women: Randomised trial: 1 year results.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 12 (pp S490-S490)
McCloskey EV, Gray RL, Kanis JA, Luchetti M, diGiovine F & Ralston SH (1997) COLIA1 Sp1 polymorphism and bone mass in elderly women. J BONE MINER RES, Vol. 12 (pp S547-S547)
Powles TJ, McCloskey E, Paterson AHG, Ashley S, Tidy A & Kanis J (1997) The effect of oral clodronate on bone mineral density in women with primary breast cancer. EUROPEAN JOURNAL OF CANCER, Vol. 33 (pp 344-344)
Paterson AHG, Kanis JA, Powles T, McCloskey EV & Ashley S (1997) Clodronate as an adjuvant to hormone and chemotherapy in patients with breast cancer. ADJUVANT THERAPY OF CANCER VIII, Vol. 8 (pp 153-162)
McCloskey EV, McLennan I, Chapman K, Grayson M & Kanis JA (1996) Vertebral fracture, loss of height and treatment with clodronate in myeloma.. J BONE MINER RES, Vol. 11 (pp T732-T732)
Beneton MNC, deTakats BJ, McCloskey EV & Kanis JA (1996) Image-based ultrasound attenuation assessment of the heel.. J BONE MINER RES, Vol. 11 (pp S611-S611)
Kanis JA, McCloskey EV, MacLennan I, Drayson M, Chapman C & Dunn J (1996) Effect of clodronate on the natural history of myelomatosis. BRIT J HAEMATOL, Vol. 93 (pp 1136-1136)
Kanis JA, McCloskey EV, Beneton MNC, Bernard J & deTakats D (1996) Bone measurements with DXA and ultrasound: Diagnostic and prognostic use. OSTEOPOROSIS 1996, Vol. 1118 (pp 181-190)
Bernard J, McCloskey E, deTakats D, Luchetti M, Parry A, Beneton M & Kanis JA (1996) Tibial ultrasound velocity and skeletal status in the normal population.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 11 (pp S632-S632)
deTakats D, McCloskey E, Bernard J, Beneton M, Charlesworth D & Kanis JA (1996) Comparison of normative data for skeletal assessment at the spine, hip and forearm.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 11 (pp S588-S588)
McCloskey EV, MacLennan ICM, Drayson M, Chapman C, Dunn J & Kanis JA (1995) Effect of clodronate on progression of skeletal disease in multiple myelomatosis. EUR J CANCER, Vol. 31A (pp 775-775)
Paterson AHG, McCloskey EV, Ashley S, Powles T & Kanis JA (1995) Effect of oral clodronate in women with recurrent breast cancer in the absence of skeletal metastases. EUR J CANCER, Vol. 31A (pp 368-368)
KANIS JA, POWLES TJ, PATERSON AHG, MCCLOSKEY EV & ASHLEY S (1995) CLODRONATE DECREASES THE FREQUENCY OF SKELETAL METASTASES IN WOMEN WITH BREAST-CANCER. J BONE MINER RES, Vol. 10 (pp S194-S194)
TAUBE T, MCCLOSKEY E, KHAN S, ORGEE J, COOMBES G, PHILLIPS R & KANIS J (1995) PHYSICAL RISK-FACTORS FOR HIP FRACTURE IN ELDERLY WOMEN IN THE COMMUNITY AND NURSING-HOMES. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 10 (pp S362-S362)
COOMBES G, MCCLOSKEY E, ORGEE J, KHAN S, BENETON M, CHARLESWORTH D & KANIS J (1995) A COMPARISON OF RADIOGRAPHIC VERTEBRAL MORPHOMETRY AND MXA IN ESTABLISHED VERTEBRAL OSTEOPOROSIS. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 10 (pp S473-S473)
MCCLOSKEY E, KHAN S, ORGEE J, COOMBES G, TAUBE T, PHILLIPS R, BRAZIER J, NICHOLL J & KANIS J (1995) ORAL CLODRONATE PREVENTS BONE LOSS AT THE HIP IN ELDERLY WOMEN - A PILOT-STUDY. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 10 (pp S356-S356)
ORGEE J, MCCLOSKEY E, KHAN S, COOMBES G, BENETON M, CHARLESWORTH D & KANIS J (1995) SKELETAL STATUS OF ELDERLY WOMEN WITH AND WITHOUT VERTEBRAL DEFORMITY. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 10 (pp S473-S473)
KHAN S, BRENNAN P, NEWMAN G, GRAY R, MCCLOSKEY E & KANIS J (1995) PAGETS-DISEASE OF BONE AND UNVACCINATED DOGS. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 10 (pp S404-S404)
MCCLOSKEY E, DOYLE D, KANIS J & SPECTOR TD (1995) INCIDENCE OF VERTEBRAL DEFORMITY IN POSTMENOPAUSAL WOMEN - THE CHINGFORD-STUDY. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 10 (pp S260-S260)
REEVE J, LUNT M, FELSENBERG D, BENEVOLENSKAYA L, CANNATA J, DEQUEKER J, DODENHOF C, FALCH J, MCCLOSKEY E, MASARYK P , POLS H et al (1995) VARIATIONS IN VERTEBRAL DEFORMITY PREVALENCE IN EUROPE ARE STATISTICALLY DEPENDENT ON POPULATION DIFFERENCES IN BONE-DENSITY - THE EVOS-STUDY. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 10 (pp S260-S260)
KHAN S, MCCLOSKEY EV, SIRTORI P, NAKATSUKA K, FOSTER H & KANIS JA (1993) THE EFFECT OF ORAL ALENDRONATE IN THE TREATMENT OF PAGETS-DISEASE OF THE BONE. J BONE MINER RES, Vol. 8 (pp S286-S286)
MCCLOSKEY EV, ASHLEY S, PATERSON AHG, POWLES T & KANIS JA (1993) COMPLIANCE AND EFFICACY OF CLODRONATE IN METASTATIC SKELETAL DISEASE IN BREAST-CANCER. J BONE MINER RES, Vol. 8 (pp S286-S286)
MCCLOSKEY EV, ORGEE J, FOSTER H & KANIS JA (1993) RISK-FACTORS IN SENILE OSTEOPOROSIS. RECENT ADVANCES IN AGING SCIENCE, VOLS I AND II (pp 1145-1150)
Kanis JA, Aaron J, Beneton M & McCloskey E (1992) Treatment of established osteoporosis. European Journal of Internal Medicine, Supplement, Vol. 3(1) (pp 125-133)
SPECTOR TD, HALL GM & MCCLOSKEY EV (1992) THE PREVALENCE OF VERTEBRAL FRACTURES IN FEMALES WITH RHEUMATOID-ARTHRITIS. ARTHRITIS RHEUM, Vol. 35(9) (pp S130-S130)
MCCLOSKEY EV, ASHLEY S, PATERSON AHG, POWLES T & KANIS JA (1992) ORAL CLODRONATE REDUCES SKELETAL MORBIDITY IN METASTATIC BREAST-CANCER. J BONE MINER RES, Vol. 7 (pp S152-S152)
MCCLOSKEY EV, SPECTOR TD, EYRES KS, OROURKE N, FERN DE & KANIS JA (1992) RELATIONSHIP BETWEEN CRITERIA FOR VERTEBRAL DEFORMITY AND BONE MASS IN A POPULATION STUDY. J BONE MINER RES, Vol. 7 (pp S137-S137)
KHAN S, EYRES KS, MCCLOSKEY EV, FERN ED, OROUKE N & KANIS JA (1992) EFFECTS OF ORAL DICHLOROMETHYLENE DIPHOSPHONATE (CL2MDP) IN THE TREATMENT OF PAGETS-DISEASE OF BONE. J BONE MINER RES, Vol. 7 (pp S293-S293)
EYRES KS, FERN ED, MCCLOSKEY EV, KHAN S & KANIS JA (1992) EFFECTS OF INTRAVENOUS DICHLOROMETHYLENE DIPHOSPHONATE (CL2MDP) IN THE TREATMENT OF PAGETS-DISEASE OF BONE. J BONE MINER RES, Vol. 7 (pp S292-S292)
MCCLOSKEY EV, SPECTOR TD, EYRES KS, OROURKE N, FERN DE, MACLENNAN I & KANIS JA (1992) ASSESSMENT OF VERTEBRAL DEFORMITY - VALIDATION OF A NEW METHOD WITH HIGH SPECIFICITY. J BONE MINER RES, Vol. 7 (pp S185-S185)
SPECTOR TD, HALL GM & MCCLOSKEY EV (1992) THE PREVALENCE OF VERTEBRAL FRACTURES IN FEMALES WITH RHEUMATOID-ARTHRITIS. BRIT J RHEUMATOL, Vol. 31 (pp 94-94)
PATERSON AHG, ERNST DS, POWLES TJ, ASHLEY S, MCCLOSKEY EV & KANIS JA (1991) TREATMENT OF SKELETAL DISEASE IN BREAST-CANCER WITH CLODRONATE. BONE, Vol. 12 (pp S25-S30)
KANIS JA, MCCLOSKEY EV, OROURKE N, PRESTON E, GREAVES M, EYRES K & VASIKARAN S (1991) BISPHOSPHONATES IN THE MANAGEMENT OF HYPERCALCEMIA OF MALIGNANCY. TUMOUR INDUCED HYPERCALCAEMIA AND ITS MANAGEMENT, Vol. 176 (pp 59-70)
KANIS JA, MCCLOSKEY EV, EYRES KS, OROURKE N & AARON J (1991) DIAGNOSTIC METHODOLOGY IN THE EVALUATION OF OSTEOPOROSIS. REHABILITATION MEDICINE /, Vol. 928 (pp 79-94)
GRAY RES, YATES AJP, SMITH R, MURRAY S, RUSSELL RGG, MCCLOSKEY E & KANIS JA (1986) OPTIMIZING TREATMENT OF PAGETS-DISEASE OF BONE. CALCIFIED TISSUE INTERNATIONAL, Vol. 39 (pp A75-A75)
URWIN GH, PERCIVAL RC, GRAY RES, MURRAY S, HAMDY NAT, GALLOWAY J, GUILLANDCUMMING DF, MCCLOSKEY EV, WILLIAMS JL & KANIS JA (1986) CALCIUM AND PHOSPHATE HOMEOSTASIS IN DISSEMINATED PROSTATIC-CANCER - EVIDENCE FOR SECONDARY HYPERPARATHYROIDISM. CALCIFIED TISSUE INT, Vol. 39 (pp A107-A107)
Gossiel F, McCloskey E, Walsh J, Naylor K, Peel N & Eastell R () . Bone Abstracts

Datasets

Montefiori E, Kalkman B, Mazza C, Paggiosi M, McCloskey E & Henson W .
Tai ZA, Montefiori E, Veen BV, Paggiosi M, McCloskey E, Viceconti M, Mazza C & Li X .

Preprints

Axelsson KF, Wallander M, Johansson H, Harvey NC, Vandenput L, McCloskey E, Liu E, Kanis JA, Litsne H & Lorentzon M () .
Almog YA, Rai A, Zhang P, Moulaison A, Powell R, Mishra A, Weinberg K, Hamilton C, Oates M, McCloskey E & Cummings SR () , JMIR Publications Inc..
Forgetta V, Keller-Baruch J, Forest M, Durand A, Bhatnagar S, Kemp J, Morris JA, Kanis JA, Kiel DP, McCloskey EV , Rivadeneira F et al () , Cold Spring Harbor Laboratory.

Research group

Current Collaborators

Prof T Skerry
Prof M Brown

Postgraduate Students

Lucy Harris

Teaching activities: I am the educational lead and teaching coordinator for Musculoskeletal Medicine across the various phases of the undergraduate curriculum at the University of ΢��Ȧ, as well as teaching on postgraduate courses (e.g. MSc in Molecular Medicine, Molecular and Cellular Basis of Disease module).

Professional activities and memberships

I am currently secretary of the Bone Research Society, chair of the American Society for Bone and Mineral Research Ancillary Program Committee and a member of the National Specialty Group for Musculoskeletal Diseases.

I also chair the Implementation Committee of the National Osteoporosis Guidance Group.

΢��Ȧ

School of Medicine and Population Health

School of Medicine and Population Health

Professor Eugene McCloskey

Current Projects

Featured publications

Journal articles

All publications

Journal articles

Chapters

Conference proceedings papers

Datasets

Preprints

Current Collaborators

Postgraduate Students

Links